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Abstract 
 
Protein kinase B (PKB) plays a key role in the phosphoinositide 3-kinase pathway, 
one of the most frequently activated proliferation pathways in cancer. A key stage in 
this pathway is PKB’s translocation to the plasma membrane, which is driven by 
direct interaction of PKB’s pleckstrin homology (PH) domain with the inositol 
phosphate head-groups of phosphoinositide lipids PtdIns(3,4,5)P3 and PtdIns(3,4)P2.  
 
In this thesis a computational approach has been applied to study the interaction 
between PKB’s PH domain and the inositol phosphate head-groups of 
phosphoinositide lipids. Herein the first full set of parameters for these inositol 
phosphates has been generated using a clearly defined algorithmic approach.  The 
parameters have been applied in a total of 6 µs of molecular dynamics (MD) 
simulations to investigate the interaction between inositol phosphates and the PKB 
PH domain. The simulations successfully mirror, and additionally rationalise, PKB’s 
experimental interactions and behaviour. As well as investigating the native system, a 
PKB mutant that has been reported in multiple human cancers has also been explored. 
This PKB mutant constitutively targets the plasma membrane due to its broadened 
phosphoinositide selectivity. The atomic-level view available from MD simulations 
has helped elucidate the molecular mechanism behind this.  
 
Information obtained about the PKB PH domain’s binding interface has been used to 
design inositol phosphate derivatives to inhibit PKB activation. MD simulations have 
allowed a number of inositol phosphate derivatives to be rapidly screened for their 
inhibitory behaviour. The predicted behaviour of a select number of these derivatives 
has been further assessed using biochemical techniques. Gratifyingly, the 
computational and biochemical results are shown to be in good agreement. 
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“Concern for man and his fate must always form the chief interest of all technical 
endeavours. Never forget this in the midst of your diagrams and equations.” 
 
Albert Einstein 
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Chapter 1 – Introduction to Biological System 
 
1. 1 Phosphoinositides and Inositol Phosphates  
 
1. 1. 1 Structure 
 
Phosphoinositides (PtdInsPns) are anionic glycerophospholipids present on the 
cytosolic face of eukaryotic cell membranes. They consist of a D-myo-inositol 
phosphate head-group covalently linked to a phosphatidate tail via a phosphodiester 
linkage at the 1-position of the inositol ring, Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The seven naturally occurring phosphoinositides. The D-myo-inositol head-group is 
covalently linked to a hydrophobic phosphatidate tail. The phosphatidate tail consists of glycerol bound 
to two long lipophilic fatty acid esters (referred to as diacyl glycerol) plus the phosphodiester. All 
seven naturally occurring phosphoinositides are illustrated, plus phosphatidylinositol (PtdIns). 
Substitution Name 
X=Y=Z=OH 
X=Y=Z=OH 
PtdIns 
PtdIns OPO( )2,Y=Z=OH (3)P 
Y=OPO(OH)2, X=Z=OH PtdIns(4)P 
Z=OPO(OH)2, X=Y=OH PtdIns(5)P 
X=Y=OPO(OH)2, Z=OH PtdIns(3,4)P2 
X=Z=OPO(OH)2, Y=OH PtdIns(3,5)P2 
Y=Z=OPO(OH)2, X=OH PtdIns(4,5)P2 
X=Y=Z=OPO(OH)2 PtdIns(3,4,5)P3 
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The inositol head-group is responsible for the main properties and interactions of 
phosphoinositide lipids. The hydroxyl groups on the inositol ring can be 
phosphorylated at the 3-, 4- and 5-positions in different combinations to form a family 
of seven phosphoinositides, illustrated in Figure 1.1 The levels of these 
phosphoinositides in the cell are regulated by a variety of kinases and phosphatases, 
which reversibly phosphorylate and dephosphorylate the hydroxyl groups on the 
inositol ring. Dysregulation of these enzymes is associated with a large number of 
human diseases, highlighting the importance of phosphoinositides in a variety of 
cellular functions, Figure 2.2  
 
 
 
Figure 2: The inter-conversion of the naturally occurring phosphoinositides. Diagram adapted 
from McCrea and De Camilli.2 Diseases associated with the kinases and phosphatases regulating the 
phosphoinositides are illustrated. Kinases and phosphatases are displayed with red and blue arrows 
respectively. PI3K, PI4K and PI5K represent phosphoinositide 3-kinases, 4-kinases and 5-kinases 
respectively. 4-Ptase and 5-Ptase represent phosphoinositide 4-phosphatases and 5-phosphatases 
respectively. MTM and MTMR refer to myotubularin and myotubularin related proteins. hJUMPY is a 
3-phosphatase. AML and ALL represent acute myeloid leukemia and acute lymphoblastic leukemia 
respectively. ALS represents amyotrophic lateral sclerosis. 
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Whilst inositol phosphates form the hydrophilic head-groups of phosphoinositide 
lipids, they also exist as soluble ligands found in the cytosol of the cell. These are also 
interconverted by families of kinases and phosphatases. 
 
1. 1. 2 Charge State 
 
At physiological pH phosphomonoesters are negatively charged and adopt either a 
fully deprotonated or singly deprotonated state, as shown for methyl phosphate in 
Figure 3. However, which of these protonation states the phosphomonoester groups of 
phosphoinositides and inositol phosphates adopt is difficult to assign. This is due to 
the extremely complex ionisation behaviour of these molecules, discussed in detail in 
Chapters 4 and 5.3-5 
 
 
 
 
Figure 3: The pKa values of the first and second deprotonations of methyl phosphate.6 The pKa 
value for the second deprotonation is close to physiological pH.  
 
 
1. 1. 3 Function 
 
Phosphoinositide lipids comprise approximately 1% of phospholipids in the plasma 
membrane.7 Despite being only a minor component of the membrane, they are 
involved in a number of critical cell processes. They provide docking sites for a 
variety of proteins that play important roles in signal transduction, cytoskeletal 
dynamics and membrane trafficking.8, 9  
 
Proteins are recruited to the plasma membrane via their phosphoinositide-binding 
domains of which there are several, including FYVE, ENTH, ANTH, PX and PH 
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domains.7, 10 These domains have a characteristic cationic pocket lined with basic 
amino acids that interact with the anionic inositol phosphate head-groups of 
phosphoinositide lipids, Figure 4.  
 
 
Figure 4: The cationic pocket of the PKB PH domain interacting with the inositol phosphate 
head-group of PtdIns(3,4,5)P3. The electrostatic surface potential of the PKB PH domain is 
illustrated, with blue areas (+10 kcal mol-1  e-1) representing positively charged residues and red areas 
(-10  kcal mol-1 e-1) representing negatively charged residues.  PDB accession code 1UNQ.11  
 
 
Phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] is the most abundant 
polyphosphorylated phosphoinositide in mammalian cells. As well as acting as a 
docking site for intracellular proteins, PtdIns(4,5)P2 can also be cleaved to form the 
second messengers Ins(1,4,5)P3 and diacylglycerol (thereby providing a link between 
the families of phosphoinositides and inositol phosphates).12, 13  
 
Under basal conditions the levels of the 3-phosphorylated phosphoinositides, 
PtdIns(3,4,5)P3 and PtdIns(3,4)P2, are much lower than that of PtdIns(4,5)P2. These 
3-phosphorylated phosphoinositides only constitute approximately 0.0001% of the 
cell membrane.7, 14 In contrast, PtdIns(4,5)P2 is thought to typically be 500 times more 
abundant.7, 14  
 20 
1. 2 Protein Kinase B 
 
1. 2. 1 Structure 
 
Protein kinase B (PKB) is a serine/threonine kinase at the focus of many cell 
signalling pathways. There are 3 known mammalian isoforms of PKB (PKB!, PKB", 
PKB#) which all show a high sequence homology. Each of these isoforms consists of 
3 functional domains: an N-terminal pleckstrin homology (PH) domain, a kinase 
domain, and a C-terminal regulatory domain containing a hydrophobic motif.  
 
 
 
Figure 5: The three PKB isoforms. Each isoform consists of three domains: an N-terminal 
phosphoinositide binding PH domain, a kinase domain, and a C-terminal regulatory domain. The 
threonine and serine residues highlighted undergo phosphorylation to produce the active protein.  
 
 
All three PKB isoforms share common roles, as well as exhibiting individual 
functionality. Whilst PKB! and PKB" are expressed throughout the body, PKB# is 
predominantly expressed in the brain, heart and kidney.15, 16 The isoform considered 
throughout this work is PKB!, which is frequently found to be elevated in human 
cancers.17 
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1. 2. 1. 1 Pleckstrin Homology Domain 
 
Pleckstrin homology domains are one of the most widely investigated lipid binding 
domains and are found in a large variety of proteins.18 They consist of approximately 
100-120 amino acids and, despite their low sequence homology, form a conserved 
secondary and tertiary structure. 
 
Pleckstrin homology domains are constructed from two perpendicular "-sheets, 
referred to as a "-sandwich, capped by a C-terminal amphipathic helix at one corner, 
Figure 6. The perpendicular "-sheets are constructed from 3 and 4 antiparallel 
"-strands respectively. Three of the loops linking the "-strands are of particular 
interest due to their variable length and structure in different proteins, referred to as 
variable loops. These loops typically contain numerous cationic residues, forming a 
surface that can interact with poly-anionic ligands.19 They are therefore thought to be 
partly responsible for the different specificities of various PH domains.20 PH domains 
typically fall into four different categories with regards to their in vitro affinities for 
different phosphoinositides:21 
 
• Group 1: PH domains specifically bind to PtdIns(3,4,5)P3. 
• Group 2: PH domains have a high affinity for both PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3. 
• Group 3: PH domains bind to PtdIns(3,4,5)P3 and PtdIns(3,4)P2 with greatest 
affinity. 
• Group 4: PH domains that exhibit a low binding affinity for 
phosphoinositides, but are able to bind non-phosphoinositide ligands.  
 
The PKB PH domain falls into group 3. 
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Figure 6: Crystal structure of the PKB! PH domain. The !–helix, "-sandwich, and variable loops 1, 
2 and 3 (VL1, VL2 and VL3) are highlighted. PDB accession code 1UNQ.11  
 
 
1. 2. 2 PKB! PH domain-Phosphoinositide Interaction 
 
It is the distinct arrangement of hydroxyl and phosphomonoester substitution on the 
inositol ring that is responsible for the specificity of many phosphoinositide-protein 
interactions.7 Experimental studies investigating PKB’s affinity for phosphoinositides 
reflect its preference for 3-phosphorylated phosphoinositides [PtdIns(3,4)P2 and 
PtdIns(3,4,5)P3], over PtdIns(4,5)P2.22-25 Mutagenesis and crystallographic studies 
have helped explain this preference, illustrating that interactions of phosphoinositides 
with the PKB PH domain occur principally via phosphate groups 3 and 4 on their 
inositol phosphate head-groups.11, 26  
 
The crystal structure of the PKB PH domain in a complex with Ins(1,3,4,5)P4 [the 
head-group of PtdIns(3,4,5)P3] illustrates that phosphate group 3 interacts with Lys14, 
Arg23, Arg25 and Asn53 and phosphate group 4 with Lys14, Asn53 and Arg86, 
Figure 7. Additionally phosphate group 1 contributes to binding by interacting with 
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Arg23. In contrast, phosphate group 5 is solvent exposed in the crystal structure and is 
hence considered to make no significant interactions.  
 
 
 
 
Figure 7: The crystal structure of Ins(1,3,4,5)P4 in a complex with the PKB PH domain (PDB 
accession code 1UNQ).11 The binding mode of Ins(1,3,4,5)P4 in the PKB PH domain, with its 
5-phosphate group pointing away from the binding site, is illustrated. A zoomed image shows the 
hydrogen bond interactions apparent in the binding site, indicated with black lines. 
 
 
This binding mode of Ins(1,3,4,5)P4 with the 5-phosphate group solvent exposed is 
also assumed for its parent lipid PtdIns(3,4,5)P3. This is due to PtdIns(3,4,5)P3’s 
similar in vitro affinity for the PKB PH domain compared to PtdIns(3,4)P2.22, 26, 27 
Furthermore, this binding mode for phosphoinositides is further consistent with the 
inability of PtdIns(4,5)P2 to bind. 
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1. 2. 2. 1 Conformational Change 
 
Upon binding the inositol phosphate head-groups of phosphoinositide lipids, the PKB 
PH domain illustrates a significant conformational change. This is displayed in 
Figure 8 which highlights the difference in structure of the PKB PH domain in its 
apo-state and bound to Ins(1,3,4,5)P4.11  
 
 
Figure 8: Comparison of the crystal structures of the PKB PH domain in its apo-state (blue) and 
bound to Ins(1,3,4,5)P4 (magenta). PDB accession codes 1UNP and 1UNQ respectively.11 Variable 
loops (VL) 1, 2 and 3 are indicated.  
 
 
Binding of Ins(1,3,4,5)P4 to the PKB PH domain is shown to interrupt a network of 
hydrogen bonds and cause significant movement of the variable loops. Differences in 
the position of variable loops 1, 2, and 3 are evident, shifting approximately 2.5, 7.6 
and 7.4 Å respectively.11 Upon binding Ins(1,3,4,5)P4, loop 1 moves away from the 
PKB binding site as residue Glu17 is repelled from the highly anionic ligand, 
highlighted in Figure 8. Loop 2 forms a short !-helix, the purpose of which has not 
yet been elucidated. Loop 3 makes an especially large shift upon Ins(1,3,4,5)P4 
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binding. The significant movement of the hydrophobic Trp80 residue on the tip of 
loop 3 (highlighted in Figure 8) has led to numerous suggestions of its role in PKB 
activity. A recent co-crystal structure of the PKB PH and kinase domains shows that 
loop 3 is in fact buried in the kinase domain in its inactive state. Upon binding to 
phosphoinositides, these domains are shown to separate allowing phosphorylation and 
activation of PKB.28  
 
1. 2. 3 Crystal Structures 
 
There are a number of crystal structures of the PKB PH domain currently available. 
High resolution crystal structures of the PKB PH domain in its apo-state, in a 
complex with Ins(1,3,4,5)P4, and in a complex with a sulfate molecule were all 
resolved in a single study in 2003 (PDB accession codes 1UNP, 1UNQ and 1UNR 
respectively).11 Only a year earlier, the crystal structure of PKB’s PH domain in a 
complex with Ins(1,3,4,5)P4 was solved for the first time (PDB accession code 
1H10).26 Since studying the native system crystal structures of a mutant PKB PH 
domain, as well as structures with alternative ligands, have also been resolved.29, 30  
 
1. 2. 4 Function 
 
PKB acts as a regulator for a variety of downstream proteins that play critical roles in 
cell survival, proliferation, growth and metabolism.31, 32 These include Bad, Caspase-9 
and FOXO transcription factors, which regulate the cell’s apoptotic machinery,33-35 
and GSK3 and the CDK (cyclin dependent kinase) inhibitors p21 and p27 associated 
with cell cycle regulation.36-38 
 
1. 2. 4. 1 Phosphoinositide 3-Kinase Pathway 
 
The phosphoinositide 3-kinase (PI3K) intracellular pathway is one of the most 
frequently activated proliferation pathways in cancer, and is illustrated in Figure 9.32 
This pathway commences with the agonist stimulation of receptor tyrosine kinases 
and G-protein coupled receptors. Stimulation of these receptors results in the 
recruitment and activation of class I phosphoinositide 3-kinases (PI3Ks). Active 
 26 
PI3Ks phosphorylate PtdIns(4,5)P2 at the 3-hydroxyl group to form PtdIns(3,4,5)P3, 
which is subsequently dephosphorylated by 5-phosphatases to form PtdIns(3,4)P2. 
The dramatic increase in the concentration of the 3-phosphorylated phosphoinositides 
from their low basal levels allows them to function as membrane anchors for PKB.7, 14 
PKB is recruited to the plasma membrane via direct interaction of its PH domain with 
the inositol phosphate head-groups of PtdIns(3,4,5)P3 and PtdIns(3,4)P2. This 
interaction induces a conformational change in PKB, which facilitates 
phosphorylation of its residues Thr308 and Ser473 by PDK1 (3-phosphoinositide-
dependent kinase 1) and mTORC2 (mammalian target of rapamycin complex 2) 
respectively.11, 39-41 As highlighted in Figure 5, residue Thr308 is located in the 
activation loop of the kinase domain and Ser473 in the hydrophobic motif of the 
regulatory domain.  
 
PDK1 phosphorylates PKB by co-localising with it at the plasma membrane; PDK1’s 
PH domain also binds to 3-phosphorylated phosphoinositides. Additionally, it has 
recently been proposed that PDK1 and PKB are in equilibrium between an associated 
and dissociated state in the cytoplasm, prior to cell stimulation.42 
 
Once activated, PKB dissociates from the plasma membrane and phosphorylates 
serine and threonine residues on a range of downstream cytosolic targets. The PI3K 
pathway is negatively regulated by PTEN (phosphatase and tensin homolog), which 
antagonises PI3K activity by dephosphorylating PtdIns(3,4,5)P3 back to 
PtdIns(4,5)P2.  
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Figure 9: The PI3K pathway. The mechanism of activation for PKB is illustrated. The second 
phosphorylation step by mTORC2 has been omitted for ease of visualisation. The yellow circle 
represents an agonist for the green cell surface receptor. 
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1. 2. 5 PKB and Cancer 
 
A number of proteins involved in the PI3K pathway are associated with a broad range 
of cancers, including class I PI3Ks, PTEN and PKB.43 Increased PKB expression or 
activation has been noted in multiple cancer types, and in some cases has an incidence 
of over 50%.44-47 Whilst this is primarily due to aberrant upstream proteins of PKB, 
an oncogenic PKB mutant has also been reported.29, 48 This mutant has been reported 
in human breast, lung, ovarian, and colorectal cancers.29, 49-51 The mutation lies at the 
binding interface of PKB’s PH domain with phosphoinositides, and is thought to 
cause PKB to constitutively target the plasma membrane leading to over-activation. 
 
As the PI3K pathway is one of the most frequently activated proliferation pathways in 
cancer, PKB presents itself as a therapeutic target at its heart. Current drugs that target 
PKB fall into three main categories: phosphoinositide mimetics, ATP-competitive and 
allosteric inhibitors.52 The majority of inhibitors that compete with ATP are 
non-selective against the different PKB isoforms and closely related kinases, due to 
the similarities of their ATP binding sites.53 PKB’s PH domain therefore presents an 
alternative site to target that has proved popular in the past few years.54 Inhibitors that 
target the PKB PH domain include phosphatidylinositol ether lipid analogues (PIAs), 
alkylphospholipids (APLs), sulfonamides and purine/pyrimidine analogues.54-58 A 
number of these are discussed in further detail in Chapter 7. 
 
Currently no targeted PKB therapeutics have reached the mass market. The most 
clinically advanced PKB inhibitor is perifosine, which currently has orphan drug 
status in the EU and the US to treat multiple myeloma. Perifosine is an 
alkylphospholipid that interferes with PKB’s recruitment to the plasma membrane.59  
 
 
Figure 10: Schematic drawing of perifosine. 
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1. 3 Background to Project/Previous Research 
 
The importance of understanding the interaction between PKB’s PH domain and the 
inositol phosphate head-groups of phosphoinositide lipids has been highlighted. In 
this thesis a computational approach, using MD simulations, has been applied to study 
this system. 
 
An advantage of using MD simulations to study a biological system is its efficiency 
compared to experimental techniques. For our system of interest computational 
techniques are of further convenience due to the micromolar affinity of PKB PH 
domain-inositol phosphate interactions.22 This relatively low binding affinity, in 
comparison to drug molecules in the nanomolar range, means that large quantities of 
protein and inositol phosphates are required for in vitro techniques. Producing large 
quantities of these is both expensive and time-consuming, particularly so for inositol 
phosphate-based ligands which are often difficult and time consuming to synthesise.60 
 
The lack of in vitro experiments investigating the interaction between PKB and 
inositol phosphates/phosphoinositides is highlighted by the repeated reference to 
Frech et al.’s work in which tryptophan fluorescence spectroscopy was used to 
determine the binding affinities of a number of inositol phosphates and 
phosphoinositide ligands for the PKB PH domain.22 Despite the fact this work was 
carried out in 1997, and some useful data points are missing, there have been few 
additional investigations in the field.  
 
Whilst a computational approach does not provide an alternative to experimental 
work, it can serve to explain and support experimental data. Additionally 
computational simulations can help direct experimental efforts and limit the number 
of in vitro experiments required. The popularity of in silico techniques in drug design 
is highlighted by the increasing number of discoveries made using computer-aided 
approaches.52  
 
Docking studies have proved fairly popular for use in targeting the PKB PH domain, 
however there are few examples of studying this system using MD simulations.52 This 
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can largely be attributed to the fact that until 2012 force fields did not contain 
parameters for inositol phosphates or phosphoinositides. In 2012 the Charmm 
carbohydrate force field was extended to enable the modelling of phosphates linked to 
carbohydrates, by transferring parameters from methylphosphates.61 However, when 
investigating the interaction of PKB’s PH domain with Ins(1,3,4,5)P4 the authors of 
the parameters noted a rotation of the inositol ring from its crystal structure 
orientation, and loss of interactions via the 4-phosphate group.61 As experimental 
studies suggest that interactions via the 4-phosphate group are of critical importance 
for binding, it is vital that the model replicates this behaviour. This work therefore 
highlights the importance of parameterising highly charged inositol phosphates 
thoroughly and algorithmically. Prior to the publication of the Charmm parameters, 
other groups also developed parameters for PtdIns(4,5)P2 to study its interaction with 
gelsolin,62 and in a lipid membrane.63  
 
Whilst the behaviour of phosphoinositides in a lipid membrane have been briefly 
explored, there are very few examples of modelling their interaction with PH 
domains.64 Sansom et al. are one of the main contributors in this field. Examples of 
their work include using MD simulations to study the interaction of PLC$1’s PH 
domain with PtdIns(4,5)P2 and Ins(1,4,5)P3,65 and GRP1’s PH domain with 
PtdIns(4,5)P2.66, 67 However, relatively little work has been carried out on PKB’s PH 
domain. The only example, other than that already mentioned, of using MD 
simulations to study the interaction of the PKB PH domain with 
phosphoinositides/inositol phosphates is by Rong et al.68 However this work was 
carried out before the crystal structure of the PKB PH domain-Ins(1,3,4,5)P4 complex 
was solved and therefore is based on a homology model. Additionally as this study 
was carried out over a decade ago, simulations were only run for 200 ps. 
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1. 4 Overview of Thesis 
 
This thesis consists of 8 further chapters (and a disc containing the Electronic 
Supplementary Information). The contents of these chapters are summarised below: 
 
Chapter 2 – Quantum Mechanics provides background information about quantum 
mechanics (QM) theory. This chapter explains the different QM methods and basis 
sets applied in this thesis.  
 
Chapter 3 – Molecular Mechanics describes the force field approach to studying 
biological systems. The Amber force field is explained in detail.  
 
Chapter 4 - Parameterisation of Inositol 1,3,4,5-Tetrakisphosphate describes the 
parameterisation of Ins(1,3,4,5)P4 for use in MD simulations. The protocol used in 
this work is in keeping with current Amber force fields. A number of variations 
within this protocol are considered.  
 
Chapter 5 – MD Simulations of the Native PKB PH Domain with Inositol 
Phosphates describes the use of MD simulations to study the interaction of 
Ins(1,3,4)P3, Ins(1,4,5)P3 and Ins(1,3,4,5)P4 [the head-groups of PtdIns(3,4)P2, 
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 respectively] with the PKB PH domain. The free 
energies of binding and the molecular behaviour of these complexes are validated by 
comparison to experimental studies. Dynamic information from the MD simulations 
helps build upon information from the crystal structure.  
 
Chapter 6 - MD Simulations of the Mutant PKB PH Domain with Inositol 
Phosphates describes the investigation of a mutant form of the PKB PH domain 
found in numerous cancer types. Previous experimental work suggests that this 
mutant has an altered phosphoinositide selectivity resulting in it constituitively 
targeting the plasma membrane. MD simulations have been applied to help explain 
the altered behaviour of this mutant. 
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Chapter 7 - Inositol Phosphate Derivatives uses information from the previous 
chapters to help design inositol phosphate derivatives. These derivatives are designed 
to target the PKB PH domain and prevent its translocation to the plasma membrane. A 
computational approach is used to screen a number of potential inositol phosphate 
derivatives. Promising derivatives were synthesised by the Conway group at Oxford 
University, who also assisted in the design of these ligands. Once computational 
predictions had been made about the behaviour/binding affinity of the inositol 
phosphate ligands, biochemical techniques were then applied to validate these 
predictions. 
 
Chapter 8 – Summary and Future Work summarises the findings within this 
thesis. Additionally, possible improvements and adaptations to the work carried out 
are considered. Numerous different directions this work could now take and further 
experiments (both computational and biochemical) that would be useful and 
interesting to carry out are suggested. Preliminary work for extending this study is 
also detailed. 
 
Chapter 9 – Materials and Methods contains further details for the biochemical 
techniques applied in this work. 
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Chapter 2 - Quantum Mechanics 
 
2. 1 Introduction to Quantum Mechanics 
 
The development of quantum mechanics began when various phenomena, such as 
black body radiation and the photoelectric effect, could not be explained by classical 
Newtonian mechanics.69, 70 These phenomena cast doubt onto the nature of an 
electron, and led to the idea that electrons were able to behave as both particles and 
waves, referred to as ‘wave-particle duality’. Schrödinger developed an equation to 
deal with this, using the concept of a wavefunction, which now forms the foundation 
of quantum mechanics.71  
 
Quantum mechanics (QM) is an aspect of molecular modelling that explicitly 
represents electrons in its calculations, offering detailed structural and energetic 
descriptions of molecules. QM calculations can therefore be applied for a multitude of 
purposes. These include investigating the formation/breaking of bonds and studying 
excited states of a system. Additionally QM calculations are frequently employed to 
optimise the geometry of a system to a local energy minimum. QM geometry 
optimisation calculations have been carried out in this work to determine the 
equilibrium structures of various inositol phosphate-based compounds.  
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2. 2 Schrödinger Equation 
 
The Schrödinger equation is used to describe the quantum state of a system. For a 
time–independent polyelectronic system, the Schrödinger equation can be written as: 
 
!" ! !!!! !!! !!!! ! !!!!!!"#$%&! !!!!!"!#$%&'(! ! !!!!!!!!!!" !!"!#$%&'(!!"#$%&!
! !!!!!!!!" ! ! !!!!!!!!!!!!" !!"#$%&!!!!"#$%&!!"!#$%&'(!!!!"!#$%&'(!  
Equation 1: The time-independent Schrödinger equation. !!is the wavefunction, which forms the 
fundamental basis of quantum mechanics.!! is the total molecular energy of the system. The first two 
terms represent the kinetic energy of the nuclei and electrons respectively, where !!!  denotes 
differentiation with respect to the particle co-ordinates and ! is Planck’s constant divided by 2!. !! is 
the mass of a nucleus with charge !, and! ! is the mass of an electron of charge !. Subscripts !!and !!refer to electrons and !!and !!to nuclei. The last three terms of this equation describe the potential 
energy due to electrostatic interactions between nuclei and electrons, electrons and electrons, and 
nuclei and nuclei. Distances separating nuclei and electrons, pairs of electrons, and pairs of nuclei are 
given by !!", !!" !and !!" respectively. 
 
 
2. 2. 1 The Born-Oppenheimer Approximation 
 
Due to its complexity, the Schrödinger equation can only be solved exactly for the 
simplest of systems. For all poly-electronic atoms or molecules, mathematical 
approximations to the true solution of Schrödinger’s equation are required.72 
 
The Born-Oppenheimer approximation allows the motions of nuclei and electrons to 
be separated. The mass of a nucleus is much greater than the mass of an electron. 
Nuclei therefore move very slowly compared to electrons. The nuclei can therefore be 
considered fixed as the electrons carry out their motions, allowing the nuclear kinetic 
energy (in equation 1) to be ignored. The Schrödinger equation can thus be simplified 
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to: 
 
!!"!!" ! ! !!!!! !!!!!"!"!#$%!"#! ! !!!!!!!!!!" !!"!"!#$%&'(!!"#$%&!
! !!!!!!!!" !!"!"!#$%&'(!!!!"!#$%&'(!  
 
Equation 2: The electronic Schrödinger equation. Where !!" is the electronic energy. The energy 
due to the coulombic interactions between nuclei and nuclei can then be added to this electronic energy 
to calculate the total energy. 
 
 
2. 3 The Hartree Fock SCF Method 
 
The Hartree Fock self-consistent field (HF SCF) method is an approximate method 
for solving the time-independent Schrödinger equation for a poly-electronic system.73 
For this method, the electron-electron repulsion term is neglected: The electron-
electron repulsion is treated in an average way in which each electron is considered to 
move in the mean field of the other electrons of the system.74 Thus for a single 
electron, the Schrödinger equation can be written as: 
 !!!! ! ! !!!!! !!!!!! ! !!!!!!!!!!! !!! ! ! !!!!!!!!!!!!!  
 
Equation 3: The one electron Schrödinger equation for electron 1. !!!!!!! is the electron-electron 
repulsion energy averaged over all the other electrons.74 
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By treating the electron-electron repulsions in an average way, the poly-electronic 
wavefunction can be written as the product of one-electron wavefunctions. This is 
referred to as the Hartree product: 
 !!" ! ! !!! !! !! !! !!!!!!! 
 
Equation 4: The electronic wavefunction as a product of single-electron wavefunctions. 
 
 
Equation 4 does not satisfy the Pauli exclusion principle and must therefore be 
adjusted to include electron spin. The Pauli exclusion principle states that if two 
electrons occupy an atomic orbital their spins must be anti-symmetric.75 Electron spin 
is incorporated into the product of the one-electron wavefunctions by use of a Slater 
determinant, which expresses the many-electron wavefunction as a single determinant 
of spin orbitals.76 
 
2. 3. 1 The Self-Consistent Field Approach 
 
In order to calculate the average repulsion energy (!!!! experienced by electron 1 in 
equation 3, all of the remaining electrons’ orbitals must be known. This therefore 
poses a circular problem. An initial guess for these ‘remaining’ orbitals is made, 
referred to as zeroth-order orbitals. The one-electron equation is then solved for !!, 
providing a first order approximation. This value for !!!is included in the first order 
approximation for !! and so on for all the electrons in the system. The first order 
approximations are then used to calculate second order approximations. The iterations 
are continued until the computed energy is self- consistent.74 
 
2. 3. 2 The Variational Principle 
 
HF theory utilises the variational principle, which states that the energy of any 
normalised anti-symmetric wavefunction will always be greater than the energy of the 
exact wavefunction.76 The variational principle therefore provides a way to calculate 
the upper limit to the true energy of a system.  
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2. 3. 3 Electron Correlation Energy 
 
The difference in energy between the true energy of the system (!!) and the HF 
calculated energy (!!") is known as the correlation energy (!!"##!.  
 !!"## ! !! ! !!" 
 
Equation 5: The correlation energy expressed as the difference between the true energy of the 
system and the HF calculated energy. 
 
 
The correlation energy is due to the HF method neglecting electron correlation. It 
should be noted that a certain amount of electron correlation is accounted for in HF 
theory in the exchange term, which describes correlation for electrons with the same 
spin. However, correlation due to electrons with opposite spin is not included.76, 77 
 
2. 4 Møller-Plesset Perturbation Theory 
 
Møller-Plesset perturbation theory adds electron correlation effects by adding higher 
excitations to HF theory as a non-iterative correction.76 This method is based on the 
Rayleigh-Schrödinger perturbation theory, in which the true Hamiltonian operator (!) 
is divided into two parts: a ‘zeroth-order’ Hamiltonian (!!!!and a small perturbation 
(!!:  
 ! ! !! ! !!!
 
Equation 6: Calculation of the true Hamiltonian operator ! from the ‘zeroth-order’ Hamiltonian !!!! and a small perturbation (!!. ! is a parameter that can vary between 0 to 1. When ! equals 0, ! 
is equal to !!. When ! is 1, ! equals the true Hamiltonian operator. 
 
The eigenfunctions (!!) and corresponding energies (!!) of the true Hamiltonian 
operator ! are expressed in powers of !. Corrections to the HF energy are thus 
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expressed as an infinite series, where !!!!! is the first-order correction and !!!!!!the 
second order correction to the energy, and so on.72 
 !! ! !!!!! ! !!!!!! ! !!!!!!! !! ! !!!!!! !!!!! 
 !! ! !!!!! ! !!!!!! ! !!!!!!! !! ! !!!!!! !!!!! 
 
Equation 7: The eigenfunctions (!!!!and corresponding eigenvalues (!!!!of !  expressed as 
powers of !! 
 
 
Many levels of MP theory exist, each offering increased orders of 
perturbation/correction. The most commonly used of these is MP2, which includes 
first and second order perturbations/corrections to the ‘zeroth-order’ Hamiltonian. 
 
The advantage of Møller-Plesset perturbation theory is that it adds electron correlation 
effects in the quantum mechanical calculations. However, MP methods are not 
variational, and can therefore result in energies lower than the true energy of the 
system.72 
 
2. 5 DFT Theory 
 
Since the late 1980’s and 1990’s there has been an increased interest in density 
functional theory (DFT) methods.72 This growth in popularity is largely due to its 
relatively low computational cost in calculating the electron correlation energy for a 
system, compared to post-HF methods.  
 
DFT methods are based on a theorem by Kohn and Hohenberg which states that the 
ground-state energy, and properties of a system, can be defined by a unique functional 
of the electron density.78 Kohn and Sham suggested that this functional should be 
approximated by partitioning it into four main terms:79 
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 ! ! ! ! !! ! !!!!!! !! ! !"! !! !!!!!!!!!!!! ! !! !!!!!! ! !!" ! ! ! !!! ! !! ! ! !"!!  
 
Equation 8: The energy of a system within the Kohn-Sham scheme, split into four terms. The first 
term describes the kinetic energy, the second the electron-electron Coulombic energy, the third the 
contributions from exchange and correlation, and the final term the potential energy of the 
electron-nuclear interactions. ! !  is the electron density. !! and !! are the electronic positions and !! 
the nuclear position.  
 
 
2. 5. 1 The Exchange Correlation Term 
 
The exchange correlation term, !!" ! ! , in equation 8 accounts for the energy due 
to electron-electron interactions not covered by the electron-electron Coulombic term. 
As there is no explicit functional form for the exchange-correlation term, a variety of 
approximations have been defined. Typically !!" ! !  is split into separate 
exchange and correlation terms. 
 
In this thesis a hybrid functional, B3LYP (Becke, three-parameter, Lee-Yang-Parr), 
has been applied.80 The exchange correlation term for B3LYP is a weighted 
sum/hybrid of contributions from the HF exchange term and the Becke 88 exchange 
functional, the VWN III correlation functional and the correlation functional of Lee, 
Yang and Parr.80, 81 
 
DFT methods are significantly less computationally expensive than post-HF methods. 
The use of a functional of the electron density reduces the many-body problem of N 
electrons with 3N spatial co-ordinates to 3 spatial co-ordinates.82 Despite its reduced 
cost, the exact form of the functional used to describe the exchange correlation term is 
unknown. Therefore approximate functionals for describing these terms are applied. 
An issue with the use of approximate functionals is that the exact electron exchange 
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and correlation effects covered are unclear. In contrast HF, and post-HF methods, 
treat the exchange contribution by essentially exact means.72 
 
2. 6 Basis Set 
 
A basis set is a mathematical description of a system’s orbitals used in QM 
calculations. Linear combinations of basis functions (also referred to as atomic 
functions) are used to form these basis sets. The choice of basis set for studying a 
system is of critical importance. A larger, more complex basis set will give a better 
approximation of the orbitals, as fewer restrictions are applied to the location of the 
electrons.76 However the accuracy of a basis set has to be balanced against its 
computational cost. 
 
Basis functions were first developed by John C. Slater in 1930.83 Unfortunately, some 
of the integrals involved in calculations for Slater-type orbitals (STOs) are 
complicated and computationally expensive. Boys noted that these STOs can be 
approximated by linear combination of Gaussian-type orbitals (GTOs), resulting in a 
large reduction in computational cost.84 Today numerous basis sets are composed of 
these GTOs, and are discussed below. 
 
Minimal basis sets are composed of the minimum number of basis functions required 
to describe each atom. For example, carbon can be described using five basis 
functions: 1s, 2s, 2px, 2py, 2pz. Minimal basis sets use fixed-size orbitals, and hence 
are often not sufficient for many calculations. 
 
In comparison to minimal basis sets, split valence basis sets have an increased number 
of basis functions for each atom. The valence shell orbitals are described using two 
(or more) sizes of basis function, whilst the core orbital/s is represented by a single 
basis function. For example, a carbon atom is described by nine basis functions (1s, 
2s, 2s’, 2px, 2py, 2pz, 2px’, 2py’, 2pz’) for a double split valence basis set such as 
3-21g.85 
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Further flexibility of the atomic orbitals can be added by accounting for excited states, 
using polarised basis sets. Basis functions of higher angular momentum than required 
to describe the ground state are included. These additional orbitals are denoted by an 
asterisk, where 6-31g* adds d functions to heavy atoms and 6-31g** adds d functions 
to heavy atoms plus p functions to hydrogen atoms.86 
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Chapter 3 - Molecular Mechanics 
 
3. 1 Introduction to Molecular Mechanics 
 
Despite recent advances in quantum mechanical methods many systems are too large, 
and hence computationally expensive, to be studied using this approach. Molecular 
mechanics (MM) methods, also referred to as force field methods, present a practical 
computational approach to study such systems at the atomic level.  
 
MM methods ignore electronic motions, and calculate the energy of a system as a 
function of the nuclear positions. The separation of the electronic and nuclear motions 
is facilitated by the Born Oppenheimer approximation, previously described in 
section 2.2.1.87 The neglect of electronic motions in MM methods significantly 
reduces the computational cost of the calculations, allowing larger systems to be 
studied. 
 
3. 2 The Force Field 
 
A force field is defined by its potential energy function and an associated set of 
parameters. For most force fields the potential energy function takes the form of: 
 !!"#$%#&'( ! !!"#$ ! !!"#$% ! !!"!!"#$% ! !!"!!!"#$ 
 
Equation 9: A general potential energy function. The potential energy of a system is typically 
described as the sum of the bond, angle, dihedral and non-bonded energy contributions. These terms 
are illustrated in Figure 11. 
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Figure 11: Representation of the different terms in the potential energy function. The non-bonded 
energy contributions are split into electrostatic and van der Waals interactions. Diagram adapted from 
Leach et al.72 
 
 
Numerous different force fields exist, each developed to deal with different types of 
biological systems.88-90 In this work the Amber ff99SB force field and General Amber 
Force Field (GAFF) extension have been applied.91, 92 The ff99SB force field includes 
amino acid and nucleic acid parameter sets, whilst the GAFF extension allows organic 
molecules to be studied. These Amber force fields use the following functional form: 
 
! !! ! ! !!!! ! !!"!! !!"#$%! !!!! ! !!"!! ! !!!!"!!"#$%&!
!"#$%&
! !! !"# !" ! !! !!"!!"!" ! !!"!!"! ! !!!!!!!!"!"!#$%&'$($)#'!!!!"#$!!!  
 
Equation 10: The potential energy function for the Amber force field. The potential energy ! is 
expressed as function of the positions !  of n atoms. !!" , !!" , !! , !! , !! , ! , ! , !!!"  and !!"  are 
parameters defined by the force field. Scale factors of 1/2 and 1/1.2 are applied for 1-4 vdW and 1-4 
electrostatic interactions respectively. 
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3. 2. 1 Bonded Interactions 
 
The first three terms in equation 10 represent interactions between atoms covalently 
attached via 1 to 3 bonds. 
 
The first term describes the energy involved in stretching a bond between two atoms, 
approximated by a harmonic potential obeying Hooke's law. The energy contribution 
from bond stretching is proportional to the square of the displacement of the bond 
length (!) from its equilibrium bond length (!!"). Similarly, the second term also 
utilises Hooke's law to describe angle bending, with the energy contribution varying 
due to distortion of the bond angle (!) from its equilibrium value (!!"). !! and !! are 
the force constants for the bond and angle terms respectively. 
 
These two terms are regarded as having 'hard' degrees of freedom, as a large amount 
of energy is required to cause a significant deviation from their equilibrium 
geometries. The 'softer' torsional and non-bonding terms are responsible for the 
majority of the variation in structure and energies observed in biological systems. 
 
The torsional/dihedral energy is described by the third term in equation 10 and 
describes the barriers to rotation about a bond. A Fourier series expansion is used to 
describe the torsional potential, where !! is the relative barrier height to rotation, ! 
the multiplicity (number of minima in a 360° rotation), ! the dihedral/torsion angle 
and !  is the phase factor (which determines the location of the minima). Most 
dihedral angles in Amber are described adequately by a single two- or three-fold term 
(! ! !!!!, however a few dihedral angles require more terms to accurately represent 
the torsional profile. Improper torsions describe out-of-plane bending and are 
accounted for in the same way as regular dihedral angles, except that the four atoms 
are not attached in sequence.  
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3. 2. 2 Non-Bonded Interactions 
 
Non-bonded interactions are considered to act ‘through-space’. In Amber force fields, 
non-bonded interactions are deemed to be of paramount importance.93 However, these 
interactions are also the most time consuming to evaluate, as the number of possible 
non-bonded interactions is equal to roughly the square of the number of atoms in the 
system. The non-bonded interactions can be split into van der Waals and electrostatic 
interactions, discussed in the following sections. 
 
3. 2. 2. 1 Van der Waals Interactions 
 
In the Amber force field, van der Waals (vdW) interactions are described by a 
Lennard Jones 12-6 function, illustrated as the penultimate term in equation 10.  
 ! ! ! !!"!!"!" ! !!"!!"!  
 
Equation 11: A Lennard Jones 12-6 function.!!!" and !!" equal !!!!" and !!!!!  respectively, where !!is the well depth and !!is the interatomic distance at which the energy is a minimum. 
 
 
VdW interactions are considered to arise from a combination of attractive and 
repulsive forces. At longer distances, attractive forces dominate. This attractive force 
varies as !!"!! , where !! is the interatomic distance between atoms !  and ! . The 
attractive forces are due to the formation of instantaneous dipoles that can induce a 
second dipole in a nearby atom, thus resulting in an attractive inductive effect. At 
short distances, repulsive forces dominate, which vary as !!"!!" in this equation.72 
 
3. 2. 2. 2 Electrostatic Interactions 
 
Different elements have different associated electronegativities, resulting in the 
unequal charge distribution in a molecule. For current Amber force fields, the charge 
distribution is represented by partial atomic charges. The energy of the electrostatic 
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interactions between a pair of partial atomic charges is calculated using Coulomb's 
law, shown in the final term of equation 10.  
 ! ! ! !!!!!!!!" 
 
Equation 12: Electrostatic interactions calculated using Coulomb’s law.!!! and !! are the partial 
atomic charges of atoms i and j, !!" !is the distance between them, and !! !is the relative permittivity of 
the medium. 
 
 
3. 2. 2. 2. 1 The RESP Procedure 
 
The restrained electrostatic potential (RESP) procedure is used to derive the charge 
parameters for the Amber ff99SB force field.94-96 In the RESP procedure the 
molecular electrostatic potential (MEP) of a geometry-optimised molecule is 
computed. Charge values are then subsequently fitted to atom centred points to best 
reproduce this MEP. The RESP procedure is “a powerful, general and algorithmic 
method to determine atomic charges for force field purposes”.94 
 
The process begins with evaluating the electrostatic potential at a large number of 
points defined by shells at 1.4, 1.6, 1.8 and 2.0 times the van der Waals radii of the 
atoms.97 The value of the electrostatic potential at each point is calculated using the 
Hartree Fock method with a 6-31g* basis set. This level of theory is chosen as it 
exaggerates the dipole moment of most residues by 10-20%, which is consistent with 
the TIP3P model of water.96 
 
A least squares fitting procedure is used to fit charges to each atomic centre in a two-
stage approach. In the first stage, charges for the entire molecule are fitted with weak 
hyperbolic restraints (0.0005 au) on non-hydrogen atoms. If the molecule contains 
methyl or methylene groups, these groups are re-fitted in a second stage with stronger 
restraints (0.001 au) on non-hydrogen atoms, whilst the remaining atoms of the 
molecule are frozen to their values from the first stage. This two-stage approach 
allows charges on buried atoms (for example, alkyl carbons) to be reduced without 
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significantly affecting the fit to the electrostatic potential.94 
 
3. 2. 2. 3 Non-bonded Cut-offs  
 
Non-bonded interactions are the most computationally expensive terms of force field 
calculations. The number of possible non-bonded interactions in a system is equal to 
roughly the square of the number of atoms in the system, !!! ! !!!! . To 
dramatically increase the speed of calculations, only atoms within a given cut-off 
distance of each other are generally considered. This approximation is justified as the 
size of vdWs interactions decrease rapidly with distance, falling to zero at ~8 Å. 
Therefore the Lennard Jones potential can be truncated without introducing 
significant errors into the calculation. The use of periodic boundary conditions 
(section 3.4) limits the maximum cut-off distance to half the size of the smallest cell 
dimension, as each atom should only ‘see’ one image of the remaining atoms in the 
system. This is referred to as minimum image convention. 
 
Unfortunately electrostatic interactions cannot be truncated in the same manner, as 
they are longer ranged than vdW interactions. The long-range electrostatic 
interactions are considered in the following section. 
 
3. 2. 2. 4 Long-Range Forces 
  
Long-range electrostatic interactions cannot be handled in the same manner as vdW 
interactions, as their range can often exceed beyond half the box length. The particle 
mesh Ewald (PME) method is applied to deal with these interactions.98 Within the 
defined cut-off distance electrostatic interactions are calculated in real/direct space. 
However long-range interactions beyond the defined cut-off distance are calculated in 
reciprocal space, which reduces the cost of these calculations to N ln N.  
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3. 2. 3 Atom Types and Parameters 
 
A good parameter set is critical to the success of a force field. In order to be practical 
a parameter set should be relatively small and transferrable, yet still be able to 
accurately represent a system. In force field calculations, atom types are used to 
describe/characterise atoms in similar environments. Parameters are then provided for 
interactions between each atom type, rather than between each individual atom, 
simplifying the number of parameters needed to describe a system. Each force field 
has a finite number of atom types that are assigned to each atom dependent on its 
element, hybridisation, aromaticity and atoms it is bonded to.  
 
In this work, atom types from the ff99SB and GAFF force fields have been applied. 
Atom types from the ff99SB force field are typically used to describe protein and 
nucleic acid systems. The GAFF force field was developed as a more general purpose 
force field, providing a broad set of parameters that can easily be transferred, covering 
most of organic chemical space.92 Both ff99SB and GAFF atom types have been 
considered for application to inositol phosphate-based ligands in this work. 
 
3. 3 The Solvent Model 
 
MD simulations are usually performed in the presence of solvent. For biological 
systems, such as proteins, the solvent typically used is water. Water models fall into 
two main categories: implicit and explicit water models.  
 
Implicit models represent solvent as a continuous medium instead of individual 
explicit water molecules. Whilst implicit models can exert some properties of water 
such as dampening the electrostatic interactions of the solute, some effects such as 
hydrogen bonding are not described adequately. Further discussion of implicit solvent 
models is provided in Chapter 4.  
 
For the MD simulations in this thesis explicit water models have been used 
throughout. Although explicit water models are more computationally expensive than 
implicit models, there are numerous approaches to reduce the cost. Simple rigid 
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solvent molecules reduce the degrees of freedom available to water molecules, and 
thus also reduce the number of interactions to be calculated. The molecules are kept 
rigid such that no bond or angle deformation can occur. A commonly applied example 
of a rigid solvent model is the TIP3P model used in this work.99 The TIP3P model is 
referred to as a 3-site model as it uses three interaction sites for electrostatic 
interactions: Charges are places on the central oxygen atom and balancing charges on 
the two hydrogen atoms. The vdW interaction between two water molecules is 
calculated using a single site located on the oxygen atom. Additionally periodic 
boundary conditions, discussed in the following section, also help to lower the cost 
associated with explicit water models. 
 
3. 4 Periodic Boundary Conditions 
 
Periodic boundary conditions allow simulations to model bulk fluid behaviour using a 
relatively small number of solvent molecules. A periodic array of boxes (each 
containing the particles being simulated) is constructed in 3 dimensions around the 
central box. This periodic array is illustrated in two-dimensions in Figure 12. If a 
particle diffuses out of the central box and into a neighbouring box, it re-enters the 
box from the opposite site as its image. The number of particles within a box 
therefore remains constant. 
 
Figure 12: A schematic representation of periodic boundary conditions, shown here in two 
dimensions. Each box is identical and repeated in all in directions so that an atom leaving a box 
reappears in the neighbouring box, highlighted by the red atom. 
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3. 5 Energy Minimisation 
 
Molecular simulations are often concerned with structures at the minima of the 
potential energy surface (PES). Energy minimisation, also referred to as geometry 
optimisation, is a technique used in both quantum mechanical and force field 
approaches. Although inadequate to provide details on the dynamics of a system, 
energy minimisation provides an efficient method to refine molecular structures to a 
local energy minimum. In this work, energy minimisation methods have been 
employed to generate suitable starting structures for MD simulations. Additionally, 
minimisation calculations have also been applied for the comparison of QM and MM 
descriptions of inositol-based ligands. Below some of the methods for finding 
minimum energy structures are discussed.72, 100 
 
Minima are stationary points on the PES corresponding to stable states of a system. 
Minima are defined as points on the PES where the first derivative of the potential 
energy function is zero with respect to all the co-ordinates and the second derivatives 
are all positive. This can be expressed for the function !!!!! !!! !!! ! !!!: 
 
 !"!!! ! !! !!!!!!!!!!!!!!!!!!!!! ! !!
 
Equation 13: The first and second derivatives of the potential energy function !!! at a minimum. 
The variables !! are the co-ordinates of the atoms. 
!
!
Locating the minimum for a system with 3N co-ordinates is extremely difficult. 
Therefore minima are determined by using numerical methods that gradually change 
the co-ordinates of a system to produce a series of configurations with increasingly 
lower energies. 
 
 
 
 51 
3. 5. 1 First Derivative Methods 
 
The first derivative (i.e. the gradient) of the potential energy with respect to a given 
co-ordinate indicates the direction in which the energy minimum lies. The magnitude 
of the gradient indicates the steepness of the local slope. The energy of a system can 
be gradually minimised/lowered by adjusting the position of each atom in response to 
the force acting on it at each step (the force is equal to the negative of the gradient). 
Steepest descent and conjugate gradient methods are first-order minimisation 
techniques that are frequently used, and have been applied in this work.72  
 
The steepest descent method always moves in a direction negative to the gradient 
(parallel to the net force), towards a minimum. This minimum then provides the 
starting point for the next step. A line search is carried out in the direction 
perpendicular to the previous line search until a minimum along this line is found, and 
so forth. This method is typically used for the beginning stages of a minimisation, as 
it is suited for systems that are far from their equilibrium. However, for systems close 
to equilibrium this method does not tend to converge well. Conjugate gradient 
methods attempt to improve upon this method. In steepest descent the directions of 
successive steps are orthogonal, which can result in oscillatory behaviour in narrow 
valleys. Instead conjugate gradient methods use a combination of the current gradient 
as well as the previous search direction to decide the direction of the next line search. 
Removing the restriction of movement in only an orthogonal direction improves the 
performance of the minimisation when close to a minimum. 
 
3. 5. 2 Second Derivative Methods 
 
Second derivative methods use both the first derivatives (i.e. the gradients) and the 
second derivatives of the potential energy to locate a minimum. The second 
derivatives of the energy describe the curvature of the function. 72 
 
The Newton-Raphson method is an example of a second derivative method. This 
method is efficient when close to a minimum, as the surface is essentially quadratic. 
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However for large systems it is impractical as it involves the calculation and inversion 
of the Hessian matrix, which is very computationally demanding.  
 
3. 6 Molecular Dynamics Simulations 
 
Molecular dynamics simulations are employed to study how the dynamics of a system 
evolves over time. MD simulations generate successive configurations of a system 
over time by integrating Newton’s second law of motion: 
 !! ! !!!!!! 
 
Equation 14: Newton’s second law of motion. This equation describes the motion of a particle, where ! is the position of a particle of mass !, operated on by a force !.   
 
 
The force is determined from the first derivative of the potential energy expression 
described by the force field equation. 
 
 ! ! !!"!"  
 
Equation 15: Force is proportional to the negative derivative of potential energy ! with respect 
to position !. 
!
 
The differential equations that arise from Newton’s second law are solved using 
numerical integration methods, such as finite difference methods. In finite difference 
methods, the integration is carried out in many small steps, each separated by a 
time-step !t.  
 
The Leap-frog algorithm is one of the commonly used finite difference methods, 
which is applied in Amber.101 In this algorithm, the positions and velocities are 
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calculated at different points in the trajectory. Positions are calculated at times !, ! ! !" etc., whilst velocities are calculated half way through these time intervals, ! ! !! !". This is illustrated in equation 16. 
 ! ! ! !! !" ! ! ! ! !! !" ! !"!!!! 
 ! ! ! !" ! ! ! ! !!"! ! ! !! !"  
 
Equations 16: Equations illustrating the Leap-frog algorithm. Velocities are calculated from the 
current acceleration and the velocity from half a time-step behind. Positions are calculated from the 
previous position and the half time-step velocity. 
 
 
3. 6. 1 Time-step 
 
The choice of time-step is important for a simulation. If a time-step is too short, the 
amount of phase space explored will be insufficient. However if the time-step is too 
large, atoms can become unreasonably close between two steps as the force is 
assumed to be constant throughout a time-step. This therefore causes instabilities in 
the simulation to arise. To avoid these inaccuracies, a time-step is limited to one order 
of magnitude smaller than the highest frequency motion in the system. The highest 
frequency motions are due to bond stretches, often involving hydrogen atoms, with a 
period of approximately 10 fs. The time-step for a simulation is thus theoretically 
limited to 1 fs. However in practice, the SHAKE algorithm allows constraints on high 
frequency motions (i.e. on bonds involving H atoms) therefore permitting a larger 
time-step of 2 fs to be used.102  
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3. 6. 2 MD Protocol 
 
Molecular dynamics simulations are carried out in multiple stages. The starting 
structure for a simulation is often taken from crystallographic or NMR data. The 
starting structure is then adapted by adding hydrogen atoms, missing atoms, 
counter-ions and solvent. Following this, the solvated system is then energy 
minimised to remove any close contacts or high energy conformations. 
 
Prior to MD, velocities are assigned to atoms by applying a Maxwell-Boltzmann 
distribution of velocities based on the system’s temperature. The force acting on each 
atom is then calculated and used to generate new positions and velocities for each 
atom using the integration method discussed previously. 
 
To begin the MD simulation, the system is gradually heated from 0 K to the desired 
temperature (usually 300 K) at constant volume. Following this, a period of 
equilibration at constant pressure and temperature is typically applied. The production 
MD simulation is then carried out. In this work the production MD simulations were 
carried out at constant temperature and pressure, as is typically used for simulations 
of biomolecules as it replicates experimental conditions. It is from this production run 
that the properties and behaviour of the equilibrated system can be determined.  
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3. 6. 3 Length of Simulation 
 
The period of equilibration and production MD can vary depending on the system 
being studied. It is important that the system is properly equilibrated so that the 
production run represents the dynamics of the system at equilibrium.  
 
The length of the production MD simulation is also an important consideration. This 
largely depends on the computational resources available and the motions of the 
biological system being investigated. Different motions occur across a number of 
different timescales, illustrated in Figure 13. Whilst microsecond simulations are 
becoming increasingly popular due to recent computational advances, the ability of 
force fields to capture realistic and stable simulations over this long timescale is still a 
big question in the computational community.103-105 
 
 
 
 
Figure 13: Comparison of motions in proteins and their timescale, taken from Werner et al.106 
Reprinted from Advanced Drug Delivery Reviews, 64, T. Werner, M. B. Morris, S. Dastmalchi, W. B. 
Church, Structural modelling and dynamics of proteins for insights into drug interactions, 323-343, 
Copyright 2012, with permission from Elsevier. 
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3. 7 MM-PBSA 
 
The MM-PBSA (Molecular Mechanics-Poisson Boltzmann Surface Area) approach 
was developed by Kollman and Case for calculating the free energy of binding for 
biomolecular systems.107, 108 MM-PBSA is classified as an ‘end point’ post-processing 
free energy approach. It merely requires conformational ensembles of the bound 
complex and of the unbound receptor and ligand separately – the end-points of the 
binding interaction, equation 17. This sets it apart from ‘pathway’ free energy 
methods, which simulate the free energy change of a chemical mutation through a 
series of alchemical intermediates. This additional simulation leads pathway free 
energy methods, such as Free Energy Perturbation (FEP) or Thermodynamic 
Integration (TI), to have a far greater computational cost than end-point methods, 
albeit with suggested improvements in accuracy.109, 110 However, the cost of pathway 
techniques makes them intractable for the large-scale simulations performed in this 
study. 
 
 !!!"#$ ! !!"#$%&' ! !!!"#"$%&! ! !!"#$%&! 
 
Equation 17: The free energy of binding (!!!"#$! ) calculated as the difference in the free energies 
of the bound (complex) and un-bound (receptor and ligand) species. 
 
 
The MM-PBSA method utilises a thermodynamic cycle to calculate the free energy of 
binding, illustrated in Figure 14. A thermodynamic cycle is required because 
fluctuations in the solvation energy due to solvent-solvent interactions can be an order 
of magnitude greater than the energy contributions from the protein and ligand, if the 
binding free energy is calculated directly from a solvated trajectory. This can 
therefore result in large errors in the calculated free energy of binding. To circumvent 
this problem the free energy of binding is calculated indirectly as illustrated in 
Figure 14.  
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 !!!"#$!!"#$! ! !!!"#$!!"#! ! !!!!"#$!!"#"$%&!! ! !!!!"#$!!"#$%&! ! !!!!"#$!!"#$%&'!  
 
Figure 14: A thermodynamic cycle for calculating the free energy of binding indirectly. The free 
energy of binding is the sum of the gas phase interaction energy (!!!"#$!!"#! ) and the difference in 
solvation free energies between the complex and the un-bound receptor and ligand. 
 
 
The gas phase interaction energy (!!!"#$!!"#! ) in the thermodynamic cycle can be 
decomposed into molecular mechanical and entropic contributions. The free energy of 
binding can therefore be written as: 
 !!!"#$!!"#$! ! !!!!! ! !!!!"#$ ! !!!!!! 
 
Equation 18: Calculation of the free energy of binding. The free energy is split into contributions 
from the gas phase MM energy (!!!!! !, the solvation free energy (!!!!"#$! and the entropy (!!!, 
where ! is the temperature in Kelvin. 
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3. 7. 1 Molecular Mechanical Energy 
 
The first!term in equation 18 represents the gas phase molecular mechanical (MM) 
energy. This is calculated using the same force field as applied in the MD simulations.  
It can be further split into the following terms:  
 !!!!!! ! !!!!"#! ! !!!!"!! ! !!!!"#!  
 
Equation 19: Calculation of the gas phase molecular mechanical energy. The MM energy includes 
contributions from the internal (!!!"#! ), electrostatic (!!!"!! ) and van der Waals (!!!"#! ) energies. 
 
 
3. 7. 2 Solvation Energy 
 
The second term of equation 18 represents the solvation free energy. The replacement 
of the explicit solvation of the simulation with an implicit model improves the speed 
of the free energy calculation and reduces errors from noise created by the random 
motion of explicit water molecules.111 The solvation free energy is split into polar and 
non-polar contributions.  These are calculated using the Poisson Boltzmann/surface 
area (PBSA) approach. 
 
3. 7. 2. 1 Polar Solvation Energy 
 
The polar solvation energy is the free energy change of transferring a molecule from 
gas phase (! ! !) to water (! ! !"), and is estimated by implicit solvent models. In 
this study the Poisson Boltzmann (PB) implicit solvent model has been applied. The 
PB model is generally considered to be the gold standard for implicit solvation 
calculations.112, 113 A variant of the MM-PBSA approach is the MM-GBSA method, 
in which the Generalised Born implicit solvent model is used in place of the Poisson 
Boltzmann model.114 The Generalised Born (GB) model offers a less theoretically 
rigorous, but also less computationally expensive, representation of implicit solvation.  
 
The performance of MM-PBSA and MM-GBSA methods in predicting free energies 
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of binding was recently assessed by Hou et al.115 MM-PBSA was shown to perform 
better at calculating absolute free energies than MM-GBSA. However, MM-PBSA’s 
ability to out-perform MM-GBSA at calculating relative free energies was system 
dependent.  
 
3. 7. 2. 2 Non-polar Solvation Energy 
 
The non-polar contribution to the solvation free energy is primarily due to the free 
energy required for cavity formation of the solute. It is assumed to be proportional to 
the solvent-accessible surface area (SASA):  
 !!"!" ! !!! !"!" 
 
Equation 20: The non-polar contribution to the solvation free energy. !"!"  is the 
solvent-accessible surface area of the molecules and ! is the solvent surface tension. 
 
 
3. 7. 3 Entropy 
 
The final term in equation 18 illustrating the entropic contribution to binding is 
usually calculated using either quasiharmonic or normal mode analysis. Both of these 
techniques are extremely computationally demanding, due to the large number of 
minimised snapshots required for quasiharmonic analysis and the extensive 
minimisation of snapshots required for normal mode analysis.111, 115 As such, entropic 
contributions are often neglected due to their computational expense. 
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Chapter 4 - Parameterisation of Ins(1,3,4,5)P4 
 
4. 1 Introduction 
 
There are no existing parameters in the Amber force field for inositol phosphates, or 
their parent phosphoinositide lipids. Therefore, in order to perform MD simulations 
involving these molecules, suitable parameters have to be generated. In this chapter 
the parameterisation of inositol 1,3,4,5-tetrakisphosphate has been explored. A 
significant portion of the work within this chapter has been submitted as a paper.116 
 
4. 2 Previous Parameters for Inositol Phosphates 
 
Until recently force fields did not contain parameters for inositol phosphates. 
However in 2012 the Charmm carbohydrate force field was extended to enable the 
modelling of phosphates linked to carbohydrates.61 The bonded and non-bonded 
parameters for these phosphate groups were generally taken from prior versions of the 
force field.61 Partial charges on the phosphate groups were transferred from previous 
parameter development on methylphosphates. Unfortunately when applied in test case 
simulations to study the interactions of inositol phosphates, the parameters sometimes 
failed to replicate the experimental behaviour of these ligands.61  
 
There are few other examples of modelling inositol phosphates or phosphoinositides 
in the literature. Those that do exist simplify the problem of the net charge and 
ionisation state of these molecules. The phosphate groups of 
phosphoinositides/inositol phosphates are often assumed to all be fully 
deprotonated.62, 63, 68 However in vitro data suggests that full deprotonation of all of 
these groups, within such a small molecule, is extremely unlikely and unfavourable.3, 
4 In other efforts a more realistic approach has been taken, where a charge state for the 
phosphoinositides/inositol phosphates has been chosen from experimental data.65, 117 
Here some of the phosphate groups are fully deprotonated, whilst others are 
mono-protonated. The issue with this approach is that the charge state for these 
molecules is uncertain, illustrated by the net charge of -3, -4 and -5 all predicted for 
PtdIns(4,5)P2 from different in vitro experiments.118-120 The variability in these results 
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is due to the fact that the net charge of inositol phosphates and phosphoinositides can 
vary strongly around physiological pH due to their complex ionisation behavior.3-5 
Additionally, local pH and interactions with proteins can further add to this 
variability.118 
 
Many of the roles of inositol phosphates are intimately linked to their ionisation 
state.3 Therefore in this work, parameters are generated for all possible ionisation 
states of Ins(1,3,4,5)P4. The Ins(1,3,4,5)P4 isomers fall into five different charge 
subsets/states ranging from -4 to -8. The in vitro probabilities of these charge states at 
varying pH are displayed in Figure 15. Within these five different charge states, there 
are sixteen possible ionisation states of Ins(1,3,4,5)P4, illustrated in Figure 16. The 
naming convention created for these isomers is as follows: All fully deprotonated 
phosphate groups are followed by the letter ‘O’ and mono-protonated phosphate 
groups by the letter ‘H’. For example, for isomer 5O134H phosphate group 5 is fully 
deprotonated and phosphate groups 1, 3 and 4 are mono-protonated. The in vitro 
probability of the different ionisation states within each charge state is also provided. 
This probability data is taken from the in vitro work of Borkovec and Spiess.3 
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Figure 15: Variation of the charge state probabilities of Ins(1,3,4,5)P4 as a function of pH, in 
0.2 M KCl. Results from Borkovec and Spiess.3 
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Figure 16: The sixteen Ins(1,3,4,5)P4 isomers. Diagram adapted from Borkovec and Spiess.3 The 
horizontal line indicates the axial hydroxyl group at position 2. Circles represent phosphate groups 1, 3, 
4 and 5.  Filled circles represent mono-protonated phosphate groups, and empty circles represent fully 
deprotonated phosphate groups.  The name given to, net charge of, and in vitro probability of each 
isomer are provided. For this naming convention, all fully deprotonated phosphate groups are followed 
by the letter ‘O’ and mono-protonated phosphate groups followed by the letter ‘H’.   
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4. 3 Parameterisation Protocol 
 
Herein we have extended the Amber force field to study Ins(1,3,4,5)P4. The 
parameterisation protocol that was used in this work is in keeping with the Amber 
ff99SB force field. A simplified view of this parameterisation protocol is illustrated in 
Figure 17. 
 
 
 
Figure 17: A schematic summary of the parameterisation protocol that was applied in this study. 
 
 
As illustrated in Figure 17, QM calculations were used to optimise the geometry of 
each Ins(1,3,4,5)P4 isomer. The molecular electrostatic potential for each optimised 
isomer was then calculated and subsequently fitted to atom centred points using the 
RESP protocol, thereby generating the charge parameters. Additional parameters for 
the bond, angle, torsion and vdW terms were assigned using pre-defined atom types.   
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The quality of the parameters was evaluated by comparing structural and energetic 
properties of the Ins(1,3,4,5)P4 isomers from the QM geometry optimisation stage, 
from which the parameters were generated, to an MM energy minimisation stage, in 
which the parameters were applied. This allowed assessment of whether the point 
charge model and atom types were able to replicate Ins(1,3,4,5)P4’s QM behaviour, 
which acts as a benchmark. 
 
Variations within this protocol were considered in order to decide the most 
appropriate method to obtain the parameters for this highly charged ligand. Different 
QM levels of theory (DFT and MP2) were investigated for the geometry optimisation 
of the Ins(1,3,4,5)P4 isomers.  Additionally atom types from two Amber force fields 
(ff99SB and GAFF) were considered. The calculations in this protocol were carried 
out in gas phase, as is customary for the Amber force field.   
 
In addition to the calculations in gas phase, calculations of the Ins(1,3,4,5)P4 isomers 
were also carried out in implicit solvent. These calculations allowed comparison and 
validation of the theoretical calculations with experimental data. 
 
4. 4 Program Details 
 
Gaussian 03121 and Gaussian 09122 were applied for the geometry optimisation 
calculations and to calculate the molecular electrostatic potential of the Ins(1,3,4,5)P4 
isomers. Graphical representations were produced with Gaussview.123 
 
The Amber10120 and Amber11124 suite of programs, implementing the ff99SB force 
field (and GAFF extension), were used for the MM calculations. Parameter and 
topology files were created using the LEaP module. The RESP program was used to 
fit the QM calculated MEP to atom-centred points. Minimisation calculations were 
performed with Sander.  Graphical representations were produced with VMD and 
Chimera.125, 126 
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4. 5 Initial Structure 
 
The X-ray crystal structure of Ins(1,3,4,5)P4 in a complex with the PKB PH domain 
(PDB accession code 1UNQ) provided the initial configuration for Ins(1,3,4,5)P4.11 In 
this crystal structure Ins(1,3,4,5)P4 adopts a chair conformation, with all phosphate 
groups occupying equatorial positions. The hydroxyl group at the 6-position is also 
equatorial, whilst the 2-hydroxyl group is axial. This conformation is referred to as 
myo-Ins(1,3,4,5)P4. The chair conformation of the cyclohexane ring of Ins(1,3,4,5)P4 
has been confirmed by NMR data.127  
 
In the crystal structure, phosphate group 3 has a planar arrangement. It was therefore 
necessary to adapt phosphate group 3 towards a tetrahedral arrangement similar to 
that of the 1-, 4- and 5-phosphate groups. In order to produce the sixteen different 
Ins(1,3,4,5)P4 isomers, hydrogen atoms were bonded to the four phosphate groups in 
the appropriate combinations. 
 
4. 6 DFT Gas Phase Investigation 
 
4. 6. 1 Protocol for Charge Derivation 
 
The sixteen Ins(1,3,4,5)P4 isomers were geometry optimised until they reached a local 
minimum on the potential energy surface.  The isomers were first optimised using the 
DFT-B3LYP/3-21g* level of theory with Gaussian03, and then further optimised 
using DFT-B3LYP/6-31g**. These electronic structure calculations were carried out 
in gas phase. The DFT-B3LYP level of theory was initially chosen for this stage as it 
accounts for electron correlation at a significantly lower computational cost than 
post-HF electron correlation methods. Furthermore previous research suggests this 
level of theory is appropriate and comparable to post-HF methods for studying highly 
charged phosphorylated species.128, 129  
 
The molecular electrostatic potential for each of the optimised isomers was calculated 
using the HF/6-31g* level of theory. The RESP algorithm, in Amber 10, was 
employed to fit the QM calculated MEP to atom-centred points. As there are no 
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degenerate hydrogen atoms in Ins(1,3,4,5)P4, a one stage RESP protocol was applied.  
 
The charge parameters obtained, and atom types assigned, for the Ins(1,3,4,5)P4 
isomers are provided in section S.3 of the Electronic Supplementary Information. 
Parameters for the -4 Ins(1,3,4,5)P4 are illustrated in Figure 18 and Table 1.  
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Figure 18: Atomic labelling scheme for the -4 isomer, 1345H of Ins(1,3,4,5)P4. 
 
 
Table 1: Assigned atom types and charge parameters for the -4 1345H isomer of Ins(1,3,4,5)P4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Atom ff99SB 
atom type 
Charge 
parameters 
 Atom ff99SB 
atom type 
Charge 
parameters 
C1 CT 0.024812  P4 P 1.241543 
O1 OS -0.467569  O7P O2 -0.832113 
C2 CT 0.024704  O8P OH -0.727447 
O2 OH -0.582613  O9P O2 -0.804811 
C3 CT 0.042999  P5 P 1.208422 
O3 OS -0.503174  OPF O2 -0.829258 
C4 CT 0.020635  OPG OH -0.702063 
O4 OS -0.473885  OPH O2 -0.775938 
C5 CT 0.049358  H1 HC 0.122736 
O5 OS -0.448672  H2 HC 0.127450 
C6 CT 0.077708  H3 HO 0.419241 
O6 OH -0.585574  H4 HC 0.155901 
P1 P 1.263615  H5 HC 0.168002 
O1P O2 -0.824174  H6 HC 0.132010 
O2P OH -0.708093  H7 HC 0.120269 
O3P O2 -0.842697  H8 HO 0.387273 
P3 P 1.287731  H9 HY 0.381048 
O4P O2 -0.830816  H10 HY 0.484520 
O5P O2 -0.853312  H11 HY 0.444755 
O6P OH -0.769119  H12 HY 0.376596 
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Atom types were assigned from the ff99SB force field by analogy to nucleotides, and 
an MD study of PtdIns(4,5)P2.62, 91, 93 Additional angle parameters were required for 
atom type HC and were assigned values from the literature, Table 2.130 
 
Table 2: Angle parameters for atom type HC. !! and !!" represent the angular force constant (in 
kcal mol-1 radian-2) and the equilibrium angle value (in °) respectively.   
 
 
4. 6. 1. 1 Atom Type HY 
 
A new atom type was developed to overcome issues with the hydrogen atoms of 
protonated phosphate groups. During energy minimisation calculations in Amber 
these hydrogen atoms, when assigned atom type HO,91 were shown to overlap with an 
oxygen atom of the same phosphate group. This effect is due to a strong electrostatic 
attraction between the large negative charge on the oxygen atom and positive charge 
on the hydrogen atom when in close proximity. As atom type HO has no vdW radius, 
the angle term is the only contribution to oppose this attraction, with the HO-OH-P 
and OH-P-O2 terms being only 45 kcal mol-1 radian-2.91, 131 This problem is well 
documented on the Amber mailing list.132 
 
A new atom type HY was therefore developed with the same bond, angle and torsion 
parameters as atom type HO, but with additional vdW parameters. The vdW 
parameters were assigned by analogy to other hydrogen atom types in the ff99SB 
force field, with a vdW radius of 1.000 Å and a well depth of 0.0157 kcal mol-1, as for 
a hydrogen bonded to a sulphur atom, HS.91  
 
 
 
 
 
 
Angle Parameter !! !!" 
HC-CT-OH 35.0 109.5 
HC-CT-OS 35.0 109.5 
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4. 6. 2 Validation of Parameters 
 
The quality of the parameters was evaluated by applying them to the Ins(1,3,4,5)P4 
isomers in an MM energy minimisation stage.  
 
4. 6. 2. 1 MM Energy Minimisation 
 
The Ins(1,3,4,5)P4 isomers, with parameters assigned, were minimised by 1500 cycles 
of steepest descent followed by 2500 cycles of conjugate gradient minimisation using 
Sander in Amber10. The isomers were then further minimised using the Newton-
Raphson method in Amber until a root-mean-square gradient of 1x10-9 kcal mol-1 Å-1 
was reached. These minimisation calculations were carried out in gas phase. For all 
cycles, the Ins(1,3,4,5)P4 isomers were minimised using an 999 Å cut-off.  
 
4. 6. 3 Results and Discussion 
 
In the following sections the quality of the parameters generated for the Ins(1,3,4,5)P4 
isomers is evaluated by comparing the structural and energetic properties of the 
isomers from the QM geometry optimisation stage and the MM energy minimisation 
stage.  
 
4. 6. 3. 1 Energetic Properties 
 
The Ins(1,3,4,5)P4 isomers were ranked, within each charge subset, according to their 
energy from the QM geometry optimisation stage and MM energy minimisation 
stage, Table 3. 
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Table 3: A comparison of the energetic ordering of the Ins(1,3,4,5)P4 isomers from the QM 
geometry optimisation stage and MM energy minimisation stage. The isomers are ranked according 
to their energy within the charge subsets. The lowest energy isomers of each charge subset are given 
the ranking 1, and the remaining isomers ranked accordingly. Energy differences to the lowest energy 
isomer of each subset are stated. Absolute energies for the lowest energy isomers of each subset are 
provided in section S.1 of the Electronic Supplementary Information. 
 
 
A comparison of the energetic ordering of the Ins(1,3,4,5)P4 isomers from the QM 
and MM stages shows them to be in very good agreement. For the -5 charge subset, 
the energetic ordering is the same for both stages. Furthermore the calculated energy 
differences, although not identical, show similar patterns in magnitude: The energy 
difference between the lowest energy isomer, 5O134H, and 1O345H is extremely 
small (approximately 1 kcal mol-1). The 3O145H and 4O135H isomers are then 
higher in energy, and of a similar order to each other.  
Charge Isomer QM geometry 
optimised 
energetic 
ordering 
QM energy 
difference in 
kcal mol-1 
MM energy 
minimised 
energetic 
ordering 
MM energy 
difference in 
kcal mol-1 
-4 1345H 1 0.00 1 0.00 
      
-5 5O134H 1 0.00 1 0.00 
 1O345H 2 1.03 2 0.87 
 4O135H 3 10.59 3 4.46 
 3O145H 4 10.74 4 6.78 
      
-6 13O45H 1 0.00 1 0.00 
 15O34H 2 2.44 2 0.36 
 45O13H 3 23.50 3 2.95 
 34O15H 4 27.69 4 7.44 
 14O35H 5 28.43 5 7.46 
 35O14H 6 35.31 6 9.54 
      
-7 135O4H 1 0.00 2 0.43 
 145O3H 2 9.95 3 3.18 
 134O5H 3 12.30 1 0.00 
 345O1H 4 21.51 4 5.93 
      
-8 1345O 1 0.00 1 0.00 
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The -6 subset also has identical energetic orderings for the two stages. Again similar 
patterns in the relative energies for this subset are apparent: The 13O45H isomer is 
the lowest in energy for this subset, with the 15O34H ranked close 2nd. The 45O13H 
isomer is then ranked 3rd, followed by the 34O15H and 14O35H isomers, which are 
approximately 5 kcal mol-1 higher in energy.  
 
Unfortunately there is a slight discrepancy between the results for the -7 subset of 
isomers. The 134O5H isomer, which is lowest in energy in the MM calculations, is 
ranked 3rd lowest in the QM calculations. Analysis of the structures does not allude to 
a reason for this difference in ordering. However for a small system with this 
extremely high charge, a 3 kcal mol-1 energy difference between the three lowest 
energy isomers in the MM calculations is small and thus some interchanging in the 
ordering could be expected here. 
 
4. 6. 3. 2 Structural Properties 
 
The structures of the geometry optimised Ins(1,3,4,5)P4 isomers were compared 
against those following energy minimisation in Amber. On visual inspection the 
Ins(1,3,4,5)P4 isomers displayed no significant structural rearrangements between 
these two stages. Further analysis supported this, showing that the bond, angle and 
dihedral parameters of the isomers were generally within 1–2, 5 and 10% respectively 
for both stages. 
 
In this gas phase investigation, the lower energy isomers uniformly adopted chair-like 
conformations. However, it should be noted that the three highest energy isomers of 
the -6 and -7 subsets optimised/minimised to conformations with some boat-like 
character. It is the large electrostatic repulsion between the highly charged phosphate 
groups that triggers these distortions, allowing the neighbouring phosphate groups to 
increase the distance between one another, Figure 19. 
 
 
 73 
 
 
Figure 19: Inositol 1,3,4,5-tetrakisphosphate in the chair and boat conformation. 
 
 
4. 7 Comparison of DFT and MP2 Levels of Theory 
 
The MP2 level of theory was also considered for the geometry optimisation of the 
Ins(1,3,4,5)P4 isomers. In this section, results using the MP2 level of theory are 
evaluated against those for the DFT-B3LYP method in section 4.6. 
 
4. 7. 1 Protocol for Geometry Optimisation 
 
The Ins(1,3,4,5)P4 isomers were geometry optimised using the MP2/3-21g* level of 
theory, followed by MP2/6-31g**, with Gaussian03. These electronic structure 
calculations were carried out in gas phase. The energetic ordering and structural 
conformations of the Ins(1,3,4,5)P4 isomers from the DFT and MP2 optimisations 
were then compared. 
 
4. 7. 2 Results and Discussion 
 
4. 7. 2. 1 Energetic Properties 
 
Interestingly, the energetic orderings of the Ins(1,3,4,5)P4 isomers for the DFT and 
MP2 methods are generally shown to be in fairly close agreement, Table 4. 
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Table 4: A comparison of the energetic ordering of the Ins(1,3,4,5)P4 isomers optimised using the 
DFT and MP2 levels of theory, in gas phase. The isomers are ranked according to their energy within 
the charge subsets. The lowest energy isomers of each charge subset are given the ranking 1, and the 
remaining isomers ranked accordingly. The energy differences to the lowest energy isomer of each 
subset are stated. Absolute energies for the lowest energy isomers of each subset are given in section 
S.1 of the Electronic Supplementary Information. 
 
 
 
For the -5 charge subset, the two isomers lowest in energy are switched in order for 
the optimisation methods. This is also true for the two highest energy isomers. 
However, the energy difference between these reversed pairs is negligible according 
to the DFT data.  Interestingly, a more significant energy difference between the two 
highest energy isomers is apparent for the MP2 method. This difference in energy can 
be rationalised by studying the optimised structures of the 4O135H isomer. When 
optimised using the MP2 level of theory, the 4O135H isomer adopts a more chair-like 
Charge Isomer 
QM geometry 
optimised 
energetic ordering 
for the DFT 
method 
QM energy 
difference for 
the DFT 
method in 
kcal mol-1 
QM geometry 
optimised 
energetic ordering 
for the MP2 
method 
QM energy 
difference for 
the MP2 
method in 
kcal mol-1 
-4 1345H 1 0.00 1 0.00 
      
-5 5O134H 1 0.00 2 1.69 
 1O345H 2 1.03 1 0.00 
 4O135H 3 10.59 4 26.38 
 3O145H 4 10.74 3 7.09 
      
-6 13O45H 1 0.00 1 0.00 
 15O34H 2 2.44 2 2.28 
 45O13H 3 23.50 4 28.59 
 34O15H 4 27.69 5 30.51 
 14O35H 5 28.43 3 9.96 
 35O14H 6 35.31 6 32.52 
      
-7 135O4H 1 0.00 1 0.00 
 145O3H 2 9.95 2 0.71 
 134O5H 3 12.30 4 7.11 
 345O1H 4 21.51 3 3.56 
      
-8 1345O 1 0.00 1 0.00 
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conformation in comparison to the DFT optimised isomer. This slight difference in 
the conformation of the inositol ring, results in a significant change to the position of 
the phosphate groups attached, and thereby its energy.  
 
For the -6 subset, the only significant difference for the optimisation methods is the 
behaviour of the 14O35H isomer. For both methods the 14O35H isomer adopts a 
boat-like conformation, forming intra-molecular hydrogen bonds to offset the 
torsional strains associated with the strong electrostatic repulsion of the highly 
charged phosphate groups. However the DFT optimised isomer forms a chain of H 
bonds between 3-P-OH%%%2-O-H%%%5-O-P (Figure 20a) that is reversed for the MP2 
optimised structure, forming interactions between 5-P-OH%%%2-O-H%%%3-O-P, 
(Figure 20b). This difference in structure and hydrogen bonding is the reason for the 
different energetic ranking of this isomer. 
 
 
 
   
 
Figure 20: The 14O35H isomer of Ins(1,3,4,5)P4 optimised using the DFT (a) and MP2 (b) level of 
theory. Phosphate groups 1, 3, 4 and 5 are labelled P1, P3, P4 and P5 respectively. 
 
 
 
(a) (b) 
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4. 7. 2. 2 Structural Properties 
 
On visual inspection the optimised isomers displayed no large conformational 
differences for the DFT-B3LYP and MP2 methods, other than those already 
mentioned. Quantitative analysis showed that the bond, angle and dihedral parameters 
for the optimised structures are in very close agreement (generally within 1, 2-3 and 
5% respectively) for both methods.   
 
Additionally charge parameters obtained from both sets of optimised structures were 
in very close agreement, with charges for the phosphate groups generally varying by 
only 0-5% between both methods.  
 
4. 8 Comparison of ff99SB and GAFF Force Fields 
 
In a separate adaptation to the protocol, atom types from the GAFF force field were 
used as a comparison to the ff99SB atom types to determine whether they would be 
suitable for modelling the Ins(1,3,4,5)P4 isomers. In previous investigations, both 
GAFF and ff99SB atom types have been applied to study PtdIns(4,5)P2.62, 133 
 
Atom types from the ff99SB force field are typically used to describe protein and 
nucleic acid systems, rather than small organic compounds. The GAFF force field 
was developed as a more general force field, to provide a broader set of parameters 
that can easily be transferred, covering most of organic chemical space.92 The GAFF 
force field is compatible with ff99SB, facilitating the investigation of interactions 
between proteins and organic compounds. 
 
4. 8. 1 Protocol for Parameter Assignment 
 
GAFF atom types were assigned to the DFT optimised Ins(1,3,4,5)P4 isomers from 
section 4.6. Atom types were assigned using the Antechamber program of Amber10. 
The initial atom types assigned by Antechamber resulted in a similar issue to that 
experienced with the ff99SB force field, with the hydrogen (atom type ho) and 
oxygen atoms of a protonated phosphate group overlapping during the energy 
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minimisation stage. Atom type hy was thus developed, with the same bond, angle and 
torsion parameters as atom type ho, but with a vdW radius of 1.000 Å and a well 
depth of 0.0157 kcal mol-1. Atom type h1,92 assigned by Antechamber for hydrogen 
atoms bonded to the inositol ring, was amended to hc, analogous to atom type HC for 
the ff99SB force field. The same RESP derived charge parameters were applied as in 
section 4.6.1.  
 
The Ins(1,3,4,5)P4 isomers, with parameters assigned, were minimised by 1500 cycles 
of steepest descent followed by 2500 cycles of conjugate gradient minimisation using 
Sander in Amber10. The isomers were then further minimised using the Newton-
Raphson method in Amber until a root-mean-square gradient of 1x10-9 kcal mol-1 was 
reached. These minimisation calculations were carried out in gas phase. For all cycles, 
the Ins(1,3,4,5)P4 isomers were minimised using an 999 Å cut-off.  
 
4. 8. 2 Results and Discussion 
 
The suitability of GAFF atom types for modelling Ins(1,3,4,5)P4 is assessed in this 
section. Properties of the Ins(1,3,4,5)P4 isomers are compared for the QM geometry 
optimisation stage (using the DFT-B3LYP method), and the MM energy minimisation 
stage with GAFF atom types. 
 
4. 8. 2. 1 Energetic Properties 
 
The energetic ordering of the DFT optimised isomers is in moderate agreement with 
that of the MM energy minimised isomers when assigned GAFF atom types, Table 5. 
The -6 subset shows promising results, with the three highest energy isomers being 
identical and the three lowest energy isomers being consistent although reordered 
within.  
 
However, results for the -5 and -7 charge subsets are less convincing. The three 
lowest energy isomers from the -5 subset are re-ordered. Whilst the energy difference 
between these isomers is less than 0.5 kcal mol-1 according to the MM results, it is 
significantly larger according to the QM data (Table 5). Additionally, the -7 isomers 
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are also reordered with those ranked 2nd and 3rd switched. 
 
Although the Amber model of the Ins(1,3,4,5)P4 isomers is in moderate agreement 
with the QM data when GAFF atom types are assigned, results were significantly 
better with the ff99SB atom types (Table 3). The assignment of GAFF atom types not 
only alters the energetic ordering between the QM and MM stages, but additionally 
upsets the energetic differences between isomers within a subset. The significant 
difference between the results for GAFF and ff99SB atom types is unsurprising as 
supposedly equivalent parameters differ significantly in these force fields.91, 92 
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Table 5: A comparison of the energetic ordering of the Ins(1,3,4,5)P4 isomers between the QM 
geometry optimisation stage and the MM energy minimisation stage using GAFF atom types. The 
isomers are ranked according to their energy within the charge subsets. The lowest energy isomers of 
each charge subset are given the ranking 1, and the remaining isomers ranked accordingly. The energy 
differences to the lowest energy isomer of each subset are stated. Absolute energies for the lowest 
energy isomers of each subset are given in section S.1 of the Electronic Supplementary Information. 
 
  
 
 
 
 
 
 
 
Charge Isomer QM geometry 
optimised 
energetic ordering 
QM energy 
difference in 
kcal mol-1 
MM energy 
minimised 
energetic ordering 
using GAFF atom 
types 
MM energy 
difference using 
GAFF atom 
types in 
kcal mol-1 
-4 1345H 1 0.00 1 0.00 
      
-5 5O134H 1 0.00 3 0.21 
 1O345H 2 1.03 2 0.16 
 4O135H 3 10.59 1 0.00 
 3O145H 4 10.74 4 5.07 
      
-6 13O45H 1 0.00 2 3.58 
 15O34H 2 2.44 3 4.74 
 45O13H 3 23.50 1 0.00 
 34O15H 4 27.69 4 11.11 
 14O35H 5 28.43 5 13.52 
 35O14H 6 35.31 6 14.55 
      
-7 135O4H 1 0.00 1 0.00 
 145O3H 2 9.95 3 8.50 
 134O5H 3 12.30 2 4.68 
 345O1H 4 21.51 4 10.43 
      
-8 1345O 1 0.00 1 0.00 
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4. 9 Calculations of Ins(1,3,4,5)P4 in Implicit Solvent 
 
In addition to the gas phase calculations in sections 4.6 to 4.8, calculations for the 
Ins(1,3,4,5)P4 isomers were also performed in implicit solvent. These calculations 
allow comparison and validation of the theoretical calculations with in vitro data.  
 
A consequence of including solvent in the model is that electrostatic interactions 
between the solute [Ins(1,3,4,5)P4] and the solvent are taken into account. As a result 
intra-molecular electrostatic interactions for the solute are dampened, which could 
prove important when investigating the structural/energetic properties of such a small 
highly charged system. The solvent used in this study is water. 
 
4. 9. 1 Implicit Solvation Models 
 
Implicit solvation models represent solvent as a continuous medium, whereby 
dielectric parameters in the surrounding environment of a solute replicate those of a 
solvent. There are numerous implicit solvent models available, which can differ in 
their description of the solute, the solvent and the interface between them.134 In this 
work the polarisable continuum model135, 136 in Gaussian09 was applied for the QM 
geometry optimisation calculations and the generalised Born model in Amber for the 
MM energy minimisation calculations.137-139  
 
4. 9. 1. 1 The PCM Method 
 
The Polarisable Continuum Model (PCM) is frequently applied in QM calculations. 
In the PCM model the solute cavity is obtained from the overlapping vdW radii of its 
atoms. The polarisation of the dielectric medium is represented by an apparent surface 
charge that resides on this solute cavity.140 
 
The vdW spheres that contribute to the cavity surface are divided into a number of 
small surface elements, with area !!. An initial charge for each surface element is 
calculated using the electric field gradient due to the solute:141 
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!! ! ! ! ! !!!" !!!! 
 
Equation 21: Calculation of the initial charge for each surface element. !! is the electric field 
gradient at point ! and ! is the dielectric constant of the medium. 
 
 
The mutual polarisation of the surface charges is then calculated, resulting in an 
additional contribution to the electric field gradient.141 The charges are modified 
iteratively until self-consistent. The potential due to the final set of surface charges !! !  is then added to the solute Hamiltonian as a perturbation, ! ! !! ! !! ! . A 
self-consistent field calculation is then initiated, which results in new values for the 
surface charges from the current wavefunction. This calculation is carried out 
iteratively until the surface charges (and solute wavefunction) are self-consistent.  
 
 
4. 9. 1. 2 The Generalised Born Method 
 
The generalised Born (GB) implicit solvent model was applied in the MM 
calculations. The GB model approximates the electrostatic contribution to the 
solvation free energy using the equation: 
 !!!" ! !! !! !! !! !!!!!!!!" !!!"!!!!  
 
Equation 22: The Generalised Born equation for calculating the electrostatic solvation free 
energy. ! is the solvent dielectric, qi and qj are the point charges on atoms i and j respectively. !!!!" ! !!"! is a function that depends upon the interparticle distances rij and the effective Born radii !!". 
 
 
The effective Born radius of an atom reflects its degree of burial inside a molecule. It 
is officially defined as “the radius that would return the electrostatic energy of the 
system according to the Born equation if all other atoms in the molecule were 
uncharged”.72 The quality of the GB model is considered strongly dependent on the 
quality of the estimated effective Born radii.112, 113  
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4. 9. 2 Protocol for Charge Derivation 
 
The sixteen Ins(1,3,4,5)P4 isomers were geometry optimised in a solvent reaction 
field using the PCM model with the integral equation formalism (IEFPCM), in 
Gaussian09.122, 135 Water was assigned as the solvent. As previous calculations in 
sections 4.6 and 4.7 suggested DFT-B3LYP was suitable for studying this system, this 
method was applied. The isomers were first optimised using the DFT-B3LYP/3-21g* 
level of theory, followed by a second optimisation with DFT-B3LYP/6-31g**. The 
MEP for each of the optimised isomers was calculated using the HF/6-31g* level of 
theory in gas phase, with Gaussian 09. A one stage RESP protocol was then employed 
to derive the atom-centred point charges. The RESP generated charge parameters for 
the solvent optimised Ins(1,3,4,5)P4 isomers are illustrated in section S.3 of the 
Electronic Supplementary Information. The same atom types from the ff99SB force 
field were assigned as in the gas phase calculations in section 4.6. 
 
4. 9. 3 Validation of Parameters 
 
4. 9. 3. 1 Quantum Mechanical versus Molecular Mechanical Properties 
 
The parameters (in section S.3 of the Electronic Supplementary Information) were 
applied to the solvent optimised Ins(1,3,4,5)P4 structures for an energy minimisation 
stage in Amber. The Ins(1,3,4,5)P4 isomers were minimised by 1500 cycles of 
steepest descent followed by 2000 cycles of conjugate gradient minimisation, in 
implicit solvent. The Hawkins, Cramer, Truhlar pairwise GB model137, 138 with 
parameters described by Tsui and Case139 (igb=1) was used as the solvent model. For 
all cycles, a 999 Å cut-off was applied. The quality of the parameters was initially 
assessed by comparing the energetic properties of the Ins(1,3,4,5)P4 isomers between 
the QM geometry optimisation stage and the MM energy minimisation stage, both in 
implicit solvent. 
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4. 9. 3. 2 Theory versus Experiment 
 
The results from the calculations in implicit solvent were also validated by 
comparison to experimental data. Borkovec et al. have previously determined the in 
vitro probabilities of the different Ins(1,3,4,5)P4 isomers within each charge subset, 
using 31P-NMR titration data, Figure 16.3 The energetic ranking of the Ins(1,3,4,5)P4 
isomers from our calculations is assessed against these experimental probabilities. 
 
4. 9. 4 Results and Discussion 
 
4. 9. 4. 1 Energetic Properties 
 
The calculations in implicit solvent were analysed by comparing the energetic 
ordering of the QM optimised and MM energy minimised Ins(1,3,4,5)4 isomers, 
(columns 1 to 6 of Table 6).  
 
The energetic ordering for the QM and MM stages are generally shown to be in good 
agreement. Exception to this is the -5 subset of isomers, for which the ordering is 
rearranged between the two stages. However, the small energy difference between 
these isomers (according to the QM calculations) provides some justification for this. 
The -6 subset of isomers shows an appreciably stronger agreement in the energetic 
ordering. The only discrepancies are reversals in the ordering of the isomers ranked 
2nd and 3rd, and 5th and 6th in energy. These reversals are considered minor, as the 
differences in energy for the isomers concerned are relatively small (less than 1 and 
4 kcal mol-1 respectively, according to the QM calculations). Additionally the 
energetic orderings for the -7 subset of isomers are in full agreement for both stages.  
 
Although there are some discrepancies in the energetic ordering of the Ins(1,3,4,5)P4 
isomers from the QM and MM stages in implicit solvent, a good agreement is still 
apparent. These discrepancies can largely be attributed to the differences in modelling 
implicit solvent for both stages.  
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Table 6: A comparison between the energetic ordering of the Ins(1,3,4,5)P4 isomers geometry 
optimised and energy minimised in implicit solvent with their in vitro probabilities.  The isomers 
are ranked according to their energy/probability within the charge subsets. The lowest energy and most 
probable isomers of each charge subset were given the ranking 1, and the remaining isomers ranked 
accordingly. For the geometry optimisation and energy minimisation calculations, energy differences 
to the lowest energy isomer of each subset are stated. Absolute energies for the lowest energy isomers 
of each subset are given in section S.1 of the Electronic Supplementary Information. 
 
 
 
 
 
 
 
 
 
Charge Isomer QM 
geometry 
optimised 
energetic 
ordering 
QM energy 
difference 
in 
kcal mol-1 
MM 
energy 
minimised 
energetic 
ordering 
MM 
energy 
difference 
in  
kcal mol-1 
In vitro 
probability 
ordering 
In vitro 
probability 
in %3 
-4 1345H 1 0.00 1 0.00 1 100 
        
-5 4O135H 1 0.00 3 23.90 1 35.4 
 5O134H 2 1.16 1 0.00 2 28.8 
 3O145H 3 3.30 4 30.57 3 25.4 
 1O345H 4 4.09 2 8.96 4 10.4 
        
-6 14O35H 1 0.00 1 0.00 1 44.5 
 15O34H 2 2.59 3 13.02 3 19.4 
 13O45H 3 3.47 2 10.85 2 31.4 
 35O14H 4 4.92 4 22.36 4 3.8 
 34O15H 5 15.68 6 74.69 6 0.4 
 45O13H 6 19.33 5 32.48 5 0.5 
        
-7 135O4H 1 0.00 1 0.00 1 75.8 
 134O5H 2 3.31 2 27.58 2 14.2 
 145O3H 3 6.76 3 32.84 3 10.1 
 345O1H 4 18.73 4 57.35 4 <0.1 
        
-8 1345O 1 0.00 1 0.00 1 100 
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4. 9. 4. 2 Structural Properties 
 
The sixteen solvent optimised isomers uniformly adopted chair-like conformations. In 
contrast, when optimised in gas phase using the same level of theory the higher 
energy isomers of the -6, -7 and -8 subsets displayed boat-like character. Furthermore, 
when optimised in the presence of solvent the Ins(1,3,4,5)P4 isomers tended to form 
fewer intra-molecular hydrogen bonds than those in gas phase. These structural 
differences between the gas phase and solvent calculations inherently altered the 
energetic ordering of the Ins(1,3,4,5)P4 isomers (see Tables 3 and 6). The pronounced 
difference in results from the gas phase and solvent calculations shows that the 
geometry and energy of the Ins(1,3,4,5)P4 isomers are particularly dependent on their 
environment. These differences allow/force us to consider whether optimisation in 
solvent should be considered for parameterisation of highly charged ligands, as 
opposed to the typical gas phase protocol.  
 
4. 9. 4. 3 Theory versus Experiment 
 
The results from the calculations in implicit solvent were also validated by 
comparison to experimental data. Borkovec et al. have previously determined the in 
vitro probabilities of the different Ins(1,3,4,5)P4 isomers within each charge subset, 
using 31P-NMR titration data.3  
 
The Ins(1,3,4,5)P4 isomers were ordered according to their experimental probability. 
This ordering was then compared against the isomers’ energetic ordering from the 
computational calculations in solvent (Table 6). The lowest energy and most probable 
isomers of each charge subset were given the ranking 1, and the remaining isomers 
ranked accordingly. 
 
There is a strong agreement between the theoretical calculations and experimental 
data, with the lower energy Ins(1,3,4,5)P4 isomers corresponding to those with higher 
probability. For the -5 and -7 charge subsets, the energetic ordering from the QM 
calculations fully agrees with the experimental probability ordering. There is also a 
strong agreement between the QM calculations and the experimental data for the -6 
subset. A minor discrepancy for this subset is the reversal of the 2nd and 3rd lowest 
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energy/most probable isomers, 13O45H and 15O34H. However these isomers have 
less than a kcal mol-1 difference in energy according to the QM calculations. 
Furthermore, this inconsistency may be explained by an assumption made by 
Borkovec et al. in which the interaction between the 1- and 5- phosphate groups was 
fixed to a value obtained for inositol 1,2,3,5-tetrakisphosphate.3 The additional 
reversal in the ordering of the least probable/highest energy isomers of this subset 
(34O15H and 45O13H) is considered insignificant as these have only a 0.1% 
difference in probability and a small energetic difference according to the QM 
calculations. The energetic ordering of the -6 charge subset according to the MM 
energy minimisation calculations fully agrees with the in vitro probability ordering. 
 
The energetic/probability ordering of the Ins(1,3,4,5)P4 isomers can largely be 
explained by the unfavourable electrostatic interactions of the highly charged, fully 
deprotonated phosphate groups (also referred to as phosphodianions). Additionally 
hydrogen bonding involving the mono-protonated phosphate groups also plays a 
critical role in stabilising Ins(1,3,4,5)P4. 
 
The isomers of the -5 charge subset are all shown to be in appreciable proportions in 
the in vitro data, and have similar energies according to the QM calculations. The fact 
that the 1O345H isomer is the least probable/has the highest energy of this subset can 
be explained by the isolation of the 1-position phosphodianion from the 
3,4,5-phosphate motif. This isolation reduces the phosphodianion’s ability to stabilise 
its high charge through hydrogen bonding with neighbouring phosphate groups. 
Conversely, the 4O135H isomer is the most probable of this subset, having two 
neighbouring phosphate groups to interact with. 
 
Isomers of the -6 charge subset, with two fully deprotonated phosphate groups, vary 
significantly in probability and energy. These larger variations are thought to be 
mainly due to the unfavourable electrostatic interactions of the two phosphodianions. 
The 14O35H isomer is the most probable, comprising a 44.5% proportion of the -6 
charge subset.3 This isomer positions the two phosphodianions furthest apart across 
the inositol ring, minimising their interaction. The next most energetically 
stable/probable isomers are those with the phosphodianions separated by one position 
around the inositol ring (13O45H, 15O34H and 35O14H). The 35O14H isomer is 
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notably the least favourable of the three, due to both phosphodianions communicating 
via the central 4-phosphate group. The 34O15H and 45O13H isomers, with adjacent 
phosphodianions, are unsurprisingly the least stable/probable of the -6 subset. 
 
Finally for the -7 subset, the 135O4H isomer is by far the most favourable/probable as 
the phosphodianions are all separated by one position around the inositol ring.  The 
134O5H and 145O3H isomers are then next, as these each have one pair of 
neighbouring phosphodianions. Lastly the 345O1H isomer has an extremely low 
probability (of less than 0.1%) and is very energetically unfavourable, due to the three 
neighbouring phosphodianions at the 3-, 4- and 5-positions. 
 
The electrostatic basis for the ordering of the -6 and -7 isomers is further supported by 
examining the electrostatic contribution to the energy of these isomers (from the MM 
energy minimisation calculations), Table 7. A clear trend of increasing positive 
(unfavourable) electrostatic contributions to the total energy of these isomers with 
decreasing experimental probability is apparent. 
 
 
Table 7: Analysis of the electrostatic contributions to the total energies of the -6 and -7 
Ins(1,3,4,5)P4 isomers.  Electrostatic energies are provided from the MM energy minimised isomers in 
implicit solvent. Experimental probabilities of these isomers are provided to illustrate the trend. 
 
a Electrostatic energies following energy minimisation in implicit solvent using Amber. 
b Probabilities determined from 31P-NMR titration data.3 
Charge Isomer Electrostatic contribution to 
total computed energya in 
kcal mol-1 
In vitro probabilityb in 
% 
-6 14O35H 250.87 44.5 
 13O45H 263.01 32.4 
 15O34H 285.45 19.4 
 35O14H 308.21 3.8 
 45O13H 324.21 0.5 
 34O15H 366.30 0.4 
    
-7 135O4H 596.88 75.8 
 134O5H 629.03 14.2 
 145O3H 638.20 10.1 
 345O1H 710.42 <0.1 
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4. 10 Conclusion 
 
This chapter explores the parameterisation of the sixteen Ins(1,3,4,5)P4 isomers. 
Parameters for these isomers were generated using a gas phase protocol analogous to 
that for the existing molecules in the ff99SB force field.91 
 
Charge parameters generated from the DFT-B3LYP optimised isomers, combined 
with ff99SB atom types, proved to be a suitable option for modelling this highly 
charged system. The similar structural and energetic properties of the Ins(1,3,4,5)P4 
isomers from the QM optimisation stage (from which the parameters were generated) 
and the MM energy minimisation stage (in which the parameters were applied) 
suggests good quality parameters have been generated/assigned. 
 
As an adaptation to this protocol, the computationally expensive MP2 level of theory 
was investigated for the geometry optimisation of the Ins(1,3,4,5)P4 isomers. Despite 
its additional cost, the MP2 level of theory was shown to alter the structural and 
energetic results very little from the DFT-B3LYP results. Furthermore, the charge 
parameters obtained from the DFT and MP2 optimised isomers were in close 
agreement, particularly for the phosphate groups. The DFT level of theory was 
therefore confirmed as an efficient and suitable method for optimising Ins(1,3,4,5)P4. 
 
As a separate adaptation to the protocol, atom types from the GAFF force field were 
also assessed. Application of these atom types, in place of ff99SB atom types, in the 
energy minimisation stage resulted in a significantly poorer agreement with the QM 
DFT-B3LYP data. This is unsurprising as GAFF parameters are designed to be 
compatible with simple organic structures. In comparison, Ins(1,3,4,5)P4 has a very 
complex and distinct structure, with highly charged vicinal phosphate groups. 
Therefore general atom types from the GAFF force field are not suitable to model this 
system. 
 
Calculations for the Ins(1,3,4,5)P4 isomers were also carried out in implicit solvent. 
These calculations provided a comparison to experimental data in solution. A 
remarkably good agreement between the more energetically favourable isomers from 
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the calculations and the more probable isomers according to experimental data is 
apparent. This validation against experimental data imparts a high degree of 
confidence in the computational calculations. 
 
The calculations in implicit solvent were of additional interest due to the difference in 
the optimised structures for the solvent and gas phase calculations. As mentioned, the 
Ins(1,3,4,5)P4 isomers all adopted chair like conformations in the implicit solvent 
calculations. In contrast, the higher charged, less energetically favourable isomers 
tended to contain some boat-like character in the gas phase calculations. NMR spectra 
show Ins(1,3,4,5)P4 adopts a chair conformation in solution, further supported by the 
chair conformation of this inositol phosphate in its crystal structure with the PH 
domain of PKB!.11, 127 This therefore led to the consideration of whether generating 
charge parameters for the less ‘sensible’ boat-like structures from the gas phase 
calculations was appropriate.  
 
The difficulty in deciding an appropriate parameterisation protocol is that there is no 
absolute rule as to how this should be carried out. Traditionally, the ff99SB force field 
uses gas phase calculations to derive/generate the charge parameters. This is because 
the HF/6-31g* level of theory used to calculate the electrostatic potential tends to 
overestimate the dipole moment of most residues by 10-20%, incorporating the 
amount of polarisation expected in an aqueous solution.94, 97 The concern of solvent 
optimisation is thus that solvent effects are over-accounted for. 
 
Interestingly the parameters from the solvent optimised and gas phase optimised 
isomers do not differ as significantly as one may expect. Nevertheless, it is unknown 
how a small change in the charge parameters may alter Ins(1,3,4,5)P4’s behaviour and 
interactions. Therefore as a preliminary test we ran separate MD simulations of the 
Ins(1,3,4,5)P4 isomers, with parameters from the gas phase and implicit solvent 
calculations, in a complex with the PKB PH domain.  Results showed that the free 
energies of binding and hydrogen bonding patterns were remarkably similar for both 
sets of parameters, Table S2 in the Electronic Supplementary Information. 
 
In this chapter numerous approaches to generate parameters for the Ins(1,3,4,5)P4 
isomers have been considered. Results show that the charge parameters generated 
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from the DFT-B3LYP gas phase optimisation, and ff99SB atom types, are suitable for 
modelling this system. This gas phase protocol is in-keeping with that for existing 
molecules in the ff99SB force field.91  
 
As far as we are aware, the parameterisation of Ins(1,3,4,5)P4 described within this 
chapter represents the first full set of parameters obtained for this molecule, with a 
clearly defined protocol.116 The parameters developed provide a basis to study the 
interactions of Ins(1,3,4,5)P4 using MD simulations. Additionally, the work within 
this chapter also provides a protocol to parameterise and study other inositol 
phosphates and related highly charged systems. 
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Chapter 5 – MD Simulations of the Native PKB PH Domain 
with Inositol Phosphates 
 
5. 1 Introduction 
 
Extension of the Amber force field to include parameters for inositol phosphates 
allows their numerous interactions to be studied using MD simulations. In this chapter 
parameters for the inositol tris-phosphates, Ins(1,3,4)P3 and Ins(1,4,5)P3, are 
generated using the protocol developed in Chapter 4. These inositol phosphate 
parameters are applied in MD simulations to investigate the interaction of 
Ins(1,3,4,5)P4, Ins(1,3,4)P3 and Ins(1,4,5)P3 with the PKB PH domain. A significant 
portion of the work within this chapter has been submitted as a paper.142 
 
5. 2 The PKB PH Domain-Inositol Phosphate Interaction 
 
The PKB PH domain has a cationic pocket that is lined with basic amino acids. These 
amino acids are responsible for recognising and interacting with the highly anionic 
inositol phosphate head-groups of phosphoinositide lipids, Figure 21a. Structural and 
mutagenesis data show that phosphoinositide lipids interact with PKB principally via 
phosphate groups 3 and 4.11, 26 Additionally phosphate group 1 is also thought to 
contribute to binding. In contrast, phosphate group 5 is presumed to make no 
significant interactions as it is solvent exposed in the crystal structure of 
Ins(1,3,4,5)P4 in a complex with the PKB PH domain.11, 26 This is illustrated in Figure 
21b. 
 
The main interactions of Ins(1,3,4,5)P4 with the PKB PH domain are illustrated in 
Figure 21c. The crystal structure shows phosphate group 3 interacts with Lys14, 
Arg23, Arg25 and Asn53, phosphate group 4 with Lys14, Asn53 and Arg86 and 
phosphate group 1 with Arg23.   
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5. 2. 1 PKB’s Selectivity 
 
The distinct arrangement of phosphomonoester substitution on the inositol ring of 
phosphoinositides/inositol phosphates is responsible for the specificity of their 
interactions with receptor proteins.7, 27 Numerous experimental studies investigating 
PKB’s affinity for phosphoinositide lipids, have illustrated its preference for the 
3-phosphorylated phosphoinositides [PtdIns(3,4,5)P3 and PtdIns(3,4)P2] over 
PtdIns(4,5)P2.22, 24, 25  
 
Interestingly, PKB does not appear to follow the same pattern of selectivity for 
inositol phosphates as for their parent phosphoinositide lipids.22, 143 In a study by 
Frech et al., Ins(1,4,5)P3 and Ins(1,3,4,5)P4 are shown to bind to the PKB PH domain 
with a similar affinity, despite their parent lipids [PtdIns(4,5)P2 and PtdIns(3,4,5)P3 
respectively] displaying markedly different binding affinities to each other in this, and 
numerous other, investigations.22-24 The relatively high affinity of Ins(1,4,5)P3 for the 
PKB PH domain therefore requires explanation, as its parent lipid PtdIns(4,5)P2 is not 
known to bind to PKB despite its relative abundance in resting cells.144 
 
5. 2. 2 Binding Mode of Inositol Phosphates/Phosphoinositides 
 
The binding mode of Ins(1,3,4,5)P4 with its 3-phosphate group pointing directly into 
the PKB binding site, and 5-phosphate group solvent exposed, is also assumed for its 
parent lipid PtdIns(3,4,5)P3 due to its similar binding affinity to PtdIns(3,4)P2.22, 26 
This proposed binding mode for phosphoinositide lipids, in which the 5-phosphate 
group projects into solvent, is further consistent with the inability of PtdIns(4,5)P2 to 
bind.  
 
However, the relatively high in vitro binding affinity of Ins(1,4,5)P3 for the PKB PH 
domain, suggests that this inositol phosphate ligand may adopt a different orientation 
in the binding site to its parent lipid PtdIns(4,5)P2. This matter is difficult to 
investigate with experiments alone. Therefore in this chapter MD simulations are 
applied to explore the interaction of Ins(1,4,5)P3, and its parent lipid PtdIns(4,5)P2, 
with the PKB PH domain. 
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5. 3 The Computational Approach 
 
This chapter describes a computational approach to investigate the interaction of the 
PKB PH domain with a number of inositol phosphates [Ins(1,3,4,5)P4, Ins(1,3,4)P3 
and Ins(1,4,5)P3]. MD simulations allow the molecular basis, dynamic behaviour and 
associated free energies of such interactions to be studied. 
 
As highlighted in Chapter 4, a major difficulty in studying inositol phosphates using a 
computational approach is that their net charge/ionisation state in the cellular medium 
is currently uncertain.5, 118 Therefore, for each inositol phosphate all possible 
isomers/ionisation states at physiological pH have been considered.3, 145, 146 
 
5. 4 Program Details 
 
Gaussian 09122 was used for the geometry optimisation calculations and to generate 
the molecular electrostatic potential for the Ins(1,3,4)P3 and Ins(1,4,5)P3 isomers. The 
RESP program (in Amber) was used to derive the partial atomic charges. 
 
The Amber10120 and Amber11124 suite of programs implementing the ff99SB force 
field were used for energy minimisation, equilibration and production MD 
calculations. Parameter and topology files for the inositol phosphate-PKB PH domain 
complexes were creating using the LEaP module. Minimisation, equilibration and 
production MD calculations were performed with PMEMD. Analysis of hydrogen 
bonding, root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF) 
and cluster analysis were carried out using Ptraj. Free energy calculations, using the 
MM-PBSA method, were carried out using the Perl scripts in Amber. Graphical 
representations were produced with VMD and Chimera.125, 126 
 
5. 5 Parameterisation of Inositol Tris-phosphates 
 
Parameters for Ins(1,3,4,5)P4 were generated in Chapter 4. Herein parameters for 
Ins(1,3,4)P3 and Ins(1,4,5)P3 are generated using the same protocol. 
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The initial structures for Ins(1,3,4)P3 and Ins(1,4,5)P3 were adapted from that of 
Ins(1,3,4,5)P4 previously studied. Phosphate groups 5 and 3 were substituted with 
hydroxyl groups for Ins(1,3,4)P3 and Ins(1,4,5)P3 respectively. Eight 
isomers/ionisation states with different levels and arrangements of protonation were 
investigated for both Ins(1,3,4)P3 and Ins(1,4,5)P3, illustrated in Figure 22. These 
isomers fall into four different charge subsets ranging from -3 to -6. The in vitro 
probabilities of these charge states at varying pH are displayed in Figure 23.145, 146 
 
As for Ins(1,3,4,5)P4, each isomer was geometry optimised until it reached a local 
minimum on the potential energy surface. The isomers were first optimised using the 
DFT-B3LYP/3-21g* level of theory and then further optimised using 
DFT-B3LYP/6-31g**. These calculations were carried out in gas phase. For each 
optimised structure the MEP was calculated using the HF/6-31g* level of theory. The 
RESP algorithm was employed to fit the QM calculated MEP to atom-centred points. 
The RESP generated point charges were assigned as the charge parameters. Atom 
types were assigned from the ff99SB force field, using analogous atom types to 
Ins(1,3,4,5)P4. Parameters for Ins(1,3,4)P3 and Ins(1,4,5)P3 are supplied in sections 
S.4 and S.5 of the Electronic Supplementary Information. 
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(a) 
 
 
 
 
(b) 
 
 
Figure 22: The eight Ins(1,3,4)P3  (a) and Ins(1,4,5)P3 (b) isomers. Diagram adapted from Borkovec 
and Spiess.3 The horizontal line indicates the axial hydroxyl group at position 2. For Figures (a) and (b) 
circles represent phosphate groups 1, 3 and 4, and 1, 4 and 5 respectively. Filled circles represent 
mono-protonated phosphate groups, and empty circles represent fully deprotonated phosphate groups. 
The name given to, net charge of, and in vitro probability of each isomer are provided.146 
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(a) 
 
 
(b) 
 
Figure 23: Variation of the charge state probabilities as a function of pH for (a) Ins(1,3,4)P3 and 
(b) Ins(1,4,5)P3 in Et4NClO4 10% D2O.145, 146 
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5. 5. 1 Validation of Parameters 
 
The parameters assigned to Ins(1,3,4)P3 and Ins(1,4,5)P3 were validated by applying 
them in a molecular mechanics energy minimisation stage, as for Ins(1,3,4,5)P4 in 
section 4.6.2. For all of the Ins(1,3,4)P3 and Ins(1,4,5)P3 isomers, the energetic 
orderings from the QM optimisation and MM energy minimisation stages were in full 
agreement. 
 
5. 6 MD Protocol 
 
5. 6. 1 Initial Configuration  
 
The X-ray crystal structure of the PKB PH domain in a complex with Ins(1,3,4,5)P4 
[from the RCSB Protein Data Bank, accession code 1UNQ] provided the initial 
co-ordinates.11 In order to study the PKB PH domain in a complex with Ins(1,3,4)P3 
and Ins(1,4,5)P3, the PDB was modified by substituting phosphate groups 5 and 3 of 
Ins(1,3,4,5)P4 with hydroxyl groups respectively. The acetyl group capping the 
N-terminus of the PH domain was deleted as it is sufficiently far from the inositol 
phosphate binding site, and is not present in vivo. Crystallographic water molecules 
present in the PDB were kept. The Leap module of Amber was used to add hydrogen 
(and missing) atoms to the crystal structure. The systems were charge neutralised with 
Na+ counter-ions and solvated with TIP3P water molecules99 within a truncated 
octahedral unit cell, with a minimum of 8 Å distance from the edge of the box to any 
protein or ligand atom. 
 
5. 6. 2 Minimisation, Equilibration and Production Run 
 
The complexes were minimised in two stages. In the first stage, the water molecules 
and Na+ counter-ions were energy minimised, whilst harmonic restraints of 
500 kcal mol&1 Å&2 were applied to the protein and ligand; 500 steps of steepest 
descent, followed by 500 steps of conjugate gradient minimisation were carried out. 
In the second stage of minimisation, the restraints were removed, and the entire 
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system was minimised using 1500 steps of steepest descent, followed by 2000 steps 
of conjugate gradient minimisation. 
 
In all simulations, periodic boundary conditions were applied. A cut-off of 8 Å was 
used for the explicit calculation of non-bonded interactions. For the calculation of 
long-range electrostatic interactions, the particle mesh Ewald method was applied 
with a direct space cut-off of 8 Å.98 Each minimised system was heated from 0 K to 
300 K at constant volume over 50 ps. Following this, 50 ps of equilibration was 
carried out at constant pressure (1 bar) and temperature (300 K). Production MD 
simulations of each system were then run for 50 ns at constant pressure (1 bar) and 
temperature (300 K), with snapshots saved every 10 ps. For each simulation the 
SHAKE algorithm was applied to constrain all bonds involving hydrogen atoms, 
allowing a time-step of 2 fs to be used.102 In order to maintain the temperature during 
the simulations, Langevin dynamics was used with a collision frequency of 1.0 ps&1.  
 
5. 6. 3 MM-PBSA Calculations 
 
MM-PBSA (Molecular Mechanics–Poisson–Boltzmann Surface Area) calculations 
were implemented to calculate the free energy of binding for the inositol phosphate-
PKB PH domain complexes. These calculations were performed on the 
conformational ensembles generated by the production MD simulations. The theory 
and explanation behind this free energy approach is provided in section 3.7. 
 
Structural snapshots of the production MD simulations were saved every 10 ps, giving 
a total of 5000 snapshots for each 50 ns simulation. Each snapshot was stripped of 
water and counter-ions. MM contributions were calculated with an interaction cut-off 
of 999 Å and a dielectric constant of 1.0. Contributions to the solvation energy were 
calculated using the pbsa module of Amber. An internal dielectric of 1.0, an external 
dielectric of 80.0, a solvent radius of 1.4 Å and grid spacing of 0.5 Å was applied. 
Non-polar contributions to the solvation energy were calculated with a solvent surface 
tension of 0.0072 kcal mol&1 Å&2. The SASA was calculated with the Molsurf 
program with a solvent probe radius of 1.4 Å and Bondi atomic radii.147, 148  
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5. 6. 3. 1 Reasoning for the MM-PBSA Method 
 
The main reason the MM-PBSA method was chosen for this work is due to the fact it 
is computationally efficient compared to many other free energy methods, such as 
FEP or TI. Further reasoning for applying the MM-PBSA method in this work is its 
previous success in ranking and/or predicting the binding affinities of numerous 
ligands to a common target.115, 149-151 Its recent use in assessing the selectivity of 
protein kinases is also particularly relevant. 152 
 
5. 6. 3. 2 Entropy 
 
In this work, the entropic contribution to binding is neglected due to its large 
computational expense. Whilst the entropic contribution can increase accuracy when 
calculating free energies of binding, it can also have a detrimental effect.115 Inclusion 
of the entropic term in free energy calculations has been shown, in some cases, to 
worsen the agreement of computational calculations with experimental data. This is 
because inclusion of inaccurate entropies can cause more harm than simply neglecting 
this term.153, 154 
 
In addition to the above reasoning, the structural similarity of the inositol phosphate 
ligands investigated in this work means that their entropic contributions to binding 
would be expected to be comparable.107, 150 152 
 
5. 6. 3. 3 Dielectric Constant 
 
The computed free energies of binding in this study are significantly overestimated. 
Although this can partly be ascribed to the lack of entropic contribution, the 
extremely large electrostatic nature of the interaction should also be considered.  
 
The MM-PBSA method can often over-estimate the free energy of binding when 
dealing with a highly charged binding interface.115 Previous research has shown that 
altering the solute dielectric constant in the calculation can scale down binding free 
energies to bring them into experimental range.115, 153, 155 However the validity of such 
an approach is still under debate. A significant issue with this approach is how to 
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choose the solute dielectric constant for each individual system.156-158 Whilst Hou et 
al. suggest a method to guide the choice of solute dielectric constant based on 
interface properties, considerable further work in this area is required.115  
 
Problems with altering the solute dielectric constant have also been experienced when 
investigating ligands with different net charges. Rastelli et al. found that free energies 
of binding tended to only scale uniformly for ligands with the same net charge.153 
Thus when a solute dielectric constant other than 1 was applied in calculations for 
ligands with different net charges, the correlation to experiment was detrimentally 
affected. As the ligands within this study fall into charge subsets ranging from -3 
to -8, an internal dielectric constant of 1 has been used throughout. 
 
5. 6. 3. 4 Weighted Free Energy Calculations 
 
In order to allow a simple comparison of the computational results to in vitro studies, 
the free energies of binding for the different isomers of each inositol phosphate were 
weighted according to their in vitro probabilities, Figures 15, 16, 22 and 23.3, 145, 146  
 
5. 6. 4 Hydrogen Bond Interactions 
 
The Ptraj program within Amber 11 was used to analyse the hydrogen bond 
interactions for each 50 ns production MD simulation. A list of all potential hydrogen 
bond donors and acceptors was specified, and pair interactions between these were 
analysed for the duration of each simulation. A cut-off distance of 3.5 Å, and angle 
cut-off of 120° were specified for the pair interactions. 
 
5. 6. 5 RMS Deviations and Fluctuations 
 
The Ptraj program was used to calculate the RMS deviations and fluctuations of 
amino acid residues in the PKB PH domain. RMS deviations were calculated for the 
PKB PH domain backbone atoms (C, C!, N) over the time of the simulation, with 
reference to the starting structure in the production MD simulation. RMS fluctuations 
of the C! atoms were calculated with reference to the average structure of the PKB 
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PH domain during the 50 ns production MD simulation. 
 
5. 6. 6 Cluster Analysis 
 
The Ptraj program was used to carry out cluster analysis. Co-ordinate frames from 
each 50 ns production MD simulation were grouped into five distinct sets. The frames 
were clustered using the pairwise RMSD of C! atoms between frames as a metric, 
and average linkage as the clustering algorithm. 
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5. 7 Results and Discussion 
 
5. 7. 1 Free Energies of Binding 
 
5. 7. 1. 1 PKB PH Domain with Inositol Phosphates 
 
The free energy of binding for each Ins(1,3,4,5)P4, Ins(1,3,4)P3 and Ins(1,4,5)P3 
isomer to the PKB PH domain is provided in Table 8. These results illustrate the 
significant variation in the free energies of binding for different isomers of the same 
inositol phosphate. Interestingly isomers with the same net charge but different 
arrangement of protonation can differ in their computational free energies of binding 
by as much as 30 kcal mol&1. Additionally inositol phosphate isomers with a greater 
net charge do not necessarily bind with a larger free energy, highlighting the 
complexity of their interactions. 
 
Generally, the statistical errors for the individual simulations are low. Exceptions to 
this are highlighted in Table 8. The larger errors are due to multiple conformational 
states in these simulations. Whilst these conformational states are similar to each 
other, the highly charged nature of this system means that small changes in 
conformation can result in large differences in the free energy of binding. For 
example, the 3O145H isomer has the highest statistical error of the simulations. 
Cluster analysis identified three main conformational states for this system. Whilst all 
three states illustrated extremely similar hydrogen bond interactions via phosphate 
groups 3 and 4, slight variations at phosphate groups 1 and 5 were apparent, 
Figure 24. 
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Figure 24: The three conformational states of the 3O145H Ins(1,3,4,5)P4 isomer in a complex 
with the PKB PH domain. Cluster 1 shown in cyan is similar to the crystal structure of this complex. 
Cluster 2 shown in yellow has increased interactions with Gln79 on loop 3 via phosphate group 5. 
Cluster 3 shown in magenta has decreased interactions between Arg23 and phosphate group 1. Most 
hydrogen atoms have been omitted from this figure for ease of visualisation. 
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Table 8: Computationally determined binding free energies (denoted "G) for the individual 
inositol phosphate isomer-PKB PH domain simulations. The free energies of binding were 
calculated using the MM-PBSA method. The statistical error was estimated from the deviation between 
block averages. 
 
 
† Larger statistical errors due to multiple conformational states. 
 
 
 
 
 
Ligand Charge Isomer 'G in kcal mol-1 
Ins(1,3,4,5)P4 -4 1345H -71.86 ± 4.16 
 -5 1O345H -79.43 ± 3.06 
  3O145H -60.33 ± 16.13† 
  4O135H -86.40 ± 5.40 
  5O134H -69.46 ± 1.39 
 -6 13O45H -71.90 ± 9.09 
  14O35H -65.58 ± 6.05 
  15O34H -81.85 ± 5.48 
  34O15H -60.81 ± 10.64† 
  35O14H -76.50 ± 6.99 
  45O13H -96.31 ± 5.92 
 -7 134O5H -64.66 ± 15.77† 
  135O4H -64.64 ± 9.46 
  145O3H -79.41 ± 2.49 
    
Ins(1,3,4)P3 -3 134H -70.17 ± 8.55 
 -4 1O34H -57.97 ± 7.53 
  3O14H -72.65 ± 9.63 
  4O13H -62.66 ± 9.93 
 -5 13O4H -65.22 ± 9.55 
  14O3H -63.67 ± 11.64† 
  34O1H -53.48 ± 4.58 
 -6 134O -61.46 ± 9.50 
    
Ins(1,4,5)P3 -3 145H -30.01 ± 5.09 
 -4 1O45H -32.56 ± 11.82† 
  4O15H -42.79 ± 3.58 
  5O14H -41.74 ± 5.68 
 -5 14O5H -47.08 ± 7.09 
  15O4H -27.33 ± 8.17 
  45O1H -42.52 ± 10.28† 
 -6 145O -32.83 ± 12.40† 
 106 
In order to allow a simple comparison of the computational results to in vitro data, the 
free energies of binding for the different isomers have been weighted for each inositol 
phosphate, Table 9. The inositol phosphate isomers were weighted according to their 
in vitro probabilities at pH7. 
 
 
Table 9: Weighted computationally determined binding free energies (denoted !!) and in vitro 
dissociation constants (Kd) for inositol phosphate-PKB PH domain complexes. In vitro dissociation 
constants for the parent phosphoinositide lipid-PKB PH domain complexes are also provided. 
 
Ligand Computational !!!(kcal mol-1)a In vitro Kd for inositol phosphate (!M)22  In vitro Kd for parent phosphoinositide lipid 
(!M)22 
Ins(1,3,4,5)P4 -71.51 ! 3.07 1.5 !!!!! 0.40 !!!!!" 
Ins(1,3,4)P3 -65.61 ! 4.35 NDb 0.57 !!!!!" 
Ins(1,4,5)P3 -40.45 ! 2.76 1.2 !!!!! 2.5 !!!!! 
 
a The statistical error was estimated from the deviation between block averages for each simulation, 
and propagated appropriately for each weighted ligand.115  
b Not determined. 
 
 
As mentioned in section 5.6.3.3 the computed free energies of binding are 
significantly overestimated due to the highly charged binding interface of this system. 
Therefore, the comparison between the computational results and experimental data 
herein is qualitative. 
 
The weighted computational results mirror PKB’s widely accepted preference for 
3-phosphorylated phosphoinositides, Table 9. The computational results show 
Ins(1,3,4,5)P4 and Ins(1,3,4)P3 to bind to the PKB PH domain with a similar free 
energy of binding, with a preference for Ins(1,3,4,5)P4, agreeing with the in vitro 
affinities of their parent lipids. In comparison, Ins(1,4,5)P3 binds to the PKB PH 
domain with a significantly lower free energy, agreeing with the low in vitro affinity 
of its parent lipid PtdIns(4,5)P2.22, 24, 25 The relatively small statistical errors for the 
weighted free energies of binding impart a high level of confidence in these results. 
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Whilst the weighting method used in this work has been justified it is important to 
note that alternative approaches, such as averaging results for all isomers or taking the 
result for the strongest binding isomer, also give similar outcomes, Table 10. All 
approaches illustrate PKB’s preference for 3-phosphorylated inositol phosphates, in 
particular Ins(1,3,4,5)P4. 
 
 
Table 10: A comparison of different methods to weight the computationally determined binding 
free energies (denoted !!). The different weighting methods include weighting according to the in 
vitro probabilities of the isomers, averaging results for the isomers and simply taking results for the 
strongest binding isomer. 
 
Ligand Weighted 
computational !!!(kcal mol-1) 
Averaged 
computational !!!(kcal mol-1) 
Isomer with largest 
computational !!!(kcal mol-1) 
Ins(1,3,4,5)P4 -71.51 ! 3.07 -73.51!!7.29 -86.40 ! 5.40† 
Ins(1,3,4)P3 -65.61 ! 4.35 -63.41! 8.86 -72.65 ! 9.63 
Ins(1,4,5)P3 -40.45 ! 2.76 -37.11!!8.01 -47.08 ! 7.09 
 
† Free energy result for 45O13H isomer ignored, as the in vitro probability for this isomer within the -6 
subset is only 0.5%. 
 
 
The in vitro data of Frech et al. suggests that the inositol phosphate head-groups do 
not follow the same pattern of selectivity as their parent lipids. Rather than illustrating 
a preference for 3-phosphorylated inositol phosphates, the experimental results show 
that the PKB PH domain binds to Ins(1,3,4,5)P4 and Ins(1,4,5)P3 with a similar 
affinity.  
 
Visual analysis of the MD trajectories of Ins(1,4,5)P3 and the PKB PH domain 
prompted an explanation for this in vitro behaviour. When visualised in VMD the 
Ins(1,4,5)P3 isomers were seen to rotate 180° along the P1/P4 axis in the binding site, 
illustrated in Figure 25. A movie of this is provided in the Electronic Supplementary 
Information, Movie M1. In general, the Ins(1,4,5)P3 ligands spent the majority of the 
50 ns simulations re-orientating, only reaching the fully flipped/inverted conformation 
towards the end of the simulation. 
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Figure 25: Rotation of Ins(1,4,5)P3 in the PKB binding site. Images are taken from snapshots at 0, 
25 and 50 ns of a simulation. At 0 ns Ins(1,4,5)P3 is in its initial orientation, with the 5-phosphate 
group pointing away from binding site. At 25 ns Ins(1,4,5)P3 has rotated approximately 90° along the 
P1/P4 axis, with the 5-phosphate group now pointing out of the page. At 50 ns Ins(1,4,5)P3 has flipped 
180° along the P1/P4 axis from its initial orientation, with the 5-phosphate group now pointing towards 
the PKB binding site. 
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To confirm the stability of the Ins(1,4,5)P3 isomers in this rotated/flipped binding 
mode the simulations were run for a further 50 ns. The Ins(1,4,5)P3 isomers were 
shown to maintain this rotated orientation. Furthermore, free energy analysis of the 
isomers following rotation in the PKB binding site corresponded to a dramatic 
increase in their free energies of binding, illustrated in Figure 26. 
 
 
 
Figure 26: The free energy of binding for Ins(1,4,5)P3 to the PKB PH domain during an 100 ns 
MD simulation. The first 10 ns (black) represent the Ins(1,4,5)P3 ligand in its initial weakly binding 
orientation in the PKB binding site with its 5-phosphate group solvent exposed. The next 40 ns (red) 
illustrate Ins(1,4,5)P3 re-orientating in the binding site. The final 60 ns (blue) illustrate Ins(1,4,5)P3 in 
its strongly binding flipped orientation. 
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Based on these results, we proposed a theory to explain the high in vitro affinity of 
Ins(1,4,5)P3 for the PKB PH domain. We hypothesised that when not bonded to a 
phosphatidate tail the Ins(1,4,5)P3 head-group is no longer restricted to bind in the 
same orientation as its parent lipid. Instead Ins(1,4,5)P3 binds to the PKB PH domain 
in a flipped orientation, in which the inositol ring is inverted 180° along the P1/P4 
axis, with respect to the other inositol phosphate ligands, Figure 27. In this flipped 
orientation phosphate group 5 points towards the PKB binding site, thus mimicking 
phosphate group 3 of Ins(1,3,4)P3. Ins(1,4,5)P3 would therefore act in a similar 
manner to Ins(1,3,4)P3, the head-group of PtdIns(3,4)P2 known to exhibit high affinity 
for the PKB PH domain.  
 
 
 
 
Figure 27: Ins(1,4,5)P3 in its initial (cyan) and flipped (magenta) orientation in the binding site of 
the PKB PH domain. A dashed line represents the P1/P4 axis around which the Ins(1,4,5)P3 ligand 
was rotated 180°. 
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5. 7. 1. 2 PKB PH Domain with Flipped Inositol Phosphates 
 
In order to further investigate Ins(1,4,5)P3’s alternative binding mode, MD 
simulations were performed with the starting orientation of Ins(1,4,5)P3 
flipped/inverted 180° along the P1/P4 axis in the PKB PH domain. Free energy 
analysis of these simulations (Table 11) showed that in this flipped orientation 
Ins(1,4,5)P3 binds with a similar free energy to Ins(1,3,4)P3 and Ins(1,3,4,5)P4 in their 
initial binding mode (Table 9). Furthermore, Ins(1,4,5)P3 appears stable in this flipped 
orientation and makes remarkably similar hydrogen bond interactions to the 3-
phosphorylated inositol phosphates.  
 
 
Table 11: Weighted computationally determined free energies of binding (denoted !!) for the 
flipped inositol phosphate-PKB PH domain complexes. 
 
 
 
 
 
 
 
a The statistical error was estimated from the deviation between block averages for each simulation, 
and propagated appropriately for each weighted ligand.115 
 
 
To extend this study, simulations of the 3-phosphorylated inositol phosphates flipped 
180° along the P1/P4 axis in the PKB PH domain were also performed. Free energy 
analysis showed that Ins(1,3,4)P3 has a significantly lower free energy of binding in 
its flipped mode (Table 11), mirroring that of Ins(1,4,5)P3 in its un-flipped and 
weakly binding orientation. Remarkably, towards the end of the simulations the 
flipped Ins(1,3,4)P3 isomers rotated back along the P1/P4 axis to their binding mode 
in which phosphate group 3 points towards the binding site. 
 
The weighted free energy of binding for the flipped Ins(1,3,4,5)P4 ligand to the PKB 
PH domain is approximately 10 kcal mol&1 lower than for its un-flipped orientation. 
Ligand Computational !!!(kcal mol-1)a 
Ins(1,3,4,5)P4 flip -60.06 ! 2.29 
Ins(1,3,4)P3 flip -42.07 ! 5.17 
Ins(1,4,5)P3 flip -60.89 ! 2.34 
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This difference in affinity is interesting, as both binding modes have phosphate 
groups at the same points along the inositol ring. We therefore hypothesise that this 
lower affinity is due to the reversed positions of the phosphate groups relative to the 
plane of the inositol ring, Figure 28, thereby affecting their interactions with amino 
acids in the binding site. 
 
 
 
 
 
Figure 28: Rotation of the Ins(1,3,4,5)P4 ligand. Phosphate groups are shown to be fully 
deprotonated for ease of visualisation. 
 
 
Inspection of the individual free energies of binding for the Ins(1,3,4,5)P4 flipped 
isomers (Table S5 in the Electronic Supplementary Information) highlights the very 
large variation in their affinity for the PKB PH domain. Interestingly isomers in 
which phosphate group 4 is singly protonated tend to be unstable in the binding site, 
displaying large movements and reorientation. Conversely, Ins(1,3,4,5)P4 isomers in 
which phosphate group 4 is fully deprotonated generally showed a significantly larger 
free energy of binding. This may be due to phosphate group 4 forming additional 
interactions with amino acids in the binding site when fully deprotonated.  
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Whilst it is feasible that both binding modes are accessible to Ins(1,3,4,5)P4, results 
demonstrate that its un-flipped mode of binding is favourable. This is supported by 
the simulations of the individual complexes, in which each isomer shows a larger free 
energy of binding in its un-flipped mode compared to its flipped. 
 
5. 7. 1. 3 PKB PH Domain with Phosphoinositide 4, 5-bisphosphate 
 
Whilst we have explained the unexpectedly high in vitro binding affinity of 
Ins(1,4,5)P3 to the PKB PH domain, one may consider the equally puzzling question 
of why its parent lipid PtdIns(4,5)P2 does not exhibit the same relatively high affinity 
in vitro or in vivo.22, 25, 34 
 
Phosphoinositide lipids have a phosphatidate tail bonded to the inositol phosphate 
head-group via phosphate group 1. It has previously been hypothesised that this tail 
restricts the binding orientation of the inositol phosphate head-group due to steric 
hindrance.143 If PtdIns(4,5)P2 was restricted to bind with the 5-phosphate group in its 
solvent exposed position, rather than pointing towards the PKB binding site, this 
could explain the different behaviour to its head-group. 
 
To investigate this steric hindrance, MD simulations of PtdIns(4,5)P2 in both its 
flipped and un-flipped orientations in the PKB PH domain were performed. These 
simulations were run for 150 ns in order to fully explore the behaviour and movement 
of the PtdIns(4,5)P2 ligand. Parameters for PtdIns(4,5)P2 were generated using the 
same protocol as for the inositol phosphate isomers. These parameters are provided in 
section S.6 in the Electronic Supplementary Information. 
 
Visual analysis of the simulations suggests that PtdIns(4,5)P2's inositol phosphate 
head-group and phosphatidate tail are locked into a specific conformation by 
intra-molecular hydrogen bonds. Of particular importance are strong hydrogen bond 
interactions between the 6-hydroxyl group and the oxygen atoms of phosphate group 
1, which are occupied during almost the entire simulation, Figure 29. Interestingly 
this interaction has also been noted in previous experimental and computational 
studies.5, 63 These hydrogen bond interactions encourage phosphate group 1 (and 
hence the lipid tail to which it is bonded) to tilt towards the 6 hydroxyl group. In its 
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un-flipped orientation the 6-hydroxyl group of PtdIns(4,5)P2 is solvent exposed, thus 
the lipid tail is encouraged to project into solvent. However, in its flipped orientation 
the 6-hydroxyl group of PtdIns(4,5)P2 points towards the binding site of PKB and 
therefore encourages the lipid chain into a position that cannot be accommodated due 
to steric clashing. As a result, the PtdIns(4,5)P2 ligand is seen to move away from its 
flipped binding mode. This movement of PtdIns(4,5)P2 and the intra-molecular 
hydrogen bond interactions are illustrated in Movie M2 in the Electronic 
Supplementary Information. 
 
The simulation of PtdIns(4,5)P2 in its un-flipped orientation further supports the 
argument of this lipid’s binding mode. Unlike its equivalent inositol phosphate head-
group, PtdIns(4,5)P2 did not rotate in the binding site during the 150 ns simulation.  
 
 
 
 
Figure 29: The intra-molecular interaction between the 6-hydroxyl group of PtdIns(4,5)P2 and 
phosphate group 1. The remainder of the lipid tail is not illustrated for ease of visualisation, but is 
attached via the 1-phosphate group as indicated. 
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5. 7. 2 Orientation and Molecular Behaviour 
 
Analysis of the MD simulations showed that the Ins(1,3,4,5)P4 and Ins(1,3,4)P3 
ligands adopted very similar and stable orientations in the PKB binding site in their 
initial un-flipped binding mode. This stability is well illustrated by the small RMSD 
values for the PKB PH domain (and binding site residues) during the simulations. 
Representative RMSD plots for one simulation are shown in Figures 30 and 31.  
 
 
 
Figure 30: RMS deviation of the backbone atoms of the PKB PH domain when in a complex with 
Ins(1,3,4,5)P4 during the 50 ns MD simulation. RMSD values are made in comparison to the starting 
structure of the production MD simulation. 
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Figure 31: RMS deviation of the backbone atoms of residues in the PKB binding site when in a 
complex with Ins(1,3,4,5)P4 during the 50 ns MD simulation. RMSD values are made in comparison 
to the starting structure of the production MD simulation. Residues include Lys17, Arg23, Arg25, 
Asn53 and Arg86. 
 
 
Hydrogen bond analysis of the simulations showed that the 3-phosphorylated inositol 
phosphates replicated the hydrogen bond interactions apparent from the crystal 
structure with phosphate groups 3 and 4 forming the major interactions, Table 12.11 
Interestingly in its flipped orientation Ins(1,4,5)P3 adopted a comparable binding 
mode, with phosphate group 5 mimicking phosphate group 3 of the 3-phosphorylated 
inositol phosphates. In contrast, the Ins(1,4,5)P3 ligand in its initial un-flipped 
orientation made many fewer H bond interactions and consequently was seen to move 
away from the PKB binding site, before rotating 180° along the P1 /P4 axis.  
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Table 12: The major H bond interactions for the PKB PH domain-inositol phosphate complexes. 
Average occupancies for the hydrogen bond interactions are provided, representing the percentage of 
time the interactions were formed during the MD simulations. Each phosphate group has three 
non-ester oxygen atoms that are able to act as hydrogen bond acceptors. The interactions of these 
oxygen atoms have been combined for each phosphate group, sometimes resulting in occupancies over 
100%. The donor atoms of the amino acid side chains are named according to the electronegative atom 
the hydrogen atoms are attached to. In cases where multiple hydrogen atoms are attached to this 
electronegative atom, their occupancies were combined. The names of the atoms in the table are taken 
from Amber. 
 
 
 
Analysis of the MD simulations of the PKB PH domain and Ins(1,3,4,5)P4 suggested 
that in addition to the hydrogen bond interactions reported from the crystal structure, 
interactions via phosphate group 5 were also apparent. Whilst phosphate group 5 is 
considered to be solvent exposed in the crystal structure, significant interactions with 
Arg86 are apparent in the simulations (with an average occupancy of 59%). 
Additionally other minor interactions of phosphate group 5 with residue Gln79 
positioned on variable loop 3 are also apparent (with an average occupancy of 9%). 
 
The interactions of phosphate group 5 stress the importance of not solely relying on a 
static crystal structure for binding information. Furthermore, they also highlight the 
Acceptor Donor Ins(1,3,4,5)P4 Ins(1,3,4)P3 Ins(1,4,5)P3 Ins(1,4,5)P3 
flip 
Phosphate 
group 1 
Arg23 (NH2) 121 103 73 83 
Arg23 (NH1) 113 100 57 82 
Phosphate 
group 3 
Lys14(NZ) 116 77   
Arg23 (NH1) 66 26   
Arg25 (NE) 107 118   
Arg25 (NH2) 191 141   
Asn53 (ND2) 110 104   
Phosphate 
group 4 
Lys14 (NZ) 96 90 70 83 
Asn53 (ND2) 105 93 68 84 
Arg86 (NH2) 152 121 83 113 
Arg86 (NE) 122 111 78 111 
Phosphate 
group 5 
Lys14(NZ)    96 
Arg23 (NH1)    20 
Arg25 (NE)    105 
Arg25 (NH2)    136 
Asn53 (ND2)    66 
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use of MD simulations in this matter. It is easily understandable how such interactions 
are not apparent in the crystal structure, as loop 3 (consisting of residues 77-84) is 
extremely flexible. This flexibility is highlighted by loop 3’s high B-factor values, 
and 7.4 Å difference in position in the apo- and complexed crystal structures of the 
PKB PH domain.11  
 
Figure 32 illustrates the RMS fluctuations of the PKB PH domain residues when in a 
complex with Ins(1,3,4,5)P4. [Results are displayed for one representative 50 ns 
simulation]. Fluctuations are calculated relative to the average structure during the 
simulation. This figure again highlights the high mobility of loop 3 (and particularly 
residues Gln79 and Trp80). 
 
 
Figure 32: RMS fluctuations by residue of the PKB PH domain when in complex with 
Ins(1,3,4,5)P4, during the 50 ns simulation. 
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5. 8 Conclusion 
 
This chapter describes the use of MD simulations to further understand the interaction 
of PKB's PH domain with the inositol phosphate head-groups of phosphoinositide 
lipids. Additionally these simulations act as further validation of the inositol 
phosphate parameters generated in this work.  
 
The MD simulations successfully mirror PKB's in vivo (and in vitro) selectivity for 
3-phosphorylated phosphoinositides. The hydrogen bond interactions apparent in 
these simulations also correspond well with that of the crystallographically 
determined structure of Ins(1,3,4,5)P4 bound to the PKB PH domain.  
 
In addition to complementing experimental work, MD simulations have also been 
successfully applied to rationalise and explain experimental data. The atomic level 
view of the computational simulations has helped to explain the unexpectedly high in 
vitro affinity of Ins(1,4,5)P3 for the PKB PH domain.22 Simulations showed that when 
not bonded to a phosphatidate tail, Ins(1,4,5)P3 is able to bind to the PKB PH domain 
in a flipped orientation, with respect to the binding mode of other inositol phosphate 
ligands and its parent lipid PtdIns(4,5)P2. This flipped orientation allows phosphate 
group 5 of Ins(1,4,5)P3 to form favourable interactions with basic amino acids in the 
PKB binding site, as opposed to being solvent exposed, thus explaining its higher than 
expected affinity. A flipped binding mode of inositol-based compounds to the PKB 
PH domain has previously been noted by Castillo et al. for a number of 
phosphatidylinositol ether lipid analogues with 2-hydroxy substitutions.159  
 
Due to Ins(1,4,5)P3's relatively high affinity for the PKB PH domain, it is important to 
consider whether this ligand plays a regulatory role in vivo by competing with 
3-phosphorylated phosphoinositides. Without additional experimental data, it is 
difficult to hypothesise the physiological relevance of this ligand, as this would 
depend on a number of factors including its intra-cellular concentration, in vivo 
lifetime, and presence of other Ins(1,4,5)P3 binding proteins.143 However, a number of 
previous reports show many higher order inositol phosphates, including 
Ins(1,3,4,5)P4, inhibit the activity of PKB by competing for its PH domain.160-162 Thus 
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the regulatory role of Ins(1,4,5)P3 may be an important consideration for future 
studies. 
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Chapter 6 - MD Simulations of the Mutant PKB PH Domain 
with Inositol Phosphates 
 
6.1 Introduction 
 
In this chapter a PKB mutant that has been reported in human breast, lung, ovarian, 
and colorectal cancers is investigated using MD simulations.29, 49-51 Substitution of 
glutamic acid to lysine at position 17 (E17K) on the PKB PH domain causes PKB to 
constitutively target the plasma membrane.29 The mechanism behind this constitutive 
membrane localisation, and how this leads to oncogenesis, is considered herein.  
 
6. 1. 1 Residue 17 
 
Residue Glu17 is located near to the phosphoinositide binding site of the PKB PH 
domain. In PKB’s native uncomplexed state Glu17 occupies this binding site forming 
hydrogen bond interactions with Lys14, Figure 33. In contrast, when native PKB is 
complexed with Ins(1,3,4,5)P4 Glu17 moves 4.7 Å away from the binding site in 
order to accommodate the anionic inositol phosphate, Figure 33. 
 
Mutation of the glutamic acid residue at position 17 to lysine (E17K) reverses the 
charge of this residue and thereby alters the electrostatic interactions in the 
phosphoinositide binding site. The crystal structure of the E17K PKB PH domain 
complexed with Ins(1,3,4,5)P4 shows that Lys17 forms (indirect) hydrogen bond 
interactions with phosphate group 5 and hydroxyl group 6 of Ins(1,3,4,5)P4, 
Figure 33.29 
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6. 1. 2 Membrane Localisation of Native PKB 
 
Upon cell stimulation, levels of the 3-phosphorylated phosphoinositides in the plasma 
membrane dramatically increase from their low basal concentrations.7 These 
3-phosphorylated phosphoinositides recruit PKB to the plasma membrane via direct 
interaction of their inositol phosphate head-groups with PKB’s PH domain.11 In 
contrast PtdIns(4,5)P2, which is relatively abundant in resting cells, is not known to 
play a role in this recruitment. At the plasma membrane PKB is phosphorylated, and 
thereby activated, by PDK1 and MTORC2.40, 41, 163 Active PKB then dissociates from 
the plasma membrane and phosphorylates a number of downstream targets. Many of 
these targets, such as Bad and Caspase-9, regulate the cell’s apoptotic machinery.33, 34 
Additionally, many others are associated with cell cycle regulation and progression, 
including the CDK inhibitors p21 and p27.36, 37 
 
6. 1. 3 Membrane Localisation of E17K PKB 
 
The E17K mutation has been found to cause PKB to constitutively target the plasma 
membrane.29, 164 This unregulated recruitment of PKB is of particular interest due to 
its links with cancer.29, 49, 51 It is understood that constitutive targeting of PKB to the 
plasma membrane leads to an elevated level of PKB phosphorylation, and thereby 
activation.164 As many of PKB’s downstream targets are involved in cell proliferation 
and survival, it is unsurprising that increased levels of active PKB can lead to 
oncogenesis. 
 
Whilst the crystal structure of the E17K PKB PH domain with Ins(1,3,4,5)P4 has been 
solved, the mechanism behind this mutant’s constitutive membrane targeting is still 
under consideration. Two models have previously been proposed for this 
recruitment.164 In the first of these models the charge reversal at residue 17 is thought 
to cause a significant increase in PKB’s affinity for 3-phosphorylated 
phosphoinositides. Therefore even at low basal levels these phosphoinositides would 
drive PKB recruitment to the membrane. The second model proposes that the E17K 
mutation alters/broadens PKB’s phosphoinositide selectivity, allowing PKB to bind to 
PtdIns(4,5)P2, which is relatively abundant in resting cells.  
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6. 1. 3. 1 Current Understanding 
 
In vitro experiments suggest it is E17K PKB’s broadened lipid selectivity that is 
primarily responsible for its enhanced recruitment to the plasma membrane.164 In 
addition, a small increase in the affinity of this mutant for PtdIns(3,4,5)P3 has also 
been proposed.164  
 
The mechanism behind this broadened selectivity is not well understood. In this 
chapter, MD simulations of the E17K PKB PH domain with Ins(1,3,4,5)P4, 
Ins(1,3,4)P3 and Ins(1,4,5)P3 [the head-groups of PtdIns(3,4,5)P3, PtdIns(3,4)P2 and 
PtdIns(4,5)P2 respectively] have been carried out. It is hoped that the atomic level 
view from these simulations will help to explain the E17K PKB PH domain’s 
behaviour.  
 
6. 2 Program Details 
 
The Amber11124 suite of programs implementing the ff99SB force field was used for 
energy minimisation, equilibration and production MD calculations. Parameter and 
topology files for the inositol phosphate-E17K PKB PH domain complexes were 
created using the LEaP module. Minimisation, equilibration and production MD 
calculations were performed with PMEMD. Analysis of hydrogen bonding was 
carried out using Ptraj. Free energy calculations, using the MM-PBSA method, were 
carried out using the Perl scripts in Amber. Graphical representations were produced 
with VMD and Chimera.125, 126 
 
6. 3 MD Protocol 
 
6. 3. 1 Initial Configuration 
 
The X-ray crystal structure of the PKB PH domain in a complex with Ins(1,3,4,5)P4 
[from the RCSB Protein Data Bank accession code 1UNQ]11 provided the initial 
co-ordinates for the system. Residue Glu17 was modified to Lys by removing all 
atoms beyond C$ from the side-chain and altering the name of the residue.  
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For ligands Ins(1,3,4)P3 and Ins(1,4,5)P3, the PDB was modified by substituting 
phosphate groups 5 and 3 of Ins(1,3,4,5)P4 with hydroxyl groups respectively. The 
initial orientation for the inositol phosphates was set to their ‘un-flipped’ mode, in 
which the 5-position is solvent exposed, and the 3-position points towards the binding 
site. As for the native studies in Chapter 5, all physiologically accessible isomers for 
Ins(1,3,4,5)P4, Ins(1,3,4)P3 and Ins(1,4,5)P3 were considered. 
 
The acetyl group bonded to the N terminus of the PH domain was removed for all 
simulations. The Leap module of Amber was used to add hydrogen (and missing) 
atoms to the crystal structure. The systems were charge neutralised with Na+ 
counter-ions and solvated with TIP3P water molecules within a truncated octahedral 
unit cell, with a minimum of 8 Å distance from the edge of the box to any protein or 
ligand atom.  
 
6. 3. 1. 1 E17K Crystal Structure 
 
The initial orientation for the system was taken from the crystal structure of the native 
PKB PH domain (PDB accession code 1UNQ), as opposed to the crystal structure of 
the E17K PKB PH domain (PDB accession code 2UZS).11, 29  
 
The reason for using an adapted version of the native PDB in this work was because 
initially multiple different PKB mutants were investigated for which crystal structures 
were not available. Therefore, the native crystal structure was adapted for each mutant 
to maintain consistency. Results from a preliminary investigation of these other 
mutants are given in the Electronic Supplementary Information (Table S.3). They 
provide further validation of the molecular model by replicating patterns from 
experimental data. 
 
A further reason for using the native crystal structure was that the B-factor values for 
Ins(1,3,4,5)P4 (and amino acids surrounding it) are significantly larger in the mutant 
crystal structure: Ins(1,3,4,5)P4 has an average B-factor value of 21 Å2 in the E17K 
PKB PH domain, almost three times that of the native crystal structure. 
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6. 3. 2 Minimisation, Equilibration and Production Run 
 
The complexes were minimised in two stages. In the first stage, the water molecules 
and Na+ counter-ions were energy minimised, whilst harmonic restraints of 
500 kcal mol&1 Å&2 were applied to the protein and ligand; 500 steps of steepest 
descent and 500 steps of conjugate gradient minimisation were carried out. In the 
second stage of minimisation, the restraints were removed, and the entire system was 
minimised using 1500 steps of steepest descent and 2000 steps of conjugate gradient 
minimisation. 
 
In all simulations, periodic boundary conditions were applied. A cut-off of 8 Å was 
used for the explicit calculation of non-bonded interactions. For the calculation of 
long-range electrostatic interactions, the particle mesh Ewald method was applied 
with a direct space cut-off of 8 Å.98 Each minimised system was heated from 0 K to 
300 K at constant volume over 50 ps. Following this, 100.05 ns of equilibration was 
carried out at constant pressure (1 bar) and temperature (300 K). The equilibration 
was run for 100.05 ns to allow the PKB PH domain and inositol phosphates to adjust 
their conformation/orientation due to the hand-altered mutation, and reach 
equilibrium. Production MD simulations of each system were then run for 50 ns at 
constant pressure (1 bar) and temperature (300 K), with snapshots saved every 10 ps.  
 
For each simulation the SHAKE algorithm was applied to constrain all bonds 
involving hydrogen atoms, allowing a time-step of 2 fs to be used.102 In order to 
maintain the temperature during the simulations, Langevin dynamics was used with a 
collision frequency of 1.0 ps&1. MD simulations were performed with the GPU 
accelerated version of PMEMD in Amber11.103 
 
6. 3. 3 Free Energy Calculations 
 
MM-PBSA calculations were implemented to calculate the free energy of binding for 
the inositol phosphate–E17K PKB PH domain complexes. Structural snapshots from 
the 50 ns production MD simulations were used for these calculations. Snapshots 
were saved every 10 ps, giving a total of 5000 snapshots for each simulation. Each 
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snapshot was stripped of water and counter-ions. MM-PBSA calculations were 
carried out using the Perl scripts in Amber. For more details about the MM-PBSA 
method applied, see section 5.6.3. 
 
The necessity for the 100.05 ns equilibration stage is illustrated in Figure 34. This 
shows that large jumps in the free energy of binding are apparent in the first 50 ns of 
the simulation, correlating with significant structural movements in the binding site. 
In the next 50 ns the system is shown to have almost reached an equilibrium state 
with much smaller jumps being apparent. Finally, the last 50 ns (representing the 
production MD) display even steadier results. Similar patterns in the free energies of 
binding were seen for many of the inositol phosphate isomers. 
 
 
 
Figure 34: The calculated free energy of binding for a representative E17K PKB PH domain-
Ins(1,3,4,5)P4 complex over the 150 ns simulation. 
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6. 3. 3. 1 Weighted Free Energy Calculations 
 
In order to allow a simple comparison of the computational results to in vitro studies, 
the free energies of binding for the different isomers of each inositol phosphate were 
weighted according to their in vitro probabilities, Figures 15, 16, 22 and 23 in 
Chapters 4 and 5 respectively.3, 145, 146 
 
6. 3. 4 Hydrogen Bond Interactions 
 
The Ptraj program within Amber 11 was used to analyse the hydrogen bond 
interactions for each simulation. A list of all potential hydrogen bond donors and 
acceptors was specified, and pair interactions between these were analysed for the 
50 ns production MD simulations. A cut-off distance of 3.5 Å, and angle cut-off of 
120 ° were specified for the pair interactions. 
 
6. 4 Results and Discussion 
 
6. 4. 1 E17K PKB PH Domain with Ins(1,4,5)P3 
 
MD simulations of the E17K PKB PH domain in a complex with Ins(1,4,5)P3 allow 
the hypothesis that the E17K mutant has an increased affinity for PtdIns(4,5)P2 to be 
investigated. 
 
6. 4. 1. 1 Free Energies of Binding 
 
Results in Table 13 illustrate that the weighted computational free energy of binding 
of Ins(1,4,5)P3 to the E17K PH domain is over 8 kcal mol-1 greater than to the native 
PKB PH domain. Results for the individual Ins(1,4,5)P3 isomers further support this 
result with each Ins(1,4,5)P3 isomer binding with greater affinity to the mutant PKB 
PH domain than the native, illustrated in Tables S.4 and S.6 in the Electronic 
Supplementary Information. 
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Table 13: Weighted computationally determined binding free energies (denoted !!) of the native 
and E17K PKB PH domains to inositol phosphates. 
 
Ligand Computational !! for 
the native PKB PH 
domain (kcal mol-1)a 
Computational !!!for 
the E17K PKB PH 
domain (kcal mol-1)a 
Ins(1,3,4,5)P4 -71.51 ! 3.07 -75.67 !!!!!" 
Ins(1,3,4)P3 -65.61 ! 4.35 -65.04 ! 2.07 
Ins(1,4,5)P3 -40.45 ! 2.76 -48.24 !!!!!" 
 
a The statistical error was estimated from the deviation between block averages for each simulation, 
and propagated appropriately for each weighted ligand.115 
 
 
6. 4. 1. 2 Orientation and Molecular Behaviour 
 
The increased affinity of the PKB PH domain for Ins(1,4,5)P3 upon mutation is easily 
explained by studying this ligand’s behaviour in the native and mutant binding sites. 
Ins(1,4,5)P3 forms many similar interactions in both binding sites, with interactions 
between P1 and Arg23, and P4 and Lys14, Asn53 and Arg86. However additional 
interactions between Lys17 and Ins(1,4,5)P3 are apparent in the mutant simulations. 
Lys17 is shown to form both direct and indirect (i.e. water-mediated) interactions 
with phosphate groups 4 and 5 of Ins(1,4,5)P3. Direct interactions via phosphate 
group 5 are most apparent with an average occupancy of !60%, compared to the !20% occupancy of interactions between Lys17 and phosphate group 4. Additionally 
indirect interactions between Lys17 and the 6-hydroxyl group of Ins(1,4,5)P3 also 
contribute to binding.  
 
Visualisation of the simulations shows that, despite Ins(1,4,5)P3’s additional 
interactions in the mutant binding site, this ligand is still not held tightly in one fixed 
orientation. This is because many of the interactions are formed via water molecules. 
The indirect nature of these interactions allows flexibility in Ins(1,4,5)P3’s binding 
orientation.  
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It is important to note that whilst there is a level of flexibility in Ins(1,4,5)P3’s 
orientation in the mutant binding site, a fairly stable un-flipped binding mode is still 
maintained throughout the 150 ns simulations. This is in contrast to the native 
simulations which show the Ins(1,4,5)P3 ligand to rotate 180° in the PKB binding site 
within 50 ns (Chapter 5).  
 
6. 4. 2 E17K PKB PH Domain with 3-phosphorylated Inositol 
Phosphates 
 
In order to further explore E17K PKB’s enhanced affinity for the plasma membrane, 
the interaction between the E17K PKB PH domain and the 3-phosphorylated inositol 
phosphates was investigated. 
 
6. 4. 2. 1 E17K PKB PH Domain with Ins(1,3,4,5)P4 
 
The weighted free energy of binding for Ins(1,3,4,5)P4 to the E17K PKB PH domain 
illustrates that this ligand binds with approximately 4 kcal mol-1 greater affinity than 
to the native PKB PH domain, Table 13. Whilst the free energies of binding are close 
considering the level of error associated with the simulations, they do reflect the 
behaviour seen in vitro for the parent lipids: Landgraf et al. illustrated that in addition 
to the large increase in affinity for PtdIns(4,5)P2, E17K PKB also showed a smaller 
increase in affinity for PtdIns(3,4,5)P3.164  
 
Whilst the free energy results for Ins(1,3,4,5)P4 should be treated with caution, the 
molecular behaviour of this ligand in the native and mutant binding sites can still be 
explored. The simulations of Ins(1,3,4,5)P4 in the mutant binding site illustrate that as 
well as maintaining the interactions from the native system, additional interactions 
between Ins(1,3,4,5)P4 and Lys17 are apparent. The side-chain amine group of Lys17 
is seen to form strong direct H-bond interactions with the oxygen atoms of phosphate 
group 5, with an average occupancy of 96%. These interactions are illustrated in 
Figure 35. Additional smaller interactions are also apparent between Lys17 and 
phosphate group 4 with an average occupancy of 31%, as well as indirect interactions 
between Lys17 and the 6-hydroxyl group.  
 131 
These interactions between Ins(1,3,4,5)P4 and Lys17 in the simulations are 
particularly interesting as many of these are not apparent in the crystal structure.29 
The crystal structure only reports indirect interactions between Lys17 and 
Ins(1,3,4,5)P4. Furthermore, the crystal structure does not report any (direct or 
indirect) interactions between Lys17 and phosphate group 4.  
 
This difference in agreement between the mutant crystal structure and the simulations 
may just be an artefact of using a static crystal structure for binding information. 
Alternatively the larger B-factor values for Ins(1,3,4,5)P4 and its surrounding amino 
acid residues in the mutant crystal structure could potentially lead to errors in atom 
placement.29 However, analysis of the atom placement using the Electron Density 
Server suggests it is of good quality.165 
 
 
 
 
Figure 35: A representative structure of Ins(1,3,4,5)P4 in the E17K PKB PH domain from the 
MD simulations. Hydrogen bond interactions are indicated with black lines. Ins(1,3,4,5)P4 is seen to 
make similar interactions as in the native PKB binding site. Additional interactions of phosphate group 
5 with K17 are also apparent.  
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6. 4. 2. 2 E17K PKB PH Domain with Ins(1,3,4)P3 
 
Ins(1,3,4)P3 has a remarkably similar free energy of binding to both the native and 
E17K PKB PH domains, with results within 1 kcal mol-1 of each other (Table 13). 
This similar affinity can be attributed to the similar interactions the Ins(1,3,4)P3 
ligand makes with both binding sites.  
 
No significant interactions between Ins(1,3,4)P3 and Lys17 are apparent in the mutant 
simulations. This is due to the fact that Ins(1,3,4)P3 does not contain a phosphate 
group at position 5. The 5-phosphate group of other inositol phosphates serves to not 
only form direct interactions with Lys17, but also brings Lys17 into close proximity 
for other smaller interactions via phosphate group 4 and the 6-hydroxyl group to 
occur. 
 
6. 5 Conclusion 
 
Simulations of the E17K PKB PH domain with Ins(1,3,4,5)P4, Ins(1,3,4)P3 and 
Ins(1,4,5)P3 have helped explain this mutant’s increased affinity for the plasma 
membrane. 
 
The computational results suggest that the mutant’s increased recruitment to the 
plasma membrane is largely due to a significantly improved affinity for the 
head-group of PtdIns(4,5)P2. This result supports, and agrees with, previous 
experimental work in the field.29, 164 Additionally, the simulations also capture the 
somewhat smaller increase in affinity of the E17K PKB PH domain for Ins(1,3,4,5)P4. 
This again mirrors experimental data for Ins(1,3,4,5)P4’s parent lipid.164 However this 
result should be treated with caution as the difference in Ins(1,3,4,5)P4’s 
computational (and in vitro) affinity for the native and mutant PH domains is fairly 
small, and the errors associated with the simulations are comparably sized. This 
highlights a potential limitation of using the MM-PBSA method to deal with this 
system, as it is not ideal for capturing the small differences in the binding affinities.166 
Additionally, the inability of the MM-PBSA method to account for the molecular 
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structure of water molecules may also affect contributions from water-mediated 
interactions.167  
 
The simulations in this chapter provide an atomic-level view to help explain the 
increased affinity of E17K PKB for PtdIns(4,5)P2 [and PtdIns(3,4,5)P3]. Simulations 
show that interactions between Lys17 and phosphate group 5 are the main 
contribution to this increased affinity. Additionally smaller interactions between 
Lys17 with phosphate group 4 and hydroxyl group 6 are also favourable for binding. 
These interactions are particularly interesting as many are not apparent in the crystal 
structure of the E17K PKB PH domain with Ins(1,3,4,5)P4.  
 
The interaction of the E17K PKB PH domain with the inositol phosphate head-groups 
of PtdIns(3,4,5)P3, PtdIns(3,4)P2 and PtdIns(4,5)P2 has been studied herein. Whilst it 
would naturally be of interest to study the parent lipids, as opposed to the inositol 
phosphate head-groups, there are a number of difficulties associated with this that are 
discussed further in Chapter 8. The use of the head-groups to extrapolate results for 
the phosphoinositide lipids is not unrealistic as it is largely the head-groups that 
mediate the interactions with the PKB PH domain. Furthermore for the E17K PKB 
PH domain, all inositol phosphates investigated maintained an orientation that would 
be accessible to the parent lipid.  
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Chapter 7 - Inositol Phosphate Derivatives 
 
7. 1 Introduction 
 
The previous chapters provide validation of the inositol phosphate parameters 
generated in this work. Additionally they also deliver a deeper understanding of the 
interaction between inositol phosphates and PKB’s PH domain.   
 
Interestingly, our simulations suggest that phosphate group 5 of Ins(1,3,4,5)P4 is 
capable of interacting with PKB’s PH domain. This interaction is particularly exciting 
as phosphate group 5 has previously been assumed to be solvent exposed when 
Ins(1,3,4,5)P4 is bound to PKB.26 In the simulations significant interactions between 
phosphate group 5 and Arg86, as well as more minor interactions with Gln79, are 
apparent.  
 
Phosphate group 5 gained further interest in these studies after investigating the E17K 
PKB mutant. This mutant is shown to have an increased affinity for Ins(1,4,5)P3 and 
Ins(1,3,4,5)P4 due to the interaction of residue Lys17 with phosphate group 5 of both 
ligands. 
 
In this chapter the aim is to a design a novel Ins(1,3,4,5)P4 derivative that binds 
strongly to the PKB PH domain, preventing its recruitment to the plasma membrane 
and hence its subsequent phosphorylation and activation.168 As many of PKB’s 
downstream targets are involved in cell proliferation and survival, such a derivative 
would prove extremely useful as a potential drug lead and/or as a tool to further probe 
the intracellular functions of PKB.60, 169  
 
The interactions of phosphate group 5 with the PKB PH domain provided an idea for 
designing an Ins(1,3,4,5)P4 derivative. Rather than focusing on the 1-, 3- and 4-
phosphate positions, which are already well optimised in their interactions with PKB, 
phosphate group 5 seemed a promising option to modify to improve binding. 
Additionally modification at this position is likely to be tolerated due to the area 
surrounding this group being fairly uncongested. Meanwhile phosphate groups 3 and 
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4 point directly into the tightly packed binding site. 
 
To design a 5-position Ins(1,3,4,5)P4 derivative with an increased affinity for the PKB 
PH domain, the aim is to target interactions with residues on loop 3 (i.e. Gln79 and 
Trp80). These residues serve as a potential source of interactions that have yet to be 
fully exploited. The desirability to target these residues is enhanced by the role they 
play in PKB activation. As mentioned in section 1.2.2.1, loop 3 of the PKB PH 
domain is buried in PKB’s kinase domain in its inactive state. Upon binding to 
3-phosphorylated phosphoinositides, the PH and kinase domains are thought to 
separate allowing phosphorylation and activation of PKB.28, 42 We are encouraged by 
previous success in targeting Trp80 with the allosteric inhibitor VIII, which has been 
shown to lock PKB into an inactive conformation, Figure 36.28, 170, 171 
 
 
 
 
 
Figure 36: Schematic drawing of inhibitor VIII. 
 
 
7. 1. 1 Previous Examples of Inositol Phosphate Derivatives 
 
There have been limited attempts at designing inositol phosphate- or 
phosphoinositide-based derivatives to target the PKB PH domain. However the 
recently reported inhibitory effects of endogenous InsP7 [5-PP-Ins(1,2,3,4,6)P5] on 
PKB suggest this is a promising area of research.161  
 
Kozikowski et al. have already demonstrated the use of phosphatidylinositol ether 
lipid analogues as potential therapeutic treatments, Figure 37. These analogues have 
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been shown to inhibit PKB with low micromolar activity, and additionally reduce the 
growth of lung and breast cancer cell lines.159, 172, 173  
 
 
 
 
 
Figure 37: An example of a phosphatidylinositol ether lipid analogue (PIA) designed by 
Kozikowski et al.159 Positions 4 and 5 are thought to undergo phosphorylation upon entering the cell. 
 
 
Examples of inositol phosphate-based derivatives largely come from the Conway 
group at Oxford University. Their work so far has focused on designing inositol 
phosphate derivatives that have a single substitution of a phosphate group for a 
phosphate bioisostere. Table 14 illustrates the Ins(1,3,4,5)P4 derivatives that have 
been synthesised by PhD members Nemeth and Elliott of the Conway group.174, 175 
The ability of these derivatives to bind to the PKB and GRP1 PH domains is also 
noted.  
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Table 14: Summary of the novel Ins(1,3,4,5)P4 derivatives synthesised by Elliott and Nemeth.174, 
175 Their biological activity against the PKB and GRP1 PH domains is provided, taken from Elliott’s 
thesis. 
Position 
Modified 
Derivative PKB PH 
Domain 
Binder 
GRP1 PH 
Domain 
Binder 
1-position 
modified 
 
No Yes 
 
No Yes 
 
Yes Yes 
4-position 
modified 
 
No No 
 
No No 
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No No 
 
No No 
5-position 
modified 
 
Yes No 
 
ND No 
 
ND No 
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As illustrated in Table 14, work conducted within the Conway group includes the 
design and synthesis of 4-position Ins(1,3,4,5)P4 derivatives by Nemeth.175 Biological 
analysis of these derivatives illustrated that they exhibit no binding affinity for the 
PKB PH domain [No binding was detected even at concentrations of 1mM]. This data 
therefore supports the argument that a significant modification at phosphate group 4 is 
unlikely to be tolerated. Building upon Nemeth’s work, Elliott broadened the possible 
modification sites of Ins(1,3,4,5)P4 to the 1- and 5-phosphate groups.174 Results from 
his work showed that modifications at the 1-position also resulted in poor binding to 
the PKB PH domain. The only exception to this was a 1-position methylphosphate 
ester. 
 
Whilst only one 5-position derivative was biologically tested against the PKB PH 
domain, it was promisingly shown to bind therefore supporting the suggestion that 
modification at the 5-position is tolerated. Additionally, the 5-position Ins(1,3,4,5)P4 
derivatives were shown not to bind to the GRP1 PH domain, suggesting that this 
position highlights an opportunity for improving PH domain selectivity.  
 
A similar approach to the Conway Group has been carried out by Falasca et al., who 
have targeted the PH domain of PDK1. They have concentrated on the inhibitory 
effects of Ins(1,3,4,5,6)P5 and its derivative 2-O-Bn-InsP5 to disrupt PDK1 
translocating to the membrane.176  
 
7. 1. 2 A Collaboration with the Conway Group 
 
The work within the following sections was performed in close collaboration with 
researchers of the Conway group at Oxford University. To clarify, all synthesis and 
purification of derivatives was performed external to this study by Aine Slowey of the 
Conway group, unless explicitly stated otherwise. All computational parameterisation 
and MD simulations performed as part of this study were carried out by myself. 
Additionally, all in vitro biochemical binding and inhibition assays (other than the in 
vitro phosphorylation assay in section 7.4.7) were performed by myself and form part 
of this study. Any reference to further work by external collaborators is explicitly 
identified in the text and referenced appropriately. 
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In collaboration with the Conway group, the aim was to design a 5-position 
Ins(1,3,4,5)P4 derivative with an increased affinity for the PKB PH domain, compared 
to Ins(1,3,4,5)P4. 
 
The remainder of this chapter is split into three sections: 
 
• Section 7.2 - In the first of these sections preliminary MD simulations were 
used to screen several 5-position Ins(1,3,4,5)P4 derivatives. These derivatives 
were designed using knowledge from our previous MD simulations, in 
collaboration with the Conway group. The derivatives were screened 
according to their affinity for, and interactions with, the PKB PH domain. The 
derivatives were additionally assessed for their synthetic potential. After these 
considerations were taken into account, the most promising derivative was 
synthesised by Aine Slowey of the Conway group.  
 
• Section 7.3 - After selecting a 5-position derivative to synthesise, its binding 
affinity for the PKB PH domain and molecular behaviour was more 
thoroughly examined by considering all possible ionisation states of the 
derivative in the MD simulations. Three other derivatives recently synthesised 
in the Conway group were also investigated using MD simulations. Again all 
ionisation states were considered. 
 
• Section 7.4 - Once the behaviour of the four Ins(1,3,4,5)P4 derivatives was 
predicted from the computational simulations in section 7.3 the binding 
affinity for, and inhibitory actions of, these derivatives on the PKB PH domain 
was assessed using in vitro techniques. 
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7. 2 Screening 5-Position Ins(1,3,4,5)P4 Derivatives 
 
Using knowledge from the previous MD simulations, a number of 5-position 
derivatives were designed in collaboration with the Conway group. Previous 
simulations suggested that interactions between the ligand and residues on loop 3 of 
the PKB PH domain (i.e. Gln79 and Trp80) are a source of interactions that have yet 
to be fully exploited. Therefore, 5-position Ins(1,3,4,5)P4 derivatives were designed to 
target these residues. 
 
The 5-position phosphomonoester group of Ins(1,3,4,5)P4 was substituted with: an 
ethylphosphate ester (5E), a carboxymethyl ether (5C), a pyrophosphate ester (5D) a 
triphosphate ester (5T), and an acetamidoethylphosphate ester (5A), illustrated in 
Figure 38. 
 
Preliminary simulations were run of these 5-position Ins(1,3,4,5)P4 derivatives in a 
complex with the PKB PH domain. Unfortunately due to time constraints we were 
unable to investigate all possible isomers of each derivative mentioned. To worsen 
matters, in vitro probability data was not readily available for these derivatives. 
Therefore in order to decide which isomer to study, numerous assumptions were 
made. In agreement with the Conway group, all phosphate groups other than the 
5-phosphate were assumed singly protonated. This assumption was based on the pKa 
values for H3PO4 being 2.12, 7.21 and 12.32 for the first, second and third 
deprotonations respectively.177 The ethylphosphate, carboxymethyl, pyrophosphate, 
and triphosphate moieties were all assumed fully deprotonated for ease of 
consistency, and additionally in the hope of maximising the interactions of these 
groups with PKB’s cationic pocket. 
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5E 
 
 
5C 
 
5D 
 
 
5T 
 
                            5A 
 
Figure 38: Summary of the novel Ins(1,3,4,5)P4 derivatives designed in this work. The derivatives 
are shown in the ionisation state they were investigated in the MD simulations. 
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7. 2. 1 Program Details 
 
Gaussian 09122 was used for the geometry optimisation calculations of the 
Ins(1,3,4,5)P4 derivatives and to calculate their molecular electrostatic potential 
(MEP). The RESP program in Amber was used to generate the charge parameters by 
fitting the QM calculated MEP to atom-centred points. Graphical representations were 
produced with Gaussview.123 
 
The Amber11124 suite of programs implementing the ff99SB force field was used for 
energy minimisation, equilibration and production MD calculations. Parameter and 
topology files for the inositol phosphate derivative-PKB PH domain complexes were 
creating using the LEaP module. Minimisation, equilibration and production MD 
calculations were performed with PMEMD. Analysis of hydrogen bonding was 
carried out using Ptraj. Free energy calculations, using the MM-PBSA method, were 
carried out using the Perl scripts in Amber. Graphical representations were produced 
with VMD and Chimera.125, 126 
 
7. 2. 2 Parameterisation of 5-position Ins(1,3,4,5)P4 Derivatives 
 
The derivatives were parameterised using the same protocol as for the inositol 
phosphates, detailed below. The initial structures for these derivatives were adapted 
from that of Ins(1,3,4,5)P4 in Gaussview, by substituting phosphate group 5 with the 
appropriate functional group. 
 
Each derivative was geometry optimised until it reached a local minimum on the 
potential energy surface. The derivatives were first optimised using the 
DFT-B3LYP/3-21g* level of theory and then further optimised using 
DFT-B3LYP/6-31g**. These calculations were carried out in gas phase. For each 
optimised structure the MEP was calculated using the HF/6-31g* level of theory. The 
RESP algorithm was employed to fit the QM calculated MEP to atom-centred points. 
The RESP generated point charges were assigned as the charge parameters. Atom 
types were assigned from the ff99SB force field, using analogous atom types to 
Ins(1,3,4,5)P4.  
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7. 2. 3 Minimisation, Equilibration and Production Run 
 
The X-ray crystal structure of the PKB PH domain in a complex with Ins(1,3,4,5)P4 
provided the initial co-ordinates, PDB accession code 1UNQ.11 The PDB was 
modified by substituting phosphate group 5 with the appropriate functional group. 
Crystallographic water molecules present in the PDB were kept. The Leap module of 
Amber was used to add hydrogen (and missing) atoms to the crystal structure. The 
systems were charge neutralised with Na+ counter-ions and solvated with TIP3P water 
molecules within a truncated octahedral unit cell, with a minimum of 8 Å distance 
from the edge of the box to any protein or ligand atom. 
 
The complexes were minimised in two stages. In the first stage, the water molecules 
and Na+ counter-ions were energy minimised, whilst harmonic restraints of 
500 kcal mol&1 Å&2 were applied to the protein and ligand; 500 steps of steepest 
descent and 500 steps of conjugate gradient minimisation were carried out. In the 
second stage of minimisation, the restraints were removed, and the entire system was 
minimised using 1500 steps of steepest descent and 2000 steps of conjugate gradient 
minimisation. 
 
In all simulations, periodic boundary conditions were applied. A cut-off of 8 Å was 
used for the explicit calculation of non-bonded interactions. For the calculation of 
long-range electrostatic interactions, the particle mesh Ewald method was applied 
with a direct space cut-off of 8 Å.98 Each minimised system was heated from 0 K to 
300 K at constant volume over 50 ps. Following this, 100.05 ns of equilibration was 
carried out at constant pressure (1 bar) and temperature (300 K). The equilibration 
was run for 100.05 ns to allow the PH domain and inositol phosphate derivatives to 
adjust their conformation/orientation and reach equilibrium. Production MD 
simulations of each system were then run for 50 ns at constant pressure (1 bar) and 
temperature (300 K), with snapshots saved every 10 ps.  
 
For each simulation the SHAKE algorithm was applied to constrain all bonds 
involving hydrogen atoms, allowing a time-step of 2 fs to be used.102 In order to 
maintain the temperature during the simulations, Langevin dynamics was used with a 
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collision frequency of 1.0 ps&1. MD simulations were performed with the GPU 
accelerated version of PMEMD in Amber11. 
 
7. 2. 4 Free Energy Calculations 
 
MM-PBSA calculations were implemented to calculate the free energy of binding for 
the inositol phosphate derivative–PKB PH domain complexes. Snapshots from the 
50 ns production MD simulations were used in these calculations. Structural 
snapshots were saved every 10 ps, giving a total of 5000 snapshots for each 
simulation. Each snapshot was stripped of water and counter-ions. MM contributions 
were calculated with an interaction cut-off of 999 Å and a dielectric constant of 1.0. 
Contributions to the solvation energy were calculated using the pbsa module of 
Amber. An internal dielectric of 1.0, an external dielectric of 80.0, a solvent radius of 
1.4 Å and grid spacing of 0.5 Å was applied. Non-polar contributions to the solvation 
energy were calculated with a solvent surface tension of 0.0072 kcal mol&1 Å&2. The 
SASA was calculated with the Molsurf program with a solvent probe radius of 1.4 Å 
and Bondi atomic radii.147, 148  
 
7. 2. 5 Hydrogen Bond Interactions 
 
The Ptraj program within Amber 11 was used to analyse the hydrogen bond 
interactions for each system. A list of all potential hydrogen bond donors and 
acceptors was specified, and pair interactions between these were analysed for each 
50 ns production MD simulation. A cut-off distance of 3.5 Å, and angle cut-off of 
120° were specified for the pair interactions. 
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7. 2. 6 Results and Discussion 
 
MD simulations (and MM-PBSA calculations) were used to assess the affinity of the 
5-position Ins(1,3,4,5)P4 derivatives for the PKB PH domain, Table 15. Additionally, 
the simulations were also used to investigate the derivatives’ binding modes and 
interactions with the PKB PH domain.  
 
 
Table 15: Computationally determined free energies of binding for the 5-position Ins(1,3,4,5)P4 
derivatives to the PKB PH domain, from the preliminary simulations. The result for Ins(1,3,4,5)P4 
was taken from previous work in chapter 4. 
 
Derivative Net 
charge of 
derivative 
Free energy of 
binding to the 
PKB PH 
domain 
(kcal mol-1) a 
 
 
-5 -69.46 ! 1.39 
 
 
5E 
-5 -59.07! !6.66 
 
 
5C 
-4 -59.12! !5.82 
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5D 
-6 -71.75! !5.90 
 
 
5T 
-7 -80.62! !2.90 
 
 
5A 
-4 -88.49 ! 5.81 
 
a The statistical error was estimated from the deviation between block averages for each simulation.115  
 
 
The initial derivative proposed was the ethylphosphate ester 5E. It was hoped that by 
extending the linker between the inositol ring and the 5-phosphate group that 
interactions between the phosphate moiety and Gln79 would be facilitated. A 
variation of this derivative was also considered in the form of the carboxymethyl ether 
5C. This derivative (with the same linker length as 5E) was also considered, as 
carboxylate moieties are widely employed as phosphate bioisosteres.178 
 
Simulations of these derivatives suggest that removal of the 5-phosphate group 
immediately attached to the inositol ring is detrimental to binding (to the PKB PH 
domain). Results show that the ethylphosphate ester 5E and carboxymethyl ether 5C 
derivatives bind to the PKB PH domain with a significantly lower affinity than 
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Ins(1,3,4,5)P4. This is unsurprising as when the phosphate linker of 
phosphatidylinositol ether lipid analogues was replaced with a carbonate linker, the 
inhibitory effects of these compounds was also lost.159 
 
The lack of 5-phosphate group immediately attached to the inositol ring means that 
interactions via this site are not possible. The phosphate and carboxylate moieties (on 
the extended linker) therefore attempt to replicate/replace these interactions with the 
PKB binding site. However, the orientations the derivatives adopt to maintain these 
interactions are significantly different to that of Ins(1,3,4,5)P4, Figure 39. A change in 
orientation of the ligand is unlikely to be favourable for binding due the already 
mentioned well-optimised interactions of the 1-, 3- and 4-phosphate groups in the 
native system. Therefore it is essential to conserve the 5-phosphate group in future 
derivatives in the hope of stabilising the Ins(1,3,4,5)P4 ligand in its native 
conformation, whilst adding further favourable interactions by potentially interacting 
with loop 3 of the PKB PH domain. 
 
 
Figure 39: The conformation of the ethylphosphate derivative 5E in the PKB binding site 
(magenta). The crystal structure of the PKB PH domain and Ins(1,3,4,5)P4 is shown in cyan for 
comparison. The altered orientation of the derivative and the binding site residues compared to the 
crystal structure is illustrated. 
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A pyrophosphate derivative 5D was subsequently designed, in the hope of 
maintaining the native interactions of Ins(1,3,4,5)P4 whilst extending the phosphate 
moiety towards loop 3 (and Gln79). Unfortunately this derivative showed a very 
similar binding affinity to Ins(1,3,4,5)P4. Analysis of the simulations illustrate that 
this is due to the fact that both ligands adopted very similar binding modes, and 
formed similar interactions, in the PKB binding site. The pyrophosphate group did not 
result in additional interactions with loop 3, but rather maintained similar interactions 
to that of phosphate group 5 in Ins(1,3,4,5)P4. 
 
An additional phosphate group was added to the above derivative to form a 
triphosphate derivative 5T. Arg86 was shown to form strong hydrogen bond 
interactions with the triphosphate group (via N(1 and N(2), whilst still maintaining its 
interactions with phosphate group 4 (via N) and N(2), Figure 40. These hydrogen 
bond interactions were fully occupied for almost the entire simulation. Furthermore, 
additional smaller interactions between the triphosphate group and Tyr18 on loop 1 
were also apparent. These favourable interactions resulted in an increased free energy 
of binding for this derivative to the PKB PH domain, compared to Ins(1,3,4,5)P4.   
 
 
Figure 40: A snapshot of the interactions between the triphosphate derivative 5T and the PKB 
PH domain. Hydrogen bond interactions are indicated with black lines. Interactions of Arg86 with the 
triphosphate moiety and phosphate group 4 are illustrated. Additionally interactions between the 
triphosphate moiety and Tyr18 on loop 1 are also highlighted. 
 150 
Whilst the triphosphate derivative showed an increased binding affinity for the PKB 
PH domain, the aim to target loop 3 was still unachieved. In an attempt to interact 
with loop 3, residue Gln79 on its tip was chosen as a suitable target. An amide-based 
derivative, 5A, was therefore designed, in the hope of exploiting glutamine’s 
propensity to form hydrogen bonds. 
 
The simulation of derivative 5A with the PKB PH domain illustrated that hydrogen 
bond interactions between the acetamidoethylphosphate ester and Gln79 are able to 
form via both their carbonyl and amine moieties. These interactions were shown to 
cause loop 3 to move closer towards the phosphoinositide binding site. As a 
consequence of this movement, a strong intra-molecular hydrogen bond interaction 
between Asn54 and Trp80 was shown to form, Figure 41. The formation of this 
hydrogen bond is particularly interesting, as these residues are 14 Å apart in the 
crystal structure of the PKB PH domain in a complex with Ins(1,3,4,5)P4.11 Free 
energy analysis highlights how the additional interactions mentioned result in a 
relatively high free energy of binding for this derivative to the PKB PH domain, 
almost 20 kcal mol-1 greater than the equivalent Ins(1,3,4,5)P4 isomer. 
 
Based on the relatively high binding affinity and molecular behaviour of the 
acetamidoethylphosphate derivative 5A it was chosen for synthesis and further 
evaluation. 
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Figure 41: A representative snapshot from the simulation of the PKB PH domain with the 
Ins(1,3,4)P3-5-O-acetamidoethylphosphate ester (magenta). The crystal structure of the PKB PH 
domain in a complex with Ins(1,3,4,5)P4 is shown as a comparison (cyan). The significant distance 
between Asn54 and Trp80 in the crystal structure is highlighted. In contrast when the Ins(1,3,4)P3-5-O-
acetamidoethylphosphate ester is bound to the PKB PH domain, a strong intra-molecular interaction 
between Asn54 and Trp80 is apparent. Additionally interactions between the acetamidoethylphosphate 
ester and Gln79 are highlighted.  
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7. 3 Detailed Computational Investigation of Selected 
Inositol Phosphate Derivatives 
 
The acetamidoethylphosphate ester 5A was selected for further analysis using both 
computational and biochemical techniques. Three other Ins(1,3,4,5)P4 derivatives 
recently synthesised in the Conway group were also selected for investigation. These 
included a 5-position sulfamate-based derivative synthesised by T. Elliott and 3-
position derivatives synthesised by A. Slowey, Figure 42.  
 
A thorough computational analysis of these derivatives was carried out prior to their 
biochemical evaluation. MD simulations allowed the derivatives’ binding affinities 
for the PKB PH domain [compared to Ins(1,3,4,5)P4] to be predicted, as well as their 
molecular behaviour to be assessed. In order to thoroughly investigate these 
derivatives all physiologically accessible ionisation states were considered in the 
simulations. 
 
 
 
 
 
 
5A 
 
5S 
 
  
3M 
 
 
3S 
 
Figure 42: The 5- and 3-position Ins(1,3,4,5)P4 derivatives fully investigated using MD 
simulations. All physiologically accessible isomers were investigated. 
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7. 3. 1 Parameterisation of Selected Ins(1,3,4,5)P4 Derivatives 
 
The 5-position acetamidoethylphosphate ester 5A and 3-position methylphosphate 
ester 3M were parameterised using the same protocol as in section 7.2.2 for the other 
inositol phosphate derivatives. Eight isomers with different levels and arrangements 
of protonation were investigated for each. The phosphate moieties of the 3-position 
methylphosphate group and the 5-position acetamidoethylphosphate group were 
assumed singly deprotonated. The reason for this is that these groups cannot be 
dianionic due to their substitution, and full protonation is extremely unlikely in vitro 
and in vivo.177  
 
Each isomer was first optimised using the DFT-B3LYP/3-21g* level of theory and 
then further optimised using DFT-B3LYP/6-31g** in Gaussian09. These calculations 
were carried out in gas phase. For each optimised structure the MEP was calculated 
using the HF/6-31g* level of theory. The RESP algorithm was employed to fit the 
QM calculated MEP to atom-centred points. The RESP generated point charges were 
assigned as the charge parameters. Atom types were assigned from the ff99SB force 
field. Parameters for these derivatives are supplied in the Electronic Supplementary 
Information, sections S.7 and S.9. 
 
7. 3. 1. 1 Sulfamate-based derivatives 
 
The sulfamate-based derivatives, at both the 3- and 5-positions, were not optimised 
using the same protocol as the other inositol phosphate derivatives. This was due to 
complications with the protocol when applying it to these derivatives. When 
optimised with the B3LYP/3-21g* level of theory followed by B3LYP/6-31g** in gas 
phase, many of the sulfamate-based isomers failed to reach convergence. A different 
approach to parameterise these molecules was therefore necessary. 
 
Based on the multiple approaches investigated in Chapter 4, it was decided to carry 
out the optimisations in implicit solvent instead [i.e. in water ()=78.3553)]. This 
adaptation to the protocol allowed all of the sulfamate-based isomers to optimise to 
low energy conformations. However, upon visualisation of the optimised structures it 
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was apparent that in many cases a proton from the sulfamate group had migrated onto 
the neighbouring phosphate group. This structure in which the sulfamate group is 
deprotonated is extremely unlikely to exist in vivo, as the pKa of MeSO2NH2 is 
17.5.179  
 
To overcome this problem the Hartree Fock method was used in place of 
DFT-B3LYP. The HF method was chosen due to its previous use in the principal 
study for generating force field parameters for sulfamates.180 The isomers were each 
optimised using the HF/6-31g** level of theory in implicit solvent (water). This 
resulted in sensible structures without proton migration. Therefore subsequent 
optimisations in lower dielectric solvents were also investigated. Optimisations in 
octanol ()=9.8629) were deemed successful, however further optimisations in even 
lower dielectric constants (e.g. cyclohexane) resulted in the proton migration problem 
mentioned. Therefore the optimised structures in octanol were used for the following 
steps.  
 
Following optimisation, the MEP for each isomer was calculated using the HF/6-31g* 
level of theory in gas phase. The RESP algorithm was employed to fit the QM 
calculated MEP to atom-centred points. The RESP generated point charges were 
assigned as the charge parameters. Atom types were assigned from the ff99SB force 
field. Missing parameters not available from the ff99SB force field, were taken from a 
study by Huige and Altona based on sulfamates.180 Any parameters still not accounted 
for were taken from the GAFF force field. The parameters for these derivatives are 
provided in the Electronic Supplementary Information, sections S.8, S.10 and S.11. 
 
7. 3. 2 Minimisation, Equilibration and Production Run 
 
The X-ray crystal structure of the PKB PH domain in a complex with Ins(1,3,4,5)P4 
provided the initial co-ordinates, PDB accession code 1UNQ.11 The PDB was 
modified by substituting phosphate group 3/5 with the appropriate functional group. 
Crystallographic water molecules present in the PDB were kept. The Leap module of 
Amber was used to add hydrogen (and missing) atoms to the crystal structure. The 
systems were charge neutralised with Na+ counter-ions and solvated with TIP3P water 
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molecules within a truncated octahedral unit cell, with a minimum of 8 Å distance 
from the edge of the box to any protein or ligand atom. 
 
The complexes were minimised in two stages. In the first stage, the water molecules 
and Na+ counter-ions were energy minimised, whilst harmonic restraints of 
500 kcal mol&1 Å&2 were applied to the protein and ligand; 500 steps of steepest 
descent and 500 steps of conjugate gradient minimisation were carried out. In the 
second stage of minimisation, the restraints were removed, and the entire system was 
minimised using 1500 steps of steepest descent and 2000 steps of conjugate gradient 
minimisation. 
 
In all simulations, periodic boundary conditions were applied. A cut-off of 8 Å was 
used for the explicit calculation of non-bonded interactions. For the calculation of 
long-range electrostatic interactions, the particle mesh Ewald method was applied 
with a direct space cut-off of 8 Å.98 Each minimised system was heated from 0 K to 
300 K at constant volume over 50 ps. Following this, 100.05 ns of equilibration was 
carried out at constant pressure (1 bar) and temperature (300 K). Production MD 
simulations of each system were then run for 50 ns at constant pressure (1 bar) and 
temperature (300 K), with snapshots saved every 10 ps.  
 
For each simulation the SHAKE algorithm was applied to constrain all bonds 
involving hydrogen atoms, allowing a time-step of 2 fs to be used.102 In order to 
maintain the temperature during the simulations, Langevin dynamics was used with a 
collision frequency of 1.0 ps&1. MD simulations were performed with the GPU 
accelerated version of PMEMD in Amber11. 
 
7. 3. 3 MM-PBSA Calculations 
 
MM-PBSA calculations were implemented to calculate the free energy of binding for 
the inositol phosphate derivative–PKB PH domain interactions. Snapshots from the 
50 ns production MD simulations were used in these calculations. MM-PBSA 
calculations were carried out using the Perl scripts in Amber, detailed in section 7.2.4. 
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The binding free energy results for the different isomers of each derivative were 
weighted. The 3-position derivatives were weighted according to the in vitro 
probabilities of the Ins(1,4,5)P3 isomers and the 5-position derivatives according to 
the Ins(1,3,4)P3 isomers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 157 
7. 3. 4 Results and Discussion 
 
The weighted free energies of binding (Table 16) and molecular behaviour of the 
selected Ins(1,3,4,5)P4 derivatives provide yet more information about the PKB 
binding site. Each of these derivatives is discussed in detail in the following sections. 
 
Table 16: Computationally determined free energies of binding for the selected 5- and 3-position 
Ins(1,3,4,5)P4 derivatives. All physiologically accessible isomers were considered. 
a The statistical error was estimated from the deviation between block averages for each simulation and 
propagated appropriately for each weighted ligand.115 
Derivative Weighted free energy of 
binding (kcal mol-1) a 
 
-71.51 ! 3.07 
 
5A 
-75.04 ! 2.88 
 
5S 
-65.20 ! 3.87 
 
3M 
-66.37 ! 1.91 
 
3S 
-50.44 ! 2.21 
 158 
7. 3. 4. 1 D-myo-Ins(1,3,4)P3-5-O-acetamidoethylphosphate ester  
 
As expected, the Ins(1,3,4)P3-5-O-acetamidoethylphosphate ester 5A is shown to 
have an increased affinity for the PKB PH domain compared to Ins(1,3,4,5)P4. 
However this increased affinity is significantly lower than was suggested by the 
preliminary simulation of this derivative in section 7.2.6. 
 
In the preliminary simulation, in which only one ionisation state was considered, the 
Ins(1,3,4)P3-5-O-acetamidoethylphosphate ester was shown to bind to the PKB PH 
domain with approximately 20 kcal mol-1 greater affinity than Ins(1,3,4,5)P4. The 
results in Table 16 illustrate a much smaller difference in the free energies of binding 
for this derivative and Ins(1,3,4,5)P4 when all isomers are considered (only 
approximately 3.5 kcal mol-1). 
 
In order to understand why the other isomers/ionisation states of the 
Ins(1,3,4)P3-5-O-acetamidoethylphosphate ester did not exhibit the same high binding 
affinity for the PKB PH domain as the initial isomer investigated, their molecular 
behaviour was investigated. Analysis showed that the inositol ring for each isomer is 
positioned almost identically to each-other, and to Ins(1,3,4,5)P4, in the PKB binding 
site. It is hence the difference in the position and orientation of the acetamide moiety 
of this derivative, which results in the different free energies of binding. In the 
preliminary simulation the acetamide moiety was seen to form favourable interactions 
with Gln79 via both its carbonyl and amine groups with a total occupancy of 
approximately 20%, Figure 41. As a result of these interactions, increased interactions 
between phosphate group 5 and Gln79 were also apparent (with an occupancy of over 
50%). However for the other isomers the interactions of the acetamide moiety and 
Gln79 are significantly less occupied, with only a 1-2% occupancy. Instead 
interactions between the carbonyl group of the acetamide moiety and Arg86 are 
apparent, Figure 43. 
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Figure 43: A representative snapshot of the lower affinity binding mode of the Ins(1,3,4)P3-5-O-
acetamidoethylphosphate ester in a complex with the PKB PH domain. The hydrogen bond 
interaction between the acetamide moiety of the derivative and Arg86 is indicated. Additional 
interactions of Arg86 with phosphate groups 4 and 5 are also shown. The distance of Glu79 from the 
binding site is highlighted. 
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7. 3. 4. 2 D-5-O-Sulfamoyl-myo-Ins(1,3,4)P3 
 
The D-5-O-Sulfamoyl-myo-Ins(1,3,4)P3 derivative 5S is shown to bind to the PKB PH 
domain with a similar, but slightly lower, free energy of binding to Ins(1,3,4,5)P4. 
This result is easily explained by considering the interactions this derivative makes 
with the PKB PH domain. Whilst interactions via phosphate groups 1, 3 and 4 are 
almost identical to that of Ins(1,3,4,5)P4, the 5-position sulfamate group does not 
replicate the behaviour of a phosphate group. This is unsurprising, as a number of 
previous studies have shown that sulfamate groups often don’t act as suitable 
phosphate bioisosteres for inositol phosphates.181, 182  
 
In contrast to the significant interactions that phosphate group 5 makes with the PKB 
PH domain (highlighted in Chapter 4), hydrogen bond analysis illustrates that the 
sulfamate group only makes relatively weak interactions. The lack of interactions via 
the 5-sulfamate group explains why this derivative binds to the PKB PH domain with 
a remarkably similar affinity (and orientation) to Ins(1,3,4)P3 in our simulations. 
 
The reason the sulfamate group is unable to replicate the behaviour of a phosphate 
group is simply due to the fact that sulfamate esters are typically neutral at 
physiological pH (the pKa value for methyl sulfamate is 17.5).179 In comparison 
phosphomonoesters are negatively charged at physiological pH and adopt either a 
fully deprotonated or singly deprotonated state. As the sulfamate moiety is neutral, 
the charges on its oxygen atoms are inherently lower than those for the oxygen atoms 
of phosphate groups. Our parameters illustrate this, with oxygen atoms of the 
sulfamate groups assigned partial charges of approximately -0.55 to -0.65, compared 
to values of around -0.75 to -0.95 for oxygen atoms belonging to the phosphate 
groups (parameters provided in section S.3 and S.8 of the Electronic Supplementary 
Information). The lower charge of the oxygen atoms belonging to the sulfamate group 
causes their electrostatic/hydrogen bond interactions with the PKB PH domain to be 
dampened. 
 
 
 
 
 161 
7. 3. 4. 3 D-myo-Ins(1,4,5)P3-3-O-methylphosphate ester 
 
The Ins(1,4,5)P3-3-O-methylphosphate ester 3M is also shown to bind to the PKB PH 
domain with a similar, but slightly lower, free energy of binding to Ins(1,3,4,5)P4. 
This result is understandable as Elliott’s previous work (Table 14) showed that the 
same derivative at the 1-position also bound to the PKB PH domain with a slightly 
lower affinity compared to Ins(1,3,4,5)P4.174 
 
The similar binding affinity of Ins(1,3,4,5)P4 and the Ins(1,4,5)P3-3-O-
methylphosphate ester is well explained by studying their molecular behaviour. Both 
these ligands adopt extremely similar orientations in the PKB binding site, Figure 44. 
Furthermore, hydrogen bond analysis illustrates that they also make near identical 
interactions. The only significant difference is that interactions via the 
3-methylphosphate group are slightly dampened compared to those of the 
3-phosphate group. This difference can be attributed to the fact that the oxygen atom 
of the methoxy moiety has a significantly lower charge than that of a protonated or 
deprotonated oxygen atom belonging to a phosphate group, with charges of 
approximately -0.40 to -0.50 and -0.75 to -0.95 respectively. This lower charge on the 
oxygen of the methoxy moiety therefore results in a lower level of interactions with 
the PKB PH domain via this site. 
 
The orientation of the Ins(1,4,5)P3-3-O-methylphosphate ester in the PKB binding site 
illustrates how the small methyl moiety is accommodated. For all eight isomers the 
methyl group is shown to position itself neatly in a pocket between residues Lys14, 
Arg23 and Arg25, as illustrated in Figure 44. 
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Figure 44: A representative structure of the Ins(1,4,5)P3-3-O-methylphosphate ester 3M in the 
PKB binding site (magenta). The methyl moiety of the derivative is circled. For comparison, the 
crystal structure of the PKB PH domain bound to Ins(1,3,4,5)P4 is shown in cyan. All hydrogen atoms, 
other than those of the methyl group, have been removed from the image for ease of visualisation. 
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7. 3. 4. 4 D-3-O-Sulfamoyl-myo-Ins(1,4,5)P3 
 
The 3-O-Sulfamoyl-Ins(1,4,5)P3 derivative 3S is shown to have a significantly lower 
affinity for the PKB PH domain compared to Ins(1,3,4,5)P4 and the other derivatives 
investigated. The inability of a sulfamate group to act as a phosphate bioisostere for 
this system has previously been explained in section 7.3.4.2. It is the lower charge on 
the oxygen atoms of the sulfamate group that causes electrostatic/hydrogen bond 
interactions with the PKB PH domain to be dampened via this site. 
 
As the 3-phosphate group of Ins(1,3,4,5)P4 is responsible for the critical hydrogen 
bond/electrostatic interactions with the PKB PH domain, substitution at this site 
understandably has a large detrimental effect. The effect this substitution has on the 
free energy of binding is well illustrated in the MM-PBSA results. The electrostatic 
contribution to binding (i.e. the sum of the MM electrostatic energy and the 
electrostatic solvation energy) is less favourable for the 3-O-Sulfamoyl derivative 
compared to Ins(1,3,4,5)P4, with contributions ranging from -1 to -40 kcal mol-1 for 
the 3-O-Sulfamoyl-Ins(1,4,5)P3 isomers and -45 to -70 kcal mol-1 for the 
Ins(1,3,4,5)P4 isomers. 
 
Whilst the above is true, the significantly higher affinity of the 5-O-Sulfamoyl 
derivative for the PKB PH domain compared to the 3-position derivative leaves many 
questions. For example, why doesn’t the 3-O-Sulfamoyl derivative rotate 180° to 
mimic the 5-position derivative?  
 
In fact the 3-O-Sulfamoyl derivative battles between two weakly binding orientations. 
One of which is indeed the flipped orientation mentioned. This flipped orientation 
allows the 5-phosphate group to point into the PKB binding site and mimic 
Ins(1,3,4,5)P4’s 3-phosphate group. However there is a cost associated with reversing 
the positions of the phosphate groups relative to the plane of the inositol ring. Whilst 
interactions via phosphate group 5 are improved, reduced interactions via the 1, 3 and 
4 positions are apparent. This cost of rotating the ligand was previously displayed by 
Ins(1,3,4,5)P4 in Chapter 4, showing the flipped orientation to be significantly less 
favourable and stable in the PKB binding site. The other conformation the 
3-O-Sulfamoyl derivative adopts is similar to that of Ins(1,3,4,5)P4. Whilst there are 
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significant interactions via the 1, 4 and 5 phosphate groups in this orientation, there is 
a lack of critical interactions via the 3-sulfamate group.  
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7. 4 In Vitro Investigation of Selected Inositol Phosphate 
Derivatives 
 
In order to validate the computational results for the inositol phosphate derivatives, it 
was necessary to compare them to experimental data. This section describes the 
development and application of in vitro assays to determine the relative 
affinity/inhibitory behaviour of the Ins(1,3,4,5)P4 derivatives for the PKB PH domain. 
I carried out this work in the Woscholski lab at Imperial College. Thanks go to all 
members of the group for their assistance, and for the use of their equipment. 
 
There are limited examples of using in vitro techniques to investigate the binding of 
phosphoinositide or inositol phosphate-based ligands to the PKB PH domain. This 
may partly be due to the micromolar affinity of these complexes, meaning large 
quantities of PKB and phosphoinositides/inositol phosphates are required for 
experiments. The lack of experimental data for such complexes is highlighted by the 
repeated reference to Frech et al.’s work in which tryptophan fluorescence was used 
to determine the binding affinities of a number of inositol phosphates and 
phosphoinositides to the PKB PH domain.22 Despite this work being carried out in 
1997 there have been few additional investigations in the field, particularly on the 
native system. 
 
7. 4. 1 Issues with the Inositol Phosphate Derivatives 
 
Deciding an appropriate biological/biochemical assay to test the affinity of the 
Ins(1,3,4,5)P4 derivatives for the PKB PH domain was extremely difficult. This was 
partly due to a number of issues with the derivatives. Due to their complicated 
synthesis, only relatively small amounts were synthesised by the Conway group. 
Furthermore, analysis by the Conway group suggested that the derivatives were not 
stable in solution for extended periods of time. This therefore meant that a stock 
solution of each ligand could not be made up. Due to the limits in the sensitivity of 
weighing scales available, this also meant that a very limited number of experiments 
were possible. As assays generally require multiple parameters to be optimised for the 
system of interest, Ins(1,3,4,5)P4 and InsP6 were used for protocol development in 
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place of the derivatives. These ligands have complications as well, as Ins(1,3,4,5)P4 is 
relatively expensive to purchase and InsP6 has a significantly lower affinity for the 
PKB PH domain compared to Ins(1,3,4,5)P4.22 
 
7. 4. 2 Expression of PKB 
 
The PKB PH domain was expressed as a GST-fusion protein. The pGEX plasmid 
expression vector containing the sequence for the PKB PH domain (kindly donated by 
the Woscholski group) was tranformed into E.coli (strain DH5!). The E.coli were 
then grown on LB plates containing ampicillin at 37°C for 16 h. Colonies were 
transferred to LB media containing ampicillin, and grown for approximately 20 hours 
at 37°C, until reaching a mid-log phase. Expression of the GST-tagged PKB PH 
domain was then induced with 1mM IPTG for 24 hours at 23°C. The cells were then 
harvested and the pellet stored at -20°C. The cells were resuspended in lysis buffer 
containing 50 mM Tris (pH 7.4), 1% Triton X-100, 2 mM EDTA, 10 mM 
benzamidine hydrochloride, 100 µg ml
–1
 soybean trypsin inhibitor, 2 mg ml-1 
lysozyme, 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride, and 2 mM 
DTT. The cell suspension was stirred at 4°C for 1 hour and then sonicated, 
homogenised and centrifuged at 11500 rpm at 4°C for 1 hour. The supernatant was 
loaded onto a glutathione sepharose column at 4°C, which was pre-equilibrated with 
50mM Tris (pH 7), 140 mM NaCl, 2.7 mM KCl. After loading, the column was 
washed with: 
• 50 mM Tris (pH 7.4), 140 mM NaCl, 2.7 mM KCl, 1% Triton and 2 mM 
DTT.  
• Followed by 50 mM Tris (pH 7.4), 140 mM NaCl, 2.7 mM KCl and 2 mM 
DTT.  
• And finally 50 mM Tris (pH 7.4), 500 mM NaCl, 2.7 mM KCl, and 2 mM 
DTT.  
 
The GST-tagged protein was eluted with 50 mM Tris (pH 7.4), 20 mM reduced 
glutathione, 250 mM NaCl and 2 mM DTT. The eluted protein was concentrated at 
4°C and 2000 rpm. For a more detailed explanation of the expression protocol please 
refer to section 9.2 in the Materials and Methods chapter. 
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Sodium dodecyl sulfate (SDS) – polyacrylamide gel (PAGE) was used to confirm that 
a protein of the correct size was isolated, Figure 45. Protein concentration was 
determined using the Bradford assay. Further details of this protocol are provided in 
section 9.4 in the Materials and Methods chapter. 
 
 
 
Figure 45: 10% SDS-PAGE gel for the eluted PKB PH domain, visualised by Coomassie Blue 
staining. Further details are provided in Materials and Methods, section 9.3. A band is clearly shown at 
around 40 kDa for the GST-tagged PKB PH domain. 
 
 
7. 4. 3 Protein Lipid Overlay (PLO) Assay 
 
A protein lipid overlay assay (also referred to as a dot blot assay) is a biochemical 
technique used to identify proteins that bind to lipid ligands. In a PLO assay, lipids 
are spotted onto a nitrocellulose membrane. This membrane is then incubated with a 
chosen protein possessing an epitope tag. After an incubation period, the protein 
bound to the lipid is then detected by immunoblotting with an antibody that 
recognises the epitope tag. 
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PLO assays have also been used widely in the Woscholski group to study multiple 
systems.183 This technique can provide information about the relative affinity of a 
protein for various lipids, or various proteins for a particular lipid.184 The PLO assay 
can also be adapted for competition-based studies. Here, the ability of a ligand to 
inhibit binding of the chosen protein to the immobilised lipid is detected. This has 
previously been applied by Miao et al. who have used a competitive PLO assay to 
illustrate the inhibitory effect of PIT-1 (a non-inositol based inhibitor) on the PKB PH 
domain binding to PtdIns(3,4,5)P3.185  
 
Advantages of the PLO assay include a) its simplicity and b) that it requires only a 
small amount of protein and lipid. It is therefore significantly cheaper than many 
other biochemical techniques. This assay has previously been used to assess the 
selectivity of different PH domains for phosphoinositides.23 Additionally it has been 
applied to determine the relative affinity of different PKB PH domain mutants for 
PtdIns(3,4,5)P3 and PtdIns(3,4)P2.23, 26 It was therefore hoped that the PLO assay 
would be suitable for assessing the binding of the Ins(1,3,4,5)P4 derivatives to the 
PKB PH domain, by investigating their ability to compete with PtdIns(3,4,5)P3. 
 
7. 4. 3. 1 General Method 
 
The basic PLO method applied in this work is described below. Any adaptations 
made to this protocol are detailed where appropriate. 
 
PtdIns(3,4,5)P3 (di-C16) was diluted in a solution of methanol, chloroform and water 
(in the ratio 2:1:0.8) to the desired lipid concentration. 2 µl aliquots of the lipid 
solution were then spotted onto Hybond-C extra membrane and allowed to dry for 
1 hour at room temperature. After drying, the membrane was incubated with blocking 
buffer [50mM Tris-HCl, pH 7.5, 150mM NaCl, 0.1% (v/v) Tween 20 and 2 mg ml-1 
fatty-acid-free BSA] for 1 hour at room temperature. The membrane was then 
incubated with the GST-tagged PKB PH domain in blocking buffer for 1 hour. The 
membrane was washed three times over 45 minutes in TBST [50mM Tris-HCl, 
pH7.5, 150mM NaCl and 0.1% (v/v) Tween 20], and then incubated with a 1:5000 
dilution of anti-GST horseradish-peroxidase (HRP) conjugate in TBST for 1 hour. 
The membrane was washed as before. For all incubation and washing stages, the 
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solution was gently agitated. The GST-tagged PKB PH domain bound to the 
membrane was detected by enhanced chemiluminescence. The following detector 
solutions were used in combination with the Fujifilm LAS-300 Imaging System: 5ml 
of detection solution 1 (2.5mM luminol, 400 µM p-coumaric acid, 100 mM Tris-HCl, 
pH 8.5), added to 5ml of detection solution 2 (100mM Tris-HCl, pH 8.5), and 3.1 µl 
of H2O2. 
 
7. 4. 3. 2 Linearity Tests  
 
Before investigating the effect that the inositol phosphate derivatives have on the 
PKB PH domain binding to PtdIns(3,4,5)P3, the PLO assay was calibrated. Binding of 
the GST-tagged PKB PH domain to increasing concentrations of PtdIns(3,4,5)P3 was 
investigated. Figure 46 illustrates the binding curve obtained with 10 nM GST-tagged 
PKB PH domain, and 0-50 µM PtdIns(3,4,5)P3. From this graph a PtdIns(3,4,5)P3 
concentration of 10 µM was chosen for future experiments as it is within the linear 
region of the graph and shows a strong signal/intensity. 
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Figure 46: Effect of increasing the concentration of PtdIns(3,4,5)P3 on the intensity of the 
chemiluminescent signal in the PLO assay. This chemiluminescent signal represents the amount of 
GST-tagged PKB PH domain bound to PtdIns(3,4,5)P3 on the nitrocellulose membrane. The 
concentration of the PKB PH domain used in this assay is 10 nM. Values are the mean of 3 repeats. 
Error bars illustrate the standard deviation between these repeats. Graph was produced using GraFit.186  
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Binding of different concentrations of the GST-tagged PKB PH domain to 10 µM 
PtdIns(3,4,5)P3 was then tested. Figure 47 illustrates the binding curve obtained with 
10 µM PtdIns(3,4,5)P3, and 0-200 nM GST-tagged PKB PH domain. A concentration 
of 50 nM for the GST-tagged PKB PH domain was chosen for future experiments, 
again due to its strong signal within the linear region. 
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Figure 47: Effect of increasing the concentration of the GST-tagged PKB PH domain on the 
intensity of the chemiluminescent signal in the PLO assay. This chemiluminescent signal represents 
the amount of GST-tagged PKB PH domain bound to PtdIns(3,4,5)P3 on the nitrocellulose membrane. 
The concentration of PtdIns(3,4,5)P3 immobilised on the nitrocellulose membrane in this assay is 
10 µM. Values are the mean of 3 repeats. Error bars illustrate the standard deviation between these 
repeats. Graph was produced using GraFit. 
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7. 4. 3. 3 Competition-based Assays 
 
In order to carry out a competition-based PLO assay, the method in section 7.4.3.1 
was adapted slightly: The chosen competitive ligand [i.e. Ins(1,3,4,5)P4, InsP6 or an 
Ins(1,3,4,5)P4 derivative] was pre-incubated with 50 nM GST-tagged PKB PH 
domain in blocking buffer for 30 minutes prior to application to the nitrocellulose 
membrane.  
 
The competition-based assay was originally carried out with InsP6. Varying 
concentrations (10-3 to 10-8 M) of InsP6 were pre-incubated with the GST-tagged PKB 
PH domain and the protocol in section 7.4.3.1 carried out. Results from this assay are 
illustrated in Figure 48. Unexpectedly the chemiluminescent signal, detecting the 
GST-tagged PKB PH domain bound to PtdIns(3,4,5)P3, was shown to increase in a 
dose dependant manner with increasing concentrations of InsP6. This result was very 
surprising as it was expected that InsP6 would bind to the PKB PH domain and thus 
inhibit/lower the level of protein bound to the immobilised PtdIns(3,4,5)P3. However, 
the reverse effect seemed to be occurring. This same ‘reverse’ effect was also 
apparent when Ins(1,3,4,5)P4 and the inositol phosphate derivatives were applied as 
the competing ligand.  
 
To detect whether this effect was also apparent with other PH domains, the 
GST-tagged GRP1 and PLC $1 PH domains were also tested. [PtdIns(4,5)P2 instead 
of PtdIns(3,4,5)P3 was spotted for the PLC$1 assay]. However these PH domains 
illustrated the expected decrease in the chemiluminescent signal when Ins(1,3,4,5)P4 
and Ins(1,4,5)P3 were pre-incubated with the GRP1 and PLC$1 PH domains 
respectively.  
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Figure 48: Effect of increasing levels of InsP6 pre-incubated with the GST-tagged PKB PH 
domain on the intensity of the chemiluminescent signal in the PLO assay. This chemiluminescent 
signal represents the amount of GST-tagged PKB PH domain bound to PtdIns(3,4,5)P3 on the 
nitrocellulose membrane. The concentration of PtdIns(3,4,5)P3 immobilised on the nitrocellulose 
membrane in this assay is 10 µM. The concentration of the PKB PH domain used in this assay is 
50 nM. Values are the mean of 3 repeats. Error bars illustrate the standard deviation. Graph was 
produced using GraFit. 
 
 
An argument for the unusual behaviour of the PKB PH domain is that the inositol 
phosphate-based compounds are causing it to dimerise. Early experiments 
investigating PKB’s activation mechanism suggested that dimerisation of PKB’s PH 
domain was required for PKB’s autophosphorylation and self-activation.25, 187, 188 As 
PDK1 and mTORC2 are now considered responsible for PKB’s phospho-activation 
there is currently a lack of evidence for the role of PKB dimerisation. Nevertheless 
recent experiments using surface plasmon resonance spectroscopy further support the 
argument for the dimerisation of the PKB PH domain, suggesting the PH domain-PH 
domain interaction to have a nanomolar affinity.54  
 
PKB’s speculated dimerisation could increase its avidity for phosphoinositides, as 
previously reported for numerous other PH domains.189 It is possible that such 
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dimerisation could be caused/enhanced by non-specific interactions between the PKB 
PH domains and an inositol phosphate ligand at an alternative binding site to 
PtdIns(3,4,5)P3. This corresponds well with the low affinity inositol phosphate 
binding site proposed by Auguin et al. for the closely related PKB": The authors note 
that inositol phosphates might bind to an extended surface of the molecule in a non-
specific manner.190 Dimerisation of PKB’s PH domain has also been reported to be 
encouraged by the TCL-1 protein (T-cell leukemia 1).191 
 
7. 4. 3. 4 Adaptations to the Competitive PLO Assay 
 
In order to further explore if the PKB PH domain is binding to inositol phosphates in 
a non-specific manner, numerous adaptations to the PLO assay were attempted. These 
included varying the Tween and salt concentrations in the washing buffer, adding 
cellular levels of MgCl2 to the PKB PH domain solution, and using a higher level of 
fatty-acid free BSA in the blocking buffer. However these all illustrated the same 
increase in PKB PH domain bound to the immobilised PtdIns(3,4,5)P3 in the presence 
of InsP6 or Ins(1,3,4,5)P4. 
 
The in vitro behaviour of PKB binding to phosphoinositides has previously been 
shown to be strongly dependent on the buffer used.24 Although TBS buffer was 
previously applied in a competitive PLO assay of PIT-1 and the PKB PH domain, it is 
important to note that this ligand is charge neutral.185 The use of TBS, which is a 
cationic buffer, may not be suitable for studying the highly anionic inositol 
phosphate-based ligands. Therefore PBS buffer (phosphate buffered saline), which is 
anionic in nature, was investigated. PBS was also the buffer of choice for Kozikowski 
et al. for in vitro assays investigating the binding of the PKB PH domain to 
phosphatidylinositol analogues.55 
 
When PBS buffer was used in place of TBS in the PLO assay, pre-incubating the 
PKB PH domain with InsP6 or Ins(1,3,4,5)P4 no longer caused an increase in the 
chemiluminescent signal. However, the expected decrease in signal also wasn’t 
apparent even at very high concentrations (100 µM) of InsP6 and Ins(1,3,4,5)P4. The 
reason for these results, and the action of the PBS buffer on the assay, is still under 
debate. It is possible that the PBS buffer is hindering the dimerisation of the GST-
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tagged PKB PH domain caused by non-specific interactions of inositol phosphate 
ligands.  
 
Although the use of PBS buffer in the PLO assay appeared promising, the lack of 
inhibitory effect of the inositol phosphate ligands still needs to be considered. High 
concentrations of phosphoinositide lipids have previously been shown, in cases, to 
form non-specific interactions with the PKB PH domain which could not be competed 
for with an excess of inositol phosphates.192 Whilst numerous precautions to prevent 
non-specific interactions (such as increased salt and Tween in washes, increased 
fatty-acid free BSA in the blocking buffer and cellular levels of Mg2+ in the protein 
solution) were attempted, this effect may still be occurring. This theory is supported 
by the fact that pre-incubation of the GST-tagged PKB PH domain with 
PtdIns(3,4,5)P3 does illustrate the expected decrease in binding to the immobilised 
PtdIns(3,4,5)P3, Figure 49. 
 
 
 
 
 
Figure 49: Image of the chemiluminescent signal on the nitrocellulose membrane from the 
competitive PLO assay. The PKB PH domain with no competing ligand, with 100 µM 
PtdIns(3,4,5)P3, and 100 µM Ins(1,3,4,5)P4 are shown. 
 
 
In the following sections, other biochemical techniques are considered to investigate 
the interaction between the PKB PH domain and the Ins(1,3,4,5)P4 derivatives. 
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7. 4. 4 Isothermal Titration Calorimetry (ITC) 
 
Isothermal titration calorimetry (ITC) offers an alternative technique for measuring 
the affinity of the different Ins(1,3,4,5)P4 derivatives for the PKB PH domain. This 
technique is not competition-based, and therefore eliminates any problems that may 
occur due to non-specific binding of phosphoinositides that cannot be competed for.  
 
ITC is a biochemical technique that can be used to determine the binding affinity and 
stoichiometry of a complex. Additionally it can be used to determine the 
thermodynamic properties of an interaction, providing the enthalpy (*H) and entropy 
(*S) change and hence the change in Gibbs free energy (*G).193 
 
An isothermal titration calorimeter consists of two cells (a reference cell and a sample 
cell) surrounded by an adiabatic jacket. The reference cell is filled with buffer or 
water and the sample cell with the desired protein. Both cells are maintained at a 
constant temperature by thermopile/thermocouple circuits. When the ligand is titrated 
into the sample cell in precise aliquots, a temperature change is detected. This 
temperature change is measured by the time-dependant input of power required to 
maintain the temperature equilibrium between the reference and sample cells.193 
Origin software is used to analyse this data and produce a binding curve. 
 
ITC has previously been used to investigate the binding patterns of several PH 
domains.23, 27 However only two accounts of using ITC to study the PKB PH domain 
exist.194, 195 Both these studies noted difficulties in performing such experiments due 
to the relatively high concentrations of PKB PH domain required.  
 
The calculation used to assess the concentration of protein required for an ITC 
experiment is provided in equation 23. This equation relies strongly on the predicted 
binding affinity (Kd) of the complex. As the binding affinities of inositol phosphates 
for the PKB PH domain are only micromolar, a very high concentration of the PKB 
PH domain is thus required.22  
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Equation 23: Equation used to calculate the amount of protein !!"!  required for an ITC 
experiment. [Mtot] is measured in M. c is a unitless constant. The recommended value for c is between 
10 and 100.196 The value of n (the binding stoichiometry) is presumed to be 1. Kd is the dissociation 
constant in M. 
 
 
7. 4. 4. 1 Method 
 
For initial experiments InsP6 was chosen as the ligand of interest due it being readily 
available and inexpensive compared to Ins(1,3,4,5)P4 and the Ins(1,3,4,5)P4 
derivatives. 
 
Using equation 23 a concentration of 6 mg ml-1 for the PKB PH domain was decided 
upon. This concentration is equivalent to a value of 17.2 for c using the dissociation 
constant of 8.7 µM from Frech et al.’s work.22 This concentration was significantly 
higher than that applied in a previous ITC experiment for the PKB PH domain and 
Ins(1,3,4,5)P4 in which a concentration of 230 µg ml-1 PKB PH domain was used.194 
 
It was necessary that an even higher concentration (than 6 mg ml-1) of the PKB PH 
domain was obtained in the protein expression stage. This is because the PKB PH 
domain is typically stored in 50% glycerol to prevent it denaturing during the 
freeze-thaw cycle. Additionally for the ITC experiment the PH domain should be 
diluted to give as low a volume of glycerol as possible. This is because glycerol is 
viscous in nature and hence can affect mixing.197, 198 
 
In order to obtain a high concentration of the PKB PH domain, a new aliquot was 
expressed. The same protocol in section 7.4.2 was carried out with an additional stage 
of buffer exchange and concentration. The GST-tagged PKB PH domain was 
transferred from the Tris pH 7.4 buffer into 25 mM MOPS, pH 6.8, 100 mM NaCl 
and 1 mM DTT using a spin concentrator. Unfortunately in concentrating the protein, 
insolubility issues arose. A significant amount of the expressed protein was seen to 
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crash out of the solution. However a sizeable amount was retrieved, and shown to be 
active using PLO assays. 
 
Titrations were performed at 25°C using the MicroCal VP-ITC MicroCalorimeter. 
For the ITC experiment the PKB PH domain was diluted to a concentration of 
6 mg ml-1 in 25 mM MOPS, pH 6.8, 100 mM NaCl, 1 mM DTT and placed in the 
calorimeter cell. Sequential 10 µl aliquots of InsP6 were injected under computer 
control to cover a range of InsP6:PKB PH domain molar ratios of 0:1 to 5:1. A control 
experiment for the heat of dilution of InsP6 into buffer was performed separately and 
the data corrected accordingly. Data was analysed using the Origin software 
(OriginLab, Northampton, MA). [Note, the first few points of Figure 50 may be 
ignored, as they are known to give spurious results due to mixing.199] 
 
7. 4. 4. 2 Results and Discussion 
 
Although a high concentration of the PKB PH domain was used in the experiments 
the signal due to binding was still weak, Figure 50. This could be due to multiple 
reasons, a few of which include: the concentration of the PKB PH domain still being 
too low (or a higher proportion was denatured than expected), the predicted binding 
affinity for InsP6 being incorrect, or the temperature the experiment was carried out at 
being too high.  
 
As there are numerous potential reasons this experiment was unsuccessful, and 
multiple parameters that could be adapted, it was decided that ITC was not a suitable 
technique to use in this work. This is mainly due to the fact that for each experiment 
(at the current concentration of PKB PH domain used) approximately 12 mg of GST-
tagged PKB PH domain is required. Therefore to assess the numerous parameters 
mentioned, vast amounts of protein would be required.  
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Figure 50: InsP6 injected into 25 mM MOPS, pH 6.8, 100 mM NaCl, 1 mM DTT buffer 
containing GST-tagged PKB PH domain. Initial concentration of the PKB PH domain was 
6 mg ml-1. InsP6 was injected in sequential aliquots (10 µl) to cover a range of InsP6:PKB PH domain 
molar ratios from 0:1 to 5:1. 
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7. 4. 5 Intrinsic Tryptophan Fluorescence Spectroscopy 
 
Intrinsic tryptophan fluorescence spectroscopy provides another option to assess the 
binding affinity of inositol phosphate derivatives for the PKB PH domain. This 
technique was used in the frequently referenced work of Frech et al. in determining 
the binding affinities of a number of inositol phosphates and phosphoinositide ligands 
for the PKB PH domain.22  
 
Tryptophan’s intrinsic fluorescence allows it to act as a probe of the conformational 
state of a protein. The binding affinity of a ligand for a protein can therefore be 
calculated for systems in which the protein: a) changes conformation upon binding 
the ligand and, b) that a tryptophan residue is suitably placed in the protein so that it 
also experiences a shift in environment. 
 
The technique essentially works by exciting the tryptophan residue/s at a wavelength 
in the range of 290-305 nm and measuring the resulting fluorescence at around 
345 nm using a fluorescence spectrometer. As tryptophan’s fluorescence parameters 
are particularly sensitive to its surrounding environment, a change in fluorescence 
intensity is detected. 
 
In this work a GST-tagged PKB PH domain was expressed. The presence of multiple 
tryptophan residues in the GST tag could result in the binding data being impaired. 
For this reason other biochemical techniques were first considered, as removal of the 
GST tag has proved difficult in regards to the stability of the PKB PH domain.194 
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7. 4. 6 Enzyme-Linked ImmunoSorbant Assay (ELISA) 
 
A competitive ELISA is typically used to determine the competitive binding of 
antigens to an antibody. This protocol has been adapted slightly herein to investigate 
the competitive binding of PtdIns(3,4,5)P3 and inositol phosphate derivatives to the 
GST-tagged PKB PH domain.  
 
In this protocol PtdIns(3,4,5)P3 is coated onto a well plate. Meanwhile the 
GST-tagged PKB PH domain is pre-incubated with an inositol phosphate derivative. 
When the pre-incubated solution is added to the well plate, the GST-tagged PKB PH 
domain is forced to compete between the inositol phosphate derivative and 
PtdIns(3,4,5)P3. The amount of GST-tagged PKB PH domain bound to 
PtdIns(3,4,5)P3 on the well plate is detected using an HRP-conjugated GST antibody 
and a TMB (3,3+,5,5+-Tetramethylbenzidine )-based detector solution. TMB acts as a 
substrate for HRP, causing a colour change in the well by producing a bright blue 
signal. This is illustrated in Figure 51. 
 
 
 
Figure 51: A schematic representation of the ELISA assay carried out in this work. For ease of 
visualisation the competing inositol phosphate derivative is not included in this diagram. 
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7. 4. 6. 1 Linearity Tests 
 
Before investigating the effect the inositol phosphate derivatives have on the PKB PH 
domain binding to PtdIns(3,4,5)P3, the assay was first calibrated to determine 
optimum concentrations of the PKB PH domain and PtdIns(3,4,5)P3.  
 
7. 4. 6. 1. 1 Method 
 
The desired concentration/s of PtdIns(3,4,5)P3 (diC16) was added to each well of a 
96-well Thermo Scientific Nunc MultiSorpTM plate and incubated overnight at 4°C. 
After incubation, the wells were washed with PBS 3 times over 15 minutes. The well 
plate was then blocked with 3% (w/v) fatty-acid-free BSA in PBS for 1.5 hours at 
37°C and washed as before. The GST-tagged PKB PH domain (at the desired 
concentration/s) was added to the well plate for 1 hour at room temperature. The well 
plate was washed as before and then incubated with an HRP-conjugated GST 
antibody at a 1:2000 dilution for 1 hour. The plate was washed 3 times over 15 
minutes with PBST (0.1% Tween 20) and subsequently 3 times over 15 minutes with 
PBS. Detergent was only included after incubation of the final reactant as 
recommended by Esser.200 Following these washes a TMB-based substrate from Frey 
et al. was added to the wells for detection, and allowed to develop for 30 minutes in 
darkness.201 After 30 minutes, a stop solution of 1M H2SO4 was added to the wells 
and the plate was read at an absorbance of 450 nm.  
 
7. 4. 6. 1. 2 Results 
 
Binding of the GST-tagged PKB PH domain to increasing concentrations of 
PtdIns(3,4,5)P3 was investigated. Figure 52 illustrates the binding curve obtained with 
2 nM GST-tagged PKB PH domain, and 0-5 µM PtdIns(3,4,5)P3. From this graph a 
PtdIns(3,4,5)P3 concentration of 1 µM was chosen for future experiments as it is 
within the linear region.  
 
Different concentrations of the GST-tagged PKB PH domain were then investigated 
binding to 1 µM PtdIns(3,4,5)P3. Figure 53 illustrates the binding curve obtained with 
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1 µM PtdIns(3,4,5)P3, and 0-32 nM GST-tagged PKB PH domain. A concentration of 
3 nM for the GST-tagged PKB PH domain was chosen for future experiments. 
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Figure 52: Effect of increasing the concentration of PtdIns(3,4,5)P3 on the intensity of the 
detected signal in the ELISA assay. This signal represents the amount of GST-tagged PKB PH 
domain bound to PtdIns(3,4,5)P3 on the well plate. The concentration of the PKB PH domain used in 
this assay is 2 nM. Values are the mean of 3 repeats. Error bars illustrate the standard deviation. Graph 
was produced using GraFit. 
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Figure 53: Effect of increasing the concentration of the GST-tagged PKB PH domain on the 
intensity of the signal in the ELISA assay. This signal represents the amount of GST-tagged PKB PH 
domain bound to PtdIns(3,4,5)P3 on the well plate. The concentration of PtdIns(3,4,5)P3 coated on the 
well plate in this assay is 1 µM. Values are the mean of 3 repeats. Error bars illustrate the standard 
deviation. Graph was produced using GraFit. 
 
 
7. 4. 6. 2 Optimisation of the ELISA assay 
 
Multiple considerations were made in the ELISA assay in order to optimise the 
signal-to-noise ratio. These included varying blocking times and washes for the well 
plate, determining the optimum dilution of the HRP-conjugated GST antibody and 
considering different TMB-based detector solutions. The final assay decided upon in 
this work for the competition-based assays is provided in section 7.4.6.3.1. 
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7. 4. 6. 3 Competitive ELISA assays with the Ins(1,3,4,5)P4 Derivatives 
 
7. 4. 6. 3. 1 Method 
 
A 50 µl solution of 1 µM PtdIns(3,4,5)P3 (diC16) was added to each well of a 96-well 
Thermo Scientific Nunc MultiSorpTM plate and incubated overnight at 4°C. After 
incubation, the wells were washed with PBS 3 times over 15 minutes. The well plate 
was then blocked with 3% (w/v) fatty acid-free BSA in PBS for 1.5 hours at 37°C and 
washed as before. The GST-tagged PKB PH domain (3nM) was pre-incubated in PBS 
with the desired Ins(1,3,4,5)P4 derivative for 30 minutes, and then added to the well 
plate for 1 hour at room temperature. Seven concentrations (ranging from 0 µM to 
100 µM) of each derivative were each pre-incubated with the GST-tagged PKB PH 
domain. The well plate was washed as before and then incubated with an 
HRP-conjugated GST antibody at a 1:2000 dilution for 1 hour. The plate was washed 
3 times over 15 minutes with PBST (0.1% Tween 20) and subsequently 3 times over 
15 minutes with PBS. Detergent was only included after incubation of the final 
reactant as recommended by Esser.200 Following these washes a TMB-based substrate 
from Frey et al. was added to the wells for detection, and allowed to develop for 30 
minutes in darkness.201 After 30 minutes, a stop solution of 1M H2SO4 was added to 
the wells and the plate was read at an absorbance of 450 nm.  
 
7. 4. 6. 3. 2 Results 
 
After carrying out the linearity tests, preliminary competition-based assays with 
Ins(1,3,4,5)P4 and InsP6 were attempted. In these preliminary assays the ligands were 
shown to compete with the immobilised PtdIns(3,4,5)P3 for the GST-tagged PKB PH 
domain in a dose-dependant manner. It was therefore decided that this assay would be 
suitable to test the relative affinities of the Ins(1,3,4,5)P4 derivatives.  
 
The protocol detailed in section 7.4.6.3.1 was carried out using seven different 
concentrations of Ins(1,3,4,5)P4 and the Ins(1,3,4,5)P4 derivatives. The seven 
concentrations (ranging from 0 µM to 100 µM) of the derivatives were each 
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investigated in three independent experiments. Within each independent experiment, 
three repeats were carried out.  
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Figure 54: ELISA competitive binding assay for the Ins(1,3,4,5)P4 derivatives. Percent of control 
represents the amount of PKB PH domain bound to PtdIns(3,4,5)P3 on the well plate for the given 
sample as a percentage of the amount of PKB PH domain bound to PtdIns(3,4,5)P3 on the well plate for 
the control (i.e. with no competing ligand/derivative). Competition binding curves for compounds D-3-
O-Sulfamoyl-myo-Ins(1,4,5)P3 (3S), D-myo-Ins(1,4,5)P3-3-O-methylphosphate ester (3M), D-5-O-
Sulfamoyl-myo-Ins(1,3,4)P3 (5S), D-myo-Ins(1,3,4)P3-5-O-acetamidoethylphosphate ester (5A) and D-
myo-Ins(1,3,4,5)P4 (IP4). Values are the mean of 3 independent experiments, results for which are 
provided in section S.12 in the Electronic Supplementary Information. Error bars illustrate the standard 
deviation between the 3 independent experiments. 
 
 
Results for these experiments are shown in Figure 54. Unfortunately due to the 
significant variability in the results (discussed shortly), only qualitative analysis of the 
data has been carried out.  
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Figure 54 illustrates a pattern in the relative affinities/inhibitory behaviour of the 
Ins(1,3,4,5)P4 derivatives for the PKB PH domain. Reassuringly, this same pattern is 
apparent at almost all concentrations. The 3-position sulfamate ester 3S is shown to 
be the weakest binding derivative at all concentrations. Conversely the 5-position 
acetamidoethylphosphate ester 5A is shown to be the strongest. Between these, the 
3-position methylphosphate ester 3M, the 5-position sulfamate ester 5S and 
Ins(1,3,4,5)P4 all illustrate similar affinity for the PKB PH domain. In general, the 
3-position methylphosphate ester binds to the PKB PH domain with a slightly weaker 
affinity than Ins(1,3,4,5)P4, and the 5-sulfamate ester a slightly stronger affinity.  
However, variation in these results makes it difficult to draw a clear conclusion here. 
 
Many of the derivatives [and Ins(1,3,4,5)P4] appear to show a slight decrease in 
affinity/inhibition at a concentration of 100 µM. Interestingly this effect is also 
apparent in Mahadevan et al.’s results when using a competitive ELISA assay to 
study the binding of non-inositol based compounds to the PKB PH domain.202 The 
reason for this effect is uncertain, and may just be an artefact of the assay. 
Alternatively precipitation of the ligand at high concentrations could be occurring. 
 
As mentioned, unfortunately the results illustrate a significant amount of variation. 
This can partly be explained by the fact that stock solutions were not made up of the 
derivatives, due to the reported instabilities of these ligands in solution for long 
periods of time by the Conway group. Additionally, the signal for the uninhibited 
PKB PH domain in this assay (after subtracting background noise) is not as high as 
one may hope (approximately 0.2 au). Therefore a small amount of variation in the 
background noise can have an effect on the data. Attempts to maximise the signal, 
whilst maintaining a low background noise, were made by investigating various 
blocking procedures, washes, well plates and detector solutions. Whilst the assay has 
been partially optimised, the use of other buffers, Mg2+, and different blocking agents 
would also be useful considerations for future work. Due to time limitations, these 
parameters were not taken into account. 
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7. 4. 7 In Vitro Phosphorylation Assay 
 
In addition to the in vitro assays detailed, additional assays were subsequently carried 
out by Mingxuan Wu and Dorothea Fiedler at Princeton University. The inhibitory 
behaviour of the Ins(1,3,4,5)P4 derivatives [and Ins(1,3,4,5)P4] was investigated by 
assessing their ability to inhibit phosphorylation of PKB on Thr308. It was 
hypothesised that the derivatives would bind to PKB and hence stabilise it in an 
inactive conformation, thus preventing its phosphorylation at Thr308 by the upstream 
kinase PDK1.203 
 
7. 4. 7. 1 Method 
 
Inactive human PKB was incubated with the Ins(1,3,4,5)P4 derivatives at two 
concentrations (625 nM and 10 µM) for 20 minutes. Following this, activated PDK1 
was then added. After a further 30 minutes, SDS loading buffer was used to quench 
the reaction. The samples were boiled for 5 minutes at 95°C and resolved by 
SDS-PAGE. After transferring onto a nitrocellulose membrane, PKB and 
phosphorylated PKB were detected by western blot analysis with PKB or 
phospho-PKB (Thr308) antibodies. Bands were quantified using ImageJ software and 
data were analysed using GraphPad Prism 5 software. For further details about the 
protocol used by the group, please refer to reference 203.203  
 
7. 4. 7. 2 Results 
 
The results of Wu and Fiedler gratifyingly illustrate the same inhibition pattern as our 
computational and in vitro results, Figure 55. Unfortunately their results for 
Ins(1,3,4,5)P4 are void, as the authors noted that their batch of this ligand was 
insoluble. We also experienced the same problem with the batch of Ins(1,3,4,5)P4 
synthesised by the Conway group, and therefore purchased this ligand from Sigma 
Aldrich for use in our assays. 
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Figure 55: Inhibition of PKB phosphorylation at Thr308 by inositol phosphate derivatives. 
Inhibition was calculated as the percent decrease in the proportion of phosphorylated PKB in the 
samples incubated with the inositol phosphate derivatives compared to the proportion in the control (in 
which PKB was incubated with water). The compounds tested include D-3-O-Sulfamoyl-myo-
Ins(1,4,5)P3 (3S), D-myo-Ins(1,4,5)P3-3-O-methylphosphate ester (3M), D-5-O-Sulfamoyl-myo-
Ins(1,3,4)P3 (5S), D-myo-Ins(1,3,4)P3-5-O-acetamidoethylphosphate ester (5A) and 
D-myo-Ins(1,3,4,5)P4 (IP4).  
 
 
In agreement with our previous findings, Wu and Fiedler’s assay illustrates that the 
5-position acetamidoethylphosphate ester 5A has the greatest inhibitory effect on the 
phosphorylation of PKB at Thr308, with approximately 70% inhibition at 625 nM. 
Additionally they also show the 3-position sulfamate-based derivative 3S to have the 
poorest inhibitory effect, with only 15% inhibition at 625 nM.  
 
Wu and Fiedler’s results further support the idea that modification at the 5-position of 
Ins(1,3,4,5)P4 is suitable and promising for the design of high affinity Ins(1,3,4,5)P4 
derivatives. As well as the strong inhibitory effect of the 5-position 
acetamidoethylphosphate ester 5A on PKB phosphorylation, the 5-position sulfamate 
ester 5S also illustrates good inhibition, with 55% inhibition at 625 nM. 
 
As suggested from our previous results, the 3-position methylphosphate ester 3M 
shows less inhibitory activity than the 5-position derivatives, with approximately 30% 
inhibition at 625 nM, but has a greater effect than the 3-position sulfamate derivative.  
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7. 5 Comparison of In Vitro and Computational Results 
 
The computational results and the two in vitro assays all illustrate a very good 
agreement. All three show that the 5-position acetamidoethylphosphate ester 5A binds 
with the strongest affinity/has the greatest inhibitory effect on PKB, and the 3-
position sulfamate ester 3S the weakest. Results for the remaining derivatives are also 
in very good agreement, with the 5-position sulfamate derivative 5S showing good 
inhibitory behaviour, and the 3-postion methylphosphate derivative 3M behaving 
very similarly to Ins(1,3,4,5)P4. 
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7. 6 Conclusion 
 
In this chapter numerous Ins(1,3,4,5)P4 derivatives were assessed for their ability to 
bind to/inhibit PKB using both computational and experimental techniques. All 
approaches showed a good agreement. This agreement not only provides further 
confidence in our computational model, but additionally provides important 
information about PKB’s binding interface.  
 
Of particular importance are the results for the 5-position derivatives. Both in vitro 
assays, as well as the computational data, show that the 5-position 
acetamidoethylphosphate ester 5A has the strongest affinity for/greatest inhibitory 
effect on PKB, of the ligands investigated. This derivative could thus potentially serve 
as a starting point for second-generation designs. Additionally, results for the 5-
position sulfamate derivative further support the argument that modification at this 
site on Ins(1,3,4,5)P4 is suitable and tolerated by the PKB PH domain. 
 
The 3-position methylphosphate ester illustrates a similar affinity to Ins(1,3,4,5)P4 in 
both the computational and experimental studies. This result informs us that adding a 
methyl moiety to the 3-position phosphate group appears to be accommodated. The 
MD simulations suggest that the small methyl group is able to fit into a pocket in the 
PKB binding site and that the only significant effect to binding is a slightly dampened 
interaction via the methoxy group. The accommodation of the methyl moiety by the 
PKB PH domain is also supported by work carried out by Elliott, which shows that 
this modification is also tolerated at the 1-position.174 
 
Results herein suggest that a sulfamate moiety is not the optimum phosphate 
bioisostere for this system if hoping to improve binding affinity. This is due to the 
fact that this system’s binding interface is highly dependant on electrostatic and 
hydrogen bond interactions. Whilst simulations show that the sulfamate group is still 
capable of forming interactions with the PKB PH domain, they are significantly 
dampened compared to those of a phosphate group. Despite this, sulfonamide-based 
compounds have previously been reported as PKB inhibitors. However these 
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compounds are not inositol-based and were shown to form numerous other 
interactions in addition to those via the sulfonamide moiety.57  
 
The computational work carried out in this chapter prompted additional questions 
about the protocol used to study this system. Firstly, the parameterisation of the 
sulfamate-based derivatives highlighted that different levels of theory may be suitable 
for the optimisation of different ligands. The idea of optimising ligands in solvent was 
also re-introduced, and should be a consideration for future studies. 
 
The simulations also highlighted the issue of sampling phase space. For the 5-postion 
acetamidoethylphosphate ester, one isomer was shown to exhibit a significantly 
higher binding affinity for the PKB PH domain compared to the other isomers. 
Additionally, different inter- and intra-molecular interactions were also apparent for 
this high affinity isomer. The different behaviour of this isomer could in fact be a true 
insight into its actions in the PKB binding site. However it is also possible that the 
system is sampling a rare event in phase space and is essentially trapped in a different 
local minimum to the other systems. Alternatively the other systems may have not 
reached an equilibrium state. To test this theory the systems were run for a further 
100 ns, however no significant changes in the free energies of binding or molecular 
behaviour were apparent. Additional computational and experimental investigations 
could assist in deciding if the binding mode illustrated for this high affinity isomer is 
true, or an artefact of the simulation. 
 
Overall this chapter has provided a large amount of information about the binding 
interface of the PKB PH domain, using a combination of computational and 
experimental techniques. The route to obtain this information has itself been useful, 
providing invaluable information about suitable computational and biochemical 
techniques to study this unique and complicated system.  
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Chapter 8 – Summary and Future Work 
 
This thesis reports the first full set of parameters for Ins(1,3,4,5)P4, Ins(1,3,4)P3 and 
Ins(1,4,5)P3, generated using a clearly defined algorithmic approach that is in-keeping 
with the Amber force field. Previous attempts at generating parameters for these 
highly charged ligands are sparse. Moreover the examples that do exist typically only 
consider one ionisation state for these molecules.62, 63, 65, 68 The Charmm force field 
has recently been extended, providing parameters for mono- and di-anionic phosphate 
groups attached to carbohydrates.61 However the use of these parameters in 
simulations of Ins(1,3,4,5)P4 with the PKB PH domain failed to capture some critical 
experimentally determined interactions, placing doubt on the quality of the 
parameters. 
 
Aside from the Charmm study mentioned above, the only other published example of 
investigating the interaction of the PKB PH domain with phosphoinositides/inositol 
phosphates using MD simulations is by Rong et al.68 Limited information is available 
from this study due to the lack of crystal structure available at the time, and the short 
time-scale of the simulations. The work herein therefore provides the first in depth 
investigation into the interaction of inositol phosphates with the PKB PH domain 
using MD simulations.  
 
We are gratified to note that our simulations support PKB’s widely accepted 
preference for 3-phosphorylated phosphoinositides.22-25 In addition to supporting 
experimental findings, our MD simulations capture subtle structural movements and 
behaviour that are not apparent from the crystal structure. Perhaps most notably, the 
simulations help to rationalise the relatively high affinity of Ins(1,4,5)P3 for the PKB 
PH domain by illustrating a different binding mode to that previously presumed.22  
 
MD simulations of the E17K PKB PH domain help explain this mutant’s increased 
affinity for the plasma membrane, and hence its affiliation with a number of human 
cancers.29 The simulations illustrate that this mutant has an increased affinity for the 
head-group of PtdIns(4,5)P2 [and PtdIns(3,4,5)P3], as has been hypothesised from 
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experimental work.164 The atomic level view provides reasoning for this, indicating 
interactions of Lys17 with phosphate group 5 to be mainly responsible.  
 
Information from the simulations mentioned was used to assist in the design of 
inositol phosphate derivatives to target the PKB PH domain. We aimed to design a 
high affinity derivative that would prevent PKB’s recruitment to the plasma 
membrane and hence its subsequent phosphorylation and activation. Whilst a similar 
approach has been attempted by others, there has been limited success in this area.54, 
159 Herein MD simulations have allowed a number of derivatives to be rapidly 
screened, without requiring the time-consuming and expensive synthesis of such 
compounds. Both computational and experimental data suggest a 5-position 
derivative with an increased affinity/inhibitory behaviour for the PKB PH domain, 
compared to Ins(1,3,4,5)P4, has been successfully designed. 
 
Additional considerations for adapting and building upon this thesis are discussed in 
the following sections. 
 
8. 1 Inositol Phosphate Parameters 
 
The parameters developed herein provide a basis to study the broad range of 
interactions that inositol phosphates are involved in. The atomic level view that MD 
simulations afford can help us understand these interactions in greater detail, 
providing assistance to experimental investigations. Particularly relevant applications 
include studying the interaction of these ligands with PDK1, which is also involved in 
the PI3K pathway. PDK1 has a lysine residue at a similar position to that of the E17K 
PKB mutant.204 It would therefore be interesting to determine if PDK1’s increased 
affinity for PtdIns(3,4,5)P3 compared to PtdIns(3,4)P2 is due to this residue.29  
 
Whilst not detailed herein, we have also applied the inositol phosphate parameters to 
study their interactions with InsP3R (inositol tris-phosphate receptor). InsP3R acts as 
Ca2+ release channel activated by Ins(1,4,5)P3. Results from these simulations are in 
good agreement with what is experimentally known, providing further validation of 
the inositol phosphate parameters. 
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8. 2 Parameterisation of Phosphoinositide Lipids 
 
Inositol phosphate parameters are useful for understanding the interactions of their 
parent phosphoinositide lipids. Whilst interactions of phosphoinositide lipids are 
primarily mediated via their head-groups, contacts via their lipid tails are also of 
importance. This has previously been illustrated by the different binding modes of 
PtdIns(4,5)P2 and its head-group Ins(1,4,5)P3 to the PKB PH domain. Other lipids 
within a bilayer are also believed to provide additional contacts with many PH 
domains, in order to supplement their interaction with phosphoinositide lipids.65, 66  
 
To investigate lipid-binding proteins in a native membrane environment, parameters 
for lipids need to be generated for the Amber force field. During my PhD, I also 
attempted to generate charge parameters for the phosphoinositide lipids 
PtdIns(3,4,5)P3, PtdIns(3,4)P2 and PtdIns(4,5)P2. Again all physiological ionisation 
states were considered. Unfortunately there were a number of issues with optimising 
the geometry of these compounds using the DFT-B3LYP method. The HF level of 
theory was therefore applied. The HF level of theory has also been used in previous 
attempts to generate charge parameters for PtdIns(4,5)P2.62, 63 As these calculations 
were extremely time consuming, a complete set of optimised geometries and 
generated parameters were not obtained for these lipids. However, this work will be 
continued within the Gould group. 
 
During a two month visit to Ross Walker’s group in San Diego, I also helped in the 
development of other lipid parameters.205 Members of both the Gould and Walker 
groups are now focusing on parameterising an Amber lipid force field.205, 206 These 
parameters will not only allow the investigation of membrane docking proteins, but 
additionally the behavior of membrane proteins, mixed lipid bilayers and the possible 
existence of lipid rafts, amongst many others applications. 
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8. 3 Full PKB Simulations 
 
Whilst carrying out my PhD, PKB’s PH and kinase domains were co-crystallised for 
the first time.28 Although this crystal structure was not applied in our simulations, it 
would be of great interest for future studies. Given the current advances in 
computational speed, with GPU accelerated calculations, it is a perfect time to study a 
system of this size (approximately 430 amino acids, and 40,000 atoms when solvated 
with 8 Å of explicit water). The simulation of both domains could provide critical 
information about their binding interface and mechanism of action. Additionally the 
study of both domains may also be of interest for investigating the E17K PKB mutant, 
as Glu17 has been proposed to interact with residues on PKB’s kinase domain in its 
inactive conformation.28 
 
8. 4 Selectivity of Ins(1,3,4,5)P4 Derivatives 
 
In Chapter 7, a number of Ins(1,3,4,5)P4 derivatives were screened for their ability to 
bind to the PKB PH domain using both experimental and computational techniques. 
These approaches led to the discovery of an Ins(1,3,4,5)P4 derivative with a proposed 
increased affinity for the PKB PH domain compared to Ins(1,3,4,5)P4. It would 
therefore be of great interest to test these ligands against the E17K PKB PH domain, 
as well as other closely related kinases to determine its selectivity.  
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8. 5 Conclusion 
 
The work described in this thesis provides a platform upon which other studies can 
now be based. The information obtained about the PKB PH domain-inositol 
phosphate binding interface will aid in future attempts to target this system. The 
importance of such information should not be understated, as targeted PKB 
therapeutics are currently of great interest. 54, 57, 159, 202 PKB plays a key role in one of 
the most frequently activated proliferation pathways in cancer (the PI3K pathway), 
yet currently no PKB-targeted drugs have reached the market.  
 
In addition to providing information about the PKB PH domain and its interactions, 
this thesis also provides parameters for members of the inositol phosphate family. 
This family of ligands are involved in a number of critical cellular activities.207 Whilst 
their interaction with the PKB PH domain has been assessed herein, these parameters 
also provide the opportunity to obtain an atomic level view of other important 
interactions that have yet to be explored. 
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Chapter 9 – Materials and Methods 
 
9. 1 General 
 
Reagents were obtained from GE Healthcare® unless stated otherwise. Ultrapure 
laboratory water was obtained from MilliQ® Millipore water purification systems. 
Ins(1,3,4,5)P4, Ins(1,4,5)P3 and InsP6 were purchased from Echelon® and 
PtdIns(3,4,5)P3, PtdIns(3,4)P3 and PtdIns(4,5)P3 from Sigma Aldrich® (C16, sodium 
salt). 
 
9. 2 Protein Expression 
 
DH5! E.coli cells were removed from the -80°C freezer and put immediately on ice. 
0.5 µl of the pGEX plasmid expression vector containing the sequence for the PKB 
PH domain (kindly donated from the Woscholski group) was added to the cells, and 
incubated on ice for 30 minutes. After 30 minutes, the cells were heat-shocked for 90 
seconds at 42°C and then put back on ice for two minutes. Under sterile conditions, 
the E.coli cells were spread onto an agar plate containing ampicillin and incubated at 
37°C for 16 hours.  
 
The plate was removed from the incubator and stored at 4°C. Under a sterile 
environment, 10 ml of lysogeny broth (LB) media was added to a sterile 50 ml falcon 
tube. 10 µl of ampicillin was added to the 10 ml of LB media. A colony from the agar 
plate was picked with a P2 pipette tip and released into the falcon. Cells were grown 
at 37°C for 16 hours, with shaking.  
 
Under a sterile environment, 1 ml of ampicillin was added to 1 l of LB media in an 
Erlenmeyer flask. The 10 ml of culture grown for 16 hours was added to the 1 l of LB 
media and grown for a further 3-5 hours at 37°C, with shaking. The OD (optical 
density) was checked regularly. At an OD between 0.6 and 0.7 (mid-log phase of 
bacterial growth), protein expression was induced with IPTG (1mM final 
concentration) and fresh ampicillin (1 ml), for 24 hours at 23°C. 
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Cells were harvested by centrifugation at 4600 rpm at 4°C for 15 minutes. The cells 
were resuspended in 60 ml of lysis buffer containing 50 mM Tris (pH 7.4), 1% Triton 
X-100, 2 mM EDTA, 10 mM benzamidine hydrochloride, 100 µg ml
–1
 soybean 
trypsin inhibitor, 2 mg ml-1 lysozyme, 1 mM 4-(2-aminoethyl)benzenesulfonyl 
fluoride hydrochloride, and 2 mM DTT. The cell suspension was stirred at 4°C for 
1 hour and then sonicated (5 x 1 minute). The cell suspension was then manually 
homogenised until no longer viscous, followed by centrifugation at 11500 rpm at 4°C 
for 1 hour, ensuring the supernatant was clear. 
 
The glutathione sepharose column was pre-equilibrated with 50mM Tris (pH 7.4), 
140 mM NaCl, 2.7 mM KCl.  The column was washed twice with this equilibrating 
buffer, with each wash totalling a volume of 30 ml. The supernatant was then filtered 
through a 0.45 µm syringe filter and loaded onto the column. After loading, the 
column was washed: 
 
• Twice with 50 mM Tris (pH 7.4), 140 mM NaCl, 2.7 mM KCl, 1% Triton 
and 2 mM DTT (each wash equaling a total volume of 20 ml) 
• Twice with 50 mM Tris (pH 7.4), 140 mM NaCl, 2.7 mM KCl and 2 mM 
DTT (each wash equaling a total volume of 20 ml) 
• Twice with 50 mM Tris (pH 7.4), 500 mM NaCl, 2.7 mM KCl, and 2 mM 
DTT (each wash equaling a total volume of 20 ml) 
 
After washing, 10 ml of elution buffer [50 mM Tris (pH 7.4), 20 mM reduced 
glutathione, 250 mM NaCl and 2 mM DTT] was added to the beads and incubated 
overnight. The eluted protein was collected in small fractions and concentrated at 4°C 
and 2000 rpm.  
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9. 3 SDS PAGE 
 
SDS PAGE gels were cast with the following compositions: 
 
Table 17: Components for 10% running gel 
 
 
 
 
 
 
 
 
Table 18: Components for 5% stacking gel 
 
 
 
 
 
 
 
 
The GST-tagged PKB PH domain was diluted in distilled water to concentrations of 
0.5 and 1.0 mg ml-1. 4 µl of 0.5 mg ml-1 GST-tagged PKB PH domain was added to 
4 µl SDS loading buffer (total 2 µg of protein). 10 µl of 1.0 mg ml-1 GST-tagged PKB 
PH domain was added to 10 µl SDS loading buffer (total 10 µg of protein). Both 
aliquots of the GST-tagged PKB PH domain in SDS loading buffer were incubated at 
95°C for 5 minutes, and then on ice for 5 minutes. Each aliquot was then loaded into 
separate wells of the gel. Molecular weight calibration was achieved by loading 2.5 µl 
of Prism Ultra Protein Ladder (10-245 kDa) from abcam®. Gels were run at 150 V in 
electrophoresis running buffer. The components of the SDS loading buffer, and 
electrophoresis running buffer are detailed below. Gels were visualised using 
Coomassie Blue Staining. The gel was stained with Coomassie blue solution 
overnight with agitation and then destained for an hour with distilled water. 
 
 
 
 
 
Component Volume 
Distilled H2O 8.2 ml 
30% Acrylamide/Bis acrylamide 6.6 ml 
1.5 M Tris-HCl pH 8.8 5 ml 
10% w/v Sodium dodecyl sulfate (SDS) 200 µl 
10% w/v Ammonium persulfate (APS) 100 µl 
Tetramethylethylenediamine (TEMED) 10 µl 
Component Volume 
Distilled H2O 5.7 ml 
30% v/v Acrylamide/Bis  1.7 ml 
0.5 M Tris-HCl pH 6.8  2.5 ml 
10% w/v Sodium dodecyl sulfate (SDS) 100 µl 
10% w/v Ammonium persulfate (APS) 50 µl 
Tetramethylethylenediamine (TEMED) 10 µl 
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Table 19: SDS loading buffer and SDS electrophoresis running buffer compositions. 
 
SDS loading buffer 62.5 mM Tris-HCl, pH 6.8, 2% w/v SDS, 10% v/v glycerol, 50 mM 
DTT, 0.01% w/v bromophenol blue. 
SDS electrophoresis running 
buffer 
25 mM Tris, 192 mM glycine, and 0.1% SDS. 
 
 
9. 4 Bradford Assay 
The Bradford assay was used to determine protein concentration. 200 µl of Bradford 
reagent was added to 20 µl of eluted protein (at varying dilutions) on a 96 well-plate. 
The absorbance of each well at 595 nm was read using a spectrophotometer. An ideal 
absorbance is between 0.5 and 1, as the assay is only linear over a short range of 
concentrations (typically 2-1500 µg ml-1 of protein). Measurements were made at 
varying dilutions of the protein to allow the concentration of the eluted protein to be 
accurately determined. The concentration of the eluted protein was calculated from 
the following equation: 
 ! ! ! ! !!!!"#!!!"#  
 
Equation 24: Calculating the concentration of protein using the Bradford assay. The 
concentration of protein within each well ! is calculated using !. ! is the difference between the 
absorbance of the sample well and of a blank cell (i.e. 20 µl of distilled water in 200 µl Bradford 
reagent) at 595 nm. The concentration of the eluted protein (before dilution) can then be calculated by 
multiplying concentration ! by the dilution factor. 
 
 
9. 5 Buffer Solutions 
 
PBS 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4.2H2O (sodium phosphate dibasic), 
2 mM KH2PO4 (monopotassium phosphate), pH 7.4 
TBS 50 mM Tris-Cl, 150 mM NaCl, pH 7.4  
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